var title_f12_53_13136="Candidal diaper dermatitis A";
var content_f12_53_13136=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F59361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F59361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Candida diaper dermatitis in an infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 427px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous plaques and pustules are visible with scattered satellite lesions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Anthony Mancini, Children's Memorial Hospital, Chicago, IL.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13136=[""].join("\n");
var outline_f12_53_13136=null;
var title_f12_53_13137="Ectopic testes";
var content_f12_53_13137=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ectopic testes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Locations of undescended (U) and ectopic (E) testes.",
"    <div class=\"footnotes\">",
"     U1: intra-abdominal; U2: intracanalicular; U3: suprascrotal; E1: suprapubic; E2: femoral; E3: perineal; E4: contralateral.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pillai SB, Besner GE. Pediatric testicular problems. Pediatr Clin North Am 1998: 45:813. Copyright &copy; 1998 Pediatric Clinics of North America.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13137=[""].join("\n");
var outline_f12_53_13137=null;
var title_f12_53_13138="Balanitis xerotica obliterans";
var content_f12_53_13138=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F78530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F78530&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Balanitis xerotica obliterans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13138=[""].join("\n");
var outline_f12_53_13138=null;
var title_f12_53_13139="Vitiligo generalized";
var content_f12_53_13139=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F79198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F79198&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Generalized vitiligo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This patient has generalized vitiligo with extensive involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy;2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13139=[""].join("\n");
var outline_f12_53_13139=null;
var title_f12_53_13140="Fused SPECT-CT of right inguinal sentinel node";
var content_f12_53_13140=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F82528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F82528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fused SPECT-CT of right inguinal sentinel node",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 435px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Kevin Donohoe.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13140=[""].join("\n");
var outline_f12_53_13140=null;
var title_f12_53_13141="Bosentan: Patient drug information";
var content_f12_53_13141=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Bosentan: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/16/40200?source=see_link\">",
"     see \"Bosentan: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/8/21641?source=see_link\">",
"     see \"Bosentan: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F142201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tracleer&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F142202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      CO Bosentan;",
"     </li>",
"     <li>",
"      Mylan-Bosentan;",
"     </li>",
"     <li>",
"      PMS-Bosentan;",
"     </li>",
"     <li>",
"      Sandoz-Bosentan;",
"     </li>",
"     <li>",
"      Tracleer&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026811\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700696",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause liver problems in some patients. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700267",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700850",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You cannot get this drug from your pharmacy. It comes only from the company that makes it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691894",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high pressure in the lungs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701642",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to bosentan or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid or limit drinking wine, beer, or mixed drinks to less than 3 drinks a day. Drinking too much alcohol may raise your chance of liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698228",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Lung infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698088",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flushing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698249",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Muscle pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698229",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to get a woman pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697869",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698521",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a woman of childbearing age, take a pregnancy test before starting this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698519",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a woman of childbearing age, take a monthly pregnancy test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11386 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-122.72.76.133-24348CF07F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13141=[""].join("\n");
var outline_f12_53_13141=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142201\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F142202\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026811\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026813\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026812\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026817\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026818\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026820\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026815\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026816\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026821\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026822\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?39/16/40200?source=related_link\">",
"      Bosentan: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?21/8/21641?source=related_link\">",
"      Bosentan: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_53_13142="Gastric bezoars";
var content_f12_53_13142=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Gastric bezoars",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Daniel Gelrud, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Moises Guelrud, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13142/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/53/13142/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric bezoars result from the accumulation of foreign ingested material in the form of masses or concretions. Bezoars are rare, being found in less than 1 percent of patients undergoing upper gastrointestinal endoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/1\">",
"     1",
"    </a>",
"    ]. In ancient times, bezoars from animals were precious and used to cure diseases and as an antidote to poisons [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TYPES OF BEZOARS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bezoars are classified according to their composition (",
"    <a class=\"graphic graphic_table graphicRef80688 \" href=\"UTD.htm?22/50/23339\">",
"     table 1",
"    </a>",
"    ). The major types are phytobezoars, trichobezoars, and pharmacobezoars.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Phytobezoars",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phytobezoars, composed of vegetable matter, are the most common type of bezoar. The diospyrobezoar (persimmon fruit) accounts for the majority of cases. Lupini beans, used by healers to treat arthritic pain, have also formed a bezoar [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Trichobezoars",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trichobezoars, composed of hair, usually occur in young women with psychiatric disorders. Trichotillomania (hair pulling) and trichophagia (hair eating) usually precede trichobezoar formation. A small number of patients have been reported in whom the gastric trichobezoar has a long tail and extends throughout the small bowel to the cecum. This condition, known as the Rapunzel syndrome, occurs almost exclusively in young girls [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pharmacobezoars",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pharmacobezoars, composed of ingested medications, have become increasing recognized. Examples include extended release",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"     nifedipine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    , enteric-coated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , sodium alginate, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"     sucralfate",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/7-11\">",
"     7-11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bezoars composed of a variety of other substances have been described. These include milk curd, tissue paper, shellac, fungus, Styrofoam cups, cement, and vinyl gloves [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/12-15\">",
"     12-15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bezoars grow by the continuing ingestion of food rich in cellulose and other indigestible materials such as hair, cotton, and tissue paper, matted together by protein, mucus, and pectin. Properties of the specific ingested material and some degree of gastric dysfunction also contribute. Bezoar formation is rare in healthy subjects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Gastric emptying",
"    </span>",
"    &nbsp;&mdash;&nbsp;It was recognized in 1938 that most patients with bezoars had undergone gastric surgery, implying that there are underlying anatomic and functional abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/2\">",
"     2",
"    </a>",
"    ]. More recent studies have shown that 70 to 94 percent of patients have a history of gastric surgery and 54 to 80 percent have undergone vagotomy and pyloroplasty (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67436 \" href=\"UTD.htm?30/35/31295\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/16-18\">",
"     16-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It was initially thought that the most common functional abnormality found in patients with bezoars was delayed gastric emptying. However, some studies have found that many patients have normal or accelerated gastric emptying. In one series, for example, gastric emptying was studied in 10 patients who presented with bezoars 1 to 20 years after some type of gastric surgery and in operated patients without bezoars [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/19\">",
"     19",
"    </a>",
"    ]. There were no differences between the two groups in gastric emptying of Tc 99m-labeled solids at 45, 75, and 105 minutes. This implies that the pathogenesis of bezoar formation is more complex than initially thought and involves other factors such as alterations in the production of acid, pepsin, and mucus, and impairments in the grinding mechanism and the interdigestive migrating motor complex [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Specific bezoars",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of the persimmon bezoar (diospyrobezoar) is well understood. The unripe fruit contains high concentrations of a soluble tannin called shibutol, which forms a coagulum when mixed with acid (as occurs in the stomach) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/17\">",
"     17",
"    </a>",
"    ]. Many patients form diospyrobezoars without gastric dysfunction.",
"   </p>",
"   <p>",
"    Trichobezoars form in patients with trichotillomania and trichophagia. They begin as retained hairs between the gastric folds; the hair is then denatured by gastric acid, becomes black (regardless of hair color) and combines with food to form an enmeshed mass. Trichobezoars become colonized by bacteria resulting in a foul smell.",
"   </p>",
"   <p>",
"    Pharmacobezoars occur in a variety of circumstances with the major predisposing factors being gastric dysfunction and the properties of the particular drug [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/21\">",
"     21",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bowel hypoactivity, dehydration, and the concomitant use of anticholinergic agents and opiates contribute to the propensity for bezoar formation in patients with renal failure treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/16/27910?source=see_link\">",
"       aluminum hydroxide",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/29/29141?source=see_link\">",
"       Sucralfate",
"      </a>",
"      bezoars typically occur in patients with gastric outlet obstruction.",
"     </li>",
"     <li>",
"      Bezoars composed of magnesium and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/32/42504?source=see_link\">",
"       calcium carbonate",
"      </a>",
"      may be seen when compressed tablets are given to patients with achlorhydria.",
"     </li>",
"     <li>",
"      Insolubility of the carrying vehicle is the major contributing factor to bezoar formation with enteric-coated",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12377?source=see_link\">",
"       nifedipine",
"      </a>",
"      &nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The hydroscopic properties of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/26/8614?source=see_link\">",
"       psyllium",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/54/16227?source=see_link\">",
"       wheat dextrin",
"      </a>",
"      contribute to the propensity of these compounds to form bezoars.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most adults with phytobezoars are men between the ages of 40 and 50 years, while trichobezoars are typically seen in women in their 20s [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/2\">",
"     2",
"    </a>",
"    ]. Affected patients remain asymptomatic for many years, and develop symptoms insidiously. Common complaints include abdominal pain, nausea, vomiting, early satiety, anorexia, and weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/2\">",
"     2",
"    </a>",
"    ]. It is hard to distinguish symptoms attributable to bezoars from those caused by the underlying condition (eg, postgastrectomy syndromes, gastroparesis, etc). Up to 20 percent of patients continue to have symptoms despite bezoar removal [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gastrointestinal bleeding is a common presentation since there is a high association of gastric ulcers in patients with bezoars who undergo surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/2\">",
"     2",
"    </a>",
"    ]. The ulcers may be due to peptic ulcer disease or pressure necrosis. Although many bezoars become quite large, gastric outlet obstruction is an uncommon presentation.",
"   </p>",
"   <p>",
"    Bezoars have rarely been associated with a vast array of other gastrointestinal complications. These include gastrointestinal perforation, peritonitis, protein losing enteropathy, steatorrhea, pancreatitis, intussusception, dysphagia, obstructive jaundice, appendicitis, constipation, and pneumatosis intestinalis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another rare problem is drug overdose from a pharmacobezoar. One patient, for example, presented with a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    overdose due to the presence of an unrecognized bezoar containing 29 grams of theophylline, the residue of many sustained-release tablets [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/8\">",
"     8",
"    </a>",
"    ]. Another patient with an enteric coated",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    bezoar presented with salicylate toxicity after being given",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    for a radiographic study [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/9\">",
"     9",
"    </a>",
"    ]. The barium created an alkaline medium which dissolved the pharmacobezoar.",
"   </p>",
"   <p>",
"    The physical examination is unremarkable in most patients with a gastric bezoar except for an occasional abdominal mass or halitosis. Patients with trichobezoars may have patchy areas of alopecia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bezoars are usually discovered as an incidental finding in a patient with nonspecific symptoms. Abdominal radiograph with (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67436 \" href=\"UTD.htm?30/35/31295\">",
"     image 1",
"    </a>",
"    ) or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82702 \" href=\"UTD.htm?21/57/22430\">",
"     image 2",
"    </a>",
"    ), abdominal ultrasound, or CT scan may show the bezoar as mass or a filling defect [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Unlike phytobezoars which are generally impervious to barium, trichobezoars tend to absorb barium, aiding in the diagnosis.",
"   </p>",
"   <p>",
"    The current gold standard for diagnosis is upper gastrointestinal endoscopy. It provides direct visualization of the bezoar and allows sample taking and therapeutic intervention. It is important to sample the bezoar for analysis since it may be difficult to determine the composition based upon appearance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy for bezoars should be tailored to the composition of the concretion and to the underlying pathophysiologic process.",
"   </p>",
"   <p>",
"    Available treatment methods include chemical dissolution, endoscopy, and surgery. Phytobezoars may be chemically dissolved; in comparison, trichobezoars are resistant to enzymatic dissolution and must be removed with either endoscopy or surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemical dissolution should be considered for phytobezoars producing mild symptoms. It is also the most effective method when endoscopic extraction of large phytobezoars is not possible. There are no prospective studies evaluating medical treatment of phytobezoars. Many agents have been tried with success, but most trials are uncontrolled and anecdotal. The following agents have been used successfully [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cellulase &ndash; Cellulase tablets can be given with meals to degrade the cellulose and hemicellulose found in plant fiber and phytobezoars [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Papain &ndash; Papain is given in the form of Adolph's Meat Tenderizer, 1 teaspoon in 120 mL of water before each meal [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/1/20504?source=see_link\">",
"       Acetylcysteine",
"      </a>",
"      &ndash; Acetylcysteine is instilled, 15 mL in 50 mL of water, via nasogastric tube three times daily for several days [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Coca-Cola &ndash; A growing number of reports describe the successful treatment of phytobezoars using a nasogastric, or oral Coca-Cola infusion or endoscopic injection of Coca-Cola [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/29-32\">",
"       29-32",
"      </a>",
"      ]. The mechanism of Coca-Cola's action may be related to its low pH, the high",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       sodium bicarbonate",
"      </a>",
"      content, and the presence of CO2 bubbles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one study, Coca-Cola alone achieved complete bezoar bubbles dissolution of 23.5 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/32\">",
"     32",
"    </a>",
"    ]. Coca-Cola appears to be more effective in dissolving bezoars in patients with phytobezoars and pharmacobezoars [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     Metoclopramide",
"    </a>",
"    is usually used in conjunction with endoscopic mechanical fragmentation and enzymatic therapy in a dose of 10 mg orally before meals and at bedtime. In one study, nine patients treated with adjunctive therapy required a mean of 1.2 courses of endoscopic therapy while 15 patients treated with endoscopic therapy alone required 1.9 courses of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cellulase appears to be preferred over papain because of side effects associated with papain. One study reviewed existing published reports of treatment of 36 patients with phytobezoars with papain and cellulase [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/22\">",
"     22",
"    </a>",
"    ]. Papain was successful in treating 13 of 15 patients and cellulase was successful in 19 of 19. Adverse effects in the papain group included gastric ulcer and esophageal perforation while no adverse effects were reported in the patients treated with cellulase. A potential complication of successful enzymatic therapy is that dissolved bezoars may cause small bowel obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trichobezoars and diospyrobezoars are treated with endoscopic and surgical techniques. Endoscopic removal involves fragmenting the bezoar with water jet, direct suction through a large channel (6 mm) endoscope, forceps, and snares and then clearing the fragments with the endoscope, Ewald tube, or passive passage through the gastrointestinal tract [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variety of other methods have been described in case reports when the above techniques have failed including use of the Nd:YAG laser, endoscopic drills, and mechanical, electrohydraulic, extracorporeal lithotripsy, and injection of enzyme solutions or Coca Cola [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/31,36-41\">",
"     31,36-41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical removal should be considered in patients who fail medical therapy or who have complications such as obstruction and significant bleeding. Initial surgical therapy has also been recommended in bezoars composed of vinyl gloves [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/15\">",
"     15",
"    </a>",
"    ]. In such cases endoscopic removal may be difficult or impossible because the gloves become hardened and matted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal of the bezoar does not alleviate the underlying problem. Preventive therapy should be implemented to avoid a reported 14 percent recurrence rate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13142/abstract/16\">",
"     16",
"    </a>",
"    ]. Patients should be encouraged to ingest increase water intake, to appropriately alter the diet (eg, avoid persimmons and stringy vegetables), to chew food carefully, and to seek psychiatric evaluation if needed (for trichobezoars). Treating an underlying motility problem may be useful as a preventive measure in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastric bezoars result from the accumulation of foreign ingested material in the form of masses or concretions. Bezoars grow by the continuing ingestion of food rich in cellulose and other indigestible materials such as hair, cotton, and tissue paper, matted together by protein, mucus, and pectin.",
"     </li>",
"     <li>",
"      Bezoars are classified according to their composition. The major types are phytobezoars, trichobezoars, and pharmacobezoars. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Types of bezoars'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Phytobezoars, composed of vegetable matter, are the most common type of bezoar.",
"     </li>",
"     <li>",
"      Trichobezoars, composed of hair, usually occur in young women with psychiatric disorders.",
"     </li>",
"     <li>",
"      Pharmacobezoars are composed of ingested medications.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The pathogenesis of bezoar formation is complex and involves factors such as delayed gastric emptying, alterations in the production of acid, pepsin, and mucus, and impairments in the grinding mechanism and the interdigestive migrating motor complex. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Affected patients remain asymptomatic for many years, and develop symptoms insidiously. Common complaints include abdominal pain, nausea, vomiting, early satiety, anorexia, and weight loss. Gastrointestinal bleeding is a common presentation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bezoars are usually discovered as an incidental finding or in a patient with nonspecific symptoms. Abdominal radiograph with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      , abdominal ultrasound, or CT scan may show the bezoar as a mass or a filling defect. The gold standard for diagnosis is upper gastrointestinal endoscopy. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy for bezoars should be tailored to the composition of the concretion and to the underlying pathophysiologic process. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with a phytobezoar producing mild symptoms, we suggest initial treatment with cellulase (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Other agents that can aid in bezoar dissolution include papain,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/1/20504?source=see_link\">",
"       acetylcysteine",
"      </a>",
"      , and Coca-Cola.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"       Metoclopramide",
"      </a>",
"      is prescribed in conjunction with these agents.",
"     </li>",
"     <li>",
"      Trichobezoars and diospyrobezoars are treated with endoscopic and surgical techniques.",
"     </li>",
"     <li>",
"      Surgical removal should be considered in patients who fail medical therapy or who have complications such as obstruction and significant bleeding.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/1\">",
"      Kadian RS, Rose JF, Mann NS. Gastric bezoars--spontaneous resolution. Am J Gastroenterol 1978; 70:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/2\">",
"      DeBakey M, Oshner A. Bezoars and concretions. Surgery 1938; 4:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/3\">",
"      Meeroff JC, Squires PA, Grasman K. Gastric lupinoma: a new variety of phytobezoar. Am J Gastroenterol 1989; 84:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/4\">",
"      Balik E, Ulman I, Taneli C, Demircan M. The Rapunzel syndrome: a case report and review of the literature. Eur J Pediatr Surg 1993; 3:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/5\">",
"      Pul N, Pul M. The Rapunzel syndrome (trichobezoar) causing gastric perforation in a child: a case report. Eur J Pediatr 1996; 155:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/6\">",
"      Singla SL, Rattan KN, Kaushik N, Pandit SK. Rapunzel syndrome--a case report. Am J Gastroenterol 1999; 94:1970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/7\">",
"      Prisant LM, Carr AA, Bottini PB, Kaesemeyer WH. Nifedipine GITS (gastrointestinal therapeutic system) bezoar. Arch Intern Med 1991; 151:1868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/8\">",
"      Bernstein G, Jehle D, Bernaski E, Braen GR. Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation. Ann Emerg Med 1992; 21:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/9\">",
"      Bogacz K, Caldron P. Enteric-coated aspirin bezoar: elevation of serum salicylate level by barium study. Case report and review of medical management. Am J Med 1987; 83:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/10\">",
"      Reddy AN. Sucralfate gastric bezoar. Am J Gastroenterol 1986; 81:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/11\">",
"      Kaneko H, Tomomasa T, Kubota Y, et al. Pharmacobezoar complicating treatment with sodium alginate. J Gastroenterol 2004; 39:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/12\">",
"      Evans JR, Mitchell RD. Tissue paper bezoar associated with percutaneously placed gastrostomy tube. Gastrointest Endosc 1988; 34:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/13\">",
"      Perttala Y, Peltokallio P, Leivisk&auml; T, Sipponen J. Yeast bezoar formation following gastric surgery. Am J Roentgenol Radium Ther Nucl Med 1975; 125:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/14\">",
"      Visvanathan R. Cement bezoars of the stomach. Br J Surg 1986; 73:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/15\">",
"      Kamal I, Thompson J, Paquette DM. The hazards of vinyl glove ingestion in the mentally retarded patient with pica: new implications for surgical management. Can J Surg 1999; 42:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/16\">",
"      Robles R, Parrilla P, Escamilla C, et al. Gastrointestinal bezoars. Br J Surg 1994; 81:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/17\">",
"      Krausz MM, Moriel EZ, Ayalon A, et al. Surgical aspects of gastrointestinal persimmon phytobezoar treatment. Am J Surg 1986; 152:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/18\">",
"      White NB, Gibbs KE, Goodwin A, Teixeira J. Gastric bezoar complicating laparoscopic adjustable gastric banding, and review of literature. Obes Surg 2003; 13:948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/19\">",
"      Calabuig R, Navarro S, Carri&oacute; I, et al. Gastric emptying and bezoars. Am J Surg 1989; 157:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/20\">",
"      Lee J. Bezoars and foreign bodies of the stomach. Gastrointest Endosc Clin N Am 1996; 6:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/21\">",
"      Stack PE, Thomas E. Pharmacobezoar: an evolving new entity. Dig Dis 1995; 13:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/22\">",
"      Zarling EJ, Thompson LE. Nonpersimmon gastric phytobezoar. A benign recurrent condition. Arch Intern Med 1984; 144:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/23\">",
"      Chintapalli KN. Gastric bezoar causing intramural pneumatosis. J Clin Gastroenterol 1994; 18:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/24\">",
"      McCracken S, Jongeward R, Silver TM, Jafri SZ. Gastric trichobezoar: sonographic findings. Radiology 1986; 161:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/25\">",
"      Newman B, Girdany BR. Gastric trichobezoars--sonographic and computed tomographic appearance. Pediatr Radiol 1990; 20:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/26\">",
"      Holloway WD, Lee SP, Nicholson GI. The composition and dissolution of phytobezoars. Arch Pathol Lab Med 1980; 104:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/27\">",
"      Walker-Renard P. Update on the medicinal management of phytobezoars. Am J Gastroenterol 1993; 88:1663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/28\">",
"      Schlang HA. Acetylcysteine in removal of bezoar. JAMA 1970; 214:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/29\">",
"      Ladas SD, Triantafyllou K, Tzathas C, et al. Gastric phytobezoars may be treated by nasogastric Coca-Cola lavage. Eur J Gastroenterol Hepatol 2002; 14:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/30\">",
"      Kato H, Nakamura M, Orito E, et al. The first report of successful nasogastric Coca-Cola lavage treatment for bitter persimmon phytobezoars in Japan. Am J Gastroenterol 2003; 98:1662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/31\">",
"      Chung YW, Han DS, Park YK, et al. Huge gastric diospyrobezoars successfully treated by oral intake and endoscopic injection of Coca-Cola. Dig Liver Dis 2006; 38:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/32\">",
"      Lee BJ, Park JJ, Chun HJ, et al. How good is cola for dissolution of gastric phytobezoars? World J Gastroenterol 2009; 15:2265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/33\">",
"      Harikumar R, Kunnel P, Sunilraj R. Dissolution of pharmacobezoar using carbonated beverage. Indian J Gastroenterol 2008; 27:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/34\">",
"      Winkler WP, Saleh J. Metoclopramide in the treatment of gastric bezoars. Am J Gastroenterol 1983; 78:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/35\">",
"      Nomura H, Kitamura T, Takahashi Y, Mai M. Small-bowel obstruction during enzymatic treatment of gastric bezoar. Endoscopy 1997; 29:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/36\">",
"      Naveau S, Poynard T, Zourabichvili O, et al. Gastric phytobezoar destruction by Nd:YAG laser therapy. Gastrointest Endosc 1986; 32:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/37\">",
"      Benes J, Chmel J, Jodl J, et al. Treatment of a gastric bezoar by extracorporeal shock wave lithotripsy. Endoscopy 1991; 23:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/38\">",
"      Wang YG, Seitz U, Li ZL, et al. Endoscopic management of huge bezoars. Endoscopy 1998; 30:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/39\">",
"      Blam ME, Lichtenstein GR. A new endoscopic technique for the removal of gastric phytobezoars. Gastrointest Endosc 2000; 52:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/40\">",
"      Sechopoulos P, Robotis JF, Rokkas T. Gastric bezoar treated endoscopically with a carbonated beverage: case report. Gastrointest Endosc 2004; 60:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13142/abstract/41\">",
"      Gold MH Jr, Patteson TE 3rd, Green GI. Cellulase bezoar injection: a new endoscopic technique. Gastrointest Endosc 1976; 22:200.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2535 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-9E6818F356-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13142=[""].join("\n");
var outline_f12_53_13142=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TYPES OF BEZOARS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Phytobezoars",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Trichobezoars",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pharmacobezoars",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Specific bezoars",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2535\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2535|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/35/31295\" title=\"diagnostic image 1\">",
"      Gastric bezoar after gastrectomy UGI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/57/22430\" title=\"diagnostic image 2\">",
"      Gastric bezoar abdominal x-ray",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2535|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/50/23339\" title=\"table 1\">",
"      Classification of gastric bezoars",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_53_13143="Latent tuberculosis infection in children";
var content_f12_53_13143=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Latent tuberculosis infection in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Lisa V Adams, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Jeffrey R Starke, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13143/contributors\">",
"     C Fordham von Reyn, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13143/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/53/13143/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identification and treatment of children with latent tuberculosis infection (LTBI) has become an important component of tuberculosis (TB) control efforts in low incidence countries such as the United States. The goals of TB screening programs are case finding and treatment of TB disease, prevention of development of disease, and decreased transmission.",
"   </p>",
"   <p>",
"    Most children with LTBI have been infected recently (especially those younger than age five years). Children and adolescents are at higher risk for progression to TB disease (with potential for disseminated disease) than adults [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/1\">",
"     1",
"    </a>",
"    ]. Most cases of progression to TB disease occur within 2 to 12 months of initial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=see_link\">",
"     \"Microbiology and pathogenesis of tuberculosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues related to diagnosis and treatment of LTBI in children will be reviewed here. Issues related to treatment of TB disease in children are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link\">",
"     \"Tuberculosis disease in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Whom to test",
"    </span>",
"    &nbsp;&mdash;&nbsp;In countries with low incidence and sufficient resources (such as the United States), testing for latent tuberculosis infection (LTBI) in children should be targeted to specific groups at risk for LTBI",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    progression to tuberculosis (TB) disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ]. Only children who would benefit from treatment should be tested, so a decision to test presupposes a decision to treat if the test is positive.",
"   </p>",
"   <p>",
"    In general, testing for LTBI is warranted to identify individuals who are at risk of new infection, and to identify individuals at increased risk of reactivation due to associated conditions (",
"    <a class=\"graphic graphic_form graphicRef72294 \" href=\"UTD.htm?27/11/27826\">",
"     form 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Among children, the major risk factor for TB is contact with patients who have TB disease, either due to household exposure or residence in a region where TB is endemic. A child with a positive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    (TST) should prompt testing of the other siblings in the household. Additional risks include reactivation due to immunosuppressive conditions or medications. A questionnaire developed by the Pediatric Tuberculosis Collaborative Group can be used to screen children in a variety of clinical settings (",
"    <a class=\"graphic graphic_form graphicRef72294 \" href=\"UTD.htm?27/11/27826\">",
"     form 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no lower age limit for screening. The American Academy of Pediatrics advises that risk assessment (ie, questionnaire) for TB should be performed at first contact with a child and every 6 months thereafter for the first year of life (eg, at 2 weeks, 6 months, and 12 months of age) and annually thereafter, if possible [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/6\">",
"     6",
"    </a>",
"    ]. A TST should be performed if TB disease is suspected at any time. However, a negative result may not be reliable in infants younger than three months of age.",
"   </p>",
"   <p>",
"    In the absence of risk factors, LTBI testing is not indicated. There is no role for routine TST placement for children entering school, daycare, or camps. Very low rates of LTBI and TB disease have been observed in evaluation of universal school-based screening in the United States (less than 2 percent and less than 0.02 percent, respectively), so universal testing would lead to a high rate of false positive tests [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Case contacts (5 mm cutoff)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Child contacts of a patient with TB disease must be evaluated for TB disease with a history, physical exam, chest radiograph, and TST or interferon-gamma release assay (IGRA). (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Ruling out tuberculosis disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Evaluation for LTBI should be pursued if there is no evidence for TB disease. Testing for LTBI early in the setting of recent exposure may result in a false negative TST or IGRA. Because child contacts &lt;5 years are at increased risk for progression to disease, these patients should initiate LTBI treatment even if their first TST or IGRA result is negative (known as \"window prophylaxis\") [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Those with a negative TST or IGRA performed as part of the initial work up should have a repeat test 8 to 12 weeks after the last date of contact with the index patient. If the repeat test is positive, the course of prophylaxis should be completed (",
"    <a class=\"graphic graphic_table graphicRef65944 \" href=\"UTD.htm?16/61/17373\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef78596 \" href=\"UTD.htm?19/49/20252\">",
"     table 2",
"    </a>",
"    ). If the repeat TST is negative, treatment may be discontinued.",
"   </p>",
"   <p>",
"    In resource-limited settings where TST and radiography are not available, evaluation for TB disease in child contacts should be performed based on clinical assessment. In the absence of evidence of TB disease, child contacts should receive treated in accordance with WHO recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Foreign-born (10 mm cutoff)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Foreign-born children from TB-endemic countries (including immigrants and adopted children) should be screened for LTBI [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/10\">",
"     10",
"    </a>",
"    ]. The optimal timing for LTBI screening among foreign-born children is uncertain, since a false negative TST or IGRA may be observed in the setting of recent TB exposure. To avoid this problem, it is appropriate to perform TST screening 8 to 12 weeks after immigration.",
"   </p>",
"   <p>",
"    However, performing a TST or IGRA immediately after immigration may be appropriate for children with significant risk of progression to TB disease (including children who are malnourished or immunosuppressed). In such cases, repeat testing should be performed three to six months later if the initial test is negative. The second TST is defined as positive if the induration measures &ge;10 mm and has increased by &ge;6 mm since the previous test [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacille Calmette-Gu&eacute;rin (BCG) vaccination administered to foreign-born children from TB-endemic countries can confound TST interpretation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. It is not possible to distinguish between a positive TST due to LTBI (\"conversion\") from a positive TST due to previous BCG vaccination (\"cross-reaction\") [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/11\">",
"     11",
"    </a>",
"    ]. IGRAs may be useful for making this distinction; these assays are positive in those with LTBI, but negative in those with BCG vaccination alone [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/14\">",
"     14",
"    </a>",
"    ]. However, data to guide interpretation of their use in children &lt;5 years of age are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therefore, until further data are available to guide the interpretation of the TST and IGRA in BCG vaccinated children, TST &ge;10 mm should be considered positive in children with increased risk of disseminated TB disease in those aged five and younger (",
"    <a class=\"graphic graphic_table graphicRef78596 \" href=\"UTD.htm?19/49/20252\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=see_link&amp;anchor=H14#H14\">",
"     \"BCG vaccination\", section on 'Tuberculin test interpretation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     How to test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic tools for LTBI include TST and IGRA (",
"    <a class=\"graphic graphic_algorithm graphicRef86574 \" href=\"UTD.htm?11/24/11663\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Tuberculin skin test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to dosing, administration, and false-positive and false-negative results in children are the same as for adults; these are discussed in detail separately (",
"    <a class=\"graphic graphic_table graphicRef58908 \" href=\"UTD.htm?8/46/8940\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=see_link&amp;anchor=H9#H9\">",
"     \"Diagnosis of latent tuberculosis infection in HIV-negative adults\", section on 'Interpreting the TST'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Definitions for positive TST results in children have been established by the American Academy of Pediatrics (",
"    <a class=\"graphic graphic_table graphicRef78596 \" href=\"UTD.htm?19/49/20252\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Interferon-gamma release assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;IGRAs are in vitro blood tests of cell-mediated immune response. These assays have sensitivity similar to the TST, but greater specificity for the diagnosis of LTBI and are most useful for evaluation of LTBI in BCG-vaccinated individuals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=see_link&amp;anchor=H365757238#H365757238\">",
"     \"Interferon-gamma release assays for diagnosis of latent tuberculosis infection\", section on 'Children'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The published data on use of IGRA in children is less extensive than in adults, but a number of studies have demonstrated that IGRAs perform well in most children &ge;4 years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. The sensitivity of IGRA in high-burden TB settings is lower than the sensitivity in low-burden settings [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/20\">",
"     20",
"    </a>",
"    ]. The American Academy of Pediatrics recommends IGRAs in place of a TST to confirm TB infection in immunocompetent children &ge;5 years who received BCG vaccination [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/6\">",
"     6",
"    </a>",
"    ]. While there is insufficient evidence to support routine IGRA use in children &lt;5 years for evaluation of TB infection in an asymptomatic patient, data suggest that children &lt;5 years can mount an adequate immune response to IGRAs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IGRAs should be interpreted with caution in immunocompromised children.",
"   </p>",
"   <p>",
"    For evaluation of LTBI among children &ge;5 years,&nbsp;the decision between use of IGRA or TST should be guided by whether sensitivity or specificity is of greater importance. For circumstances in which high specificity is desired (for example, among healthy children who received BCG vaccination), IGRA is superior; it may be used alone or to confirm or refute a prior TST result. For circumstances in which high sensitivity is desired (for example among children with suspected TB disease or children who require immunosuppressive therapy), either a TST or IGRA (or both) may be performed; any positive result should be considered significant [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A positive IGRA result in a child should be considered indicative of infection with M. tuberculosis (as LTBI or TB disease). A negative IGRA result cannot conclusively exclude a diagnosis of LTBI (or TB disease) and should be interpreted in the context of other clinical data. Indeterminate IGRA results can occur frequently in children &lt;5 years; an indeterminate result in a child of any age should not be used for clinical decision-making.",
"   </p>",
"   <p>",
"    Interpretation of discordant results between TST and IGRA is challenging in part because neither can be considered a gold standard for diagnosing LTBI. As with the TST, recent conversion from a negative to a positive IGRA result has been shown to be associated with an increased risk for developing TB disease; the risk was eightfold higher in a study of adolescents in South Africa [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RULING OUT TUBERCULOSIS DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation for tuberculosis (TB) disease must be pursued in children with a positive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/35/15924?source=see_link\">",
"     tuberculin skin test",
"    </a>",
"    (TST). Evaluation should include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A detailed history to elicit details regarding recent contact with an adult who has active TB disease (if not already known)",
"     </li>",
"     <li>",
"      History to assess for symptoms of active disease",
"     </li>",
"     <li>",
"      Physical exam",
"     </li>",
"     <li>",
"      Chest radiograph",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Findings suggestive of TB disease should prompt diagnostic evaluation as outlined separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H9#H9\">",
"     \"Tuberculosis disease in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the setting of latent tuberculosis infection (LTBI), chest radiographs are usually normal but may show dense nodules with calcifications, calcified nonenlarged regional lymph nodes, or pleural thickening (scarring) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H9#H9\">",
"     \"Tuberculosis disease in children\", section on 'Diagnosis'",
"    </a>",
"    ). Treatment for LTBI should be initiated only after active TB disease has been ruled out.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Isoniazid",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"     Isoniazid",
"    </a>",
"    (INH) is the regimen of choice for treatment of latent tuberculosis infection (LTBI) among children known to have INH-susceptible infection or for whom the source case is unknown (",
"    <a class=\"graphic graphic_table graphicRef65944 \" href=\"UTD.htm?16/61/17373\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ]. Daily therapy for nine months is preferred; in the setting of difficulty with adherence, two or three times weekly therapy under direct observation for nine months also provides substantial protection. Protection from six months of isoniazid may be adequate, but is 20 to 30 percent less than nine months of treatment, if adherence is good [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/24\">",
"     24",
"    </a>",
"    ]. Guidelines in most resource-limited countries advise six months of treatment, which is in accordance with World Health Organization (WHO) recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In some jurisdictions, directly observed therapy for LTBI can be instituted twice weekly. This is especially useful for household contacts of cases or other children who are at particularly high risk of progression to tuberculosis (TB) disease.",
"   </p>",
"   <p>",
"    Ideally, children on LTBI treatment should be monitored by a healthcare worker to reinforce adherence, assess for possible drug toxicity, and to evaluate for potential progression to disease. Depending on clinical circumstances, in general, monitoring every four to six weeks for the first three months is appropriate, followed by every two to three months. Liver function tests do not need to be monitored routinely unless the child has underlying liver disease or is taking other potentially hepatotoxic medications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10341?source=see_link\">",
"     \"Adherence to tuberculosis treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ensuring adherence to LTBI treatment remains a public health challenge. In one health department TB clinic in Texas, only 49 percent of children receiving self-administered daily INH completed treatment, compared with 95 percent of those on twice weekly directly observed therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/25\">",
"     25",
"    </a>",
"    ]. Until shorter or simpler regimens become more widely available, use of intermittent dosing with directly observed therapy can be considered.",
"   </p>",
"   <p>",
"    INH is generally well tolerated, and although adverse reactions including drug-induced hepatitis, gastrointestinal disturbances, peripheral neuropathy, and skin rashes can occur, they are rare. Presentation of hepatotoxicity due to INH is variable; asymptomatic transaminase elevation is most common. Other manifestations include clinical hepatitis that resolves upon discontinuation of INH and fulminant hepatitis with liver failure [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ]. Severe hepatitis requiring liver transplant has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ]. Severe hepatitis requiring liver transplant has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/26\">",
"     26",
"    </a>",
"    ]. Children and",
"    <span class=\"nowrap\">",
"     parents/caregivers",
"    </span>",
"    should be advised that if abdominal pain, vomiting,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    jaundice develop, they should discontinue the medication and seek immediate medical attention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\", section on 'Monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Baseline liver function tests are not recommended routinely. However, since the risk for developing INH-induced hepatitis is increased in the setting of malnutrition, pre-existing liver disease, and use of other hepatotoxic drugs, baseline liver function assessment should be performed prior to initiation of INH when these conditions are present [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pyridoxine supplementation (25 to 50 mg daily) should be administered together with INH for patients with conditions that can predispose to neuropathy (including diabetes, uremia, malnutrition, and HIV infection). It should also be administered in the setting of pregnancy and to infants of breastfeeding mothers receiving INH. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29096?source=see_link\">",
"     \"Tuberculosis in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10168047\">",
"    <span class=\"h2\">",
"     Isoniazid and rifapentine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A three-month regimen of weekly",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"     isoniazid",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/51/15160?source=see_link\">",
"     rifapentine",
"    </a>",
"    (RPT) has been shown to be noninferior to a nine-month regimen of daily isoniazid in a randomized, open label trial including individuals &ge;12 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/27\">",
"     27",
"    </a>",
"    ]. INH-RPT is generally well tolerated in children &gt;2 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/28\">",
"     28",
"    </a>",
"    ]. Therefore, INH-RPT can be considered for children aged 2 to 11 years when the circumstances make completion of nine months of daily INH difficult",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the likelihood of TB is high [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/29\">",
"     29",
"    </a>",
"    ]. INH-RPT is not recommended for children &lt;2 years because the safety and pharmacokinetics of RPT have not been established for this group.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Rifampin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     Rifampin",
"    </a>",
"    (daily) is an alternative choice for treatment of LTBI. The optimal duration in children is not known; the American Academy of Pediatrics recommends six months, although four months is recommended for adults [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/6\">",
"     6",
"    </a>",
"    ]. Rifampin should be used for patients who are intolerant of INH or who are presumed to have infection with INH-resistant, rifampin-sensitive strains of TB [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13143/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=see_link\">",
"     \"Treatment of latent tuberculosis infection in HIV-negative adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUBSEQUENT MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, individuals with ongoing potential tuberculosis (TB) exposure who have a history of a positive test for latent tuberculosis infection (LTBI) and have completed a course of LTBI treatment should undergo baseline chest x-ray. If symptoms develop subsequently that raise the possibility of active TB disease, evaluation should be pursued with chest x-ray and other investigation as outlined in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=see_link&amp;anchor=H9#H9\">",
"     \"Tuberculosis disease in children\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with documented positive tuberculin skin testing (TST) should never have repeat TST; once the test is positive, it will remain positive, and repeating the test has no clinical utility. There are no additional mechanisms to evaluate for subsequent TB exposure in these individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testing for latent tuberculosis infection (LTBI) in children should be targeted to specific groups at risk for LTBI",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      progressing to active tuberculosis (TB) disease. Only children who would benefit from treatment should be tested, so a decision to test presupposes a decision to treat if the test is positive. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Whom to test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among children, the major risk factor for TB infection (or disease) is contact with patients who have active TB, either due to household exposure or residence in a region where TB is endemic (",
"      <a class=\"graphic graphic_form graphicRef72294 \" href=\"UTD.htm?27/11/27826\">",
"       form 1",
"      </a>",
"      ). Children and adolescents are at a higher risk for progression to active TB disease (with potential for disseminated disease) than adults. Therefore, prompt identification and treatment of LTBI is important in these age groups. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Whom to test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For evaluation of LTBI in children &lt;5 years old, tuberculin skin testing (TST) is recommended (",
"      <a class=\"graphic graphic_algorithm graphicRef86574 \" href=\"UTD.htm?11/24/11663\">",
"       algorithm 1",
"      </a>",
"      ). Thus far there is insufficient evidence to support the routine use of IGRAs in children &lt;5 years when testing an asymptomatic child for TB infection. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'How to test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For evaluation of LTBI among children &ge;5 years,&nbsp;the decision between use of IGRA or TST should be guided by whether sensitivity or specificity is of greater importance. For circumstances in which high specificity is desired (for example, among healthy children who received BCG vaccination), IGRA is superior; it may be used alone or to confirm or refute a prior TST result. For circumstances in which high sensitivity is desired (for example among children with suspected TB disease or children who require immunosuppressive therapy), either a TST or IGRA (or both) may be performed; any positive result should be considered significant. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Interferon-gamma release assays'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because child contacts &lt;5 years of age are at increased risk for progression to TB disease, these patients should begin LTBI treatment even if their first TST or IGRA result is negative. Those with negative TST or IGRA performed as part of the initial work up should have repeat testing 8 to 12 weeks after the last date of contact with the index patient. If the repeat test is positive, the prophylaxis course should be completed (",
"      <a class=\"graphic graphic_table graphicRef65944 \" href=\"UTD.htm?16/61/17373\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef78596 \" href=\"UTD.htm?19/49/20252\">",
"       table 2",
"      </a>",
"      ). If the repeat test is negative, prophylaxis may be discontinued. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Case contacts (5 mm cutoff)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal timing for LTBI screening among foreign-born children is uncertain, since a false negative TST or IGRA may be observed in the setting of recent TB exposure. In addition, it is not possible to distinguish between a positive TST due to LTBI (\"conversion\") and a positive TST due to previous BCG vaccination (\"boosting\"). Therefore, TST &ge;10 mm should be considered positive in young children with high risk of disease progression (",
"      <a class=\"graphic graphic_table graphicRef78596 \" href=\"UTD.htm?19/49/20252\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Foreign-born (10 mm cutoff)'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation for active TB disease must be pursued in children with positive TST or IGRA. Treatment for LTBI should be initiated only after TB disease has been ruled out. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Ruling out tuberculosis disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/24/38278?source=see_link\">",
"       isoniazid",
"      </a>",
"      for treatment of LTBI (",
"      <a class=\"graphic graphic_table graphicRef65944 \" href=\"UTD.htm?16/61/17373\">",
"       table 1",
"      </a>",
"      )&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We suggest daily therapy for nine months (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For patients with difficulties related to adherence, twice weekly directly observed therapy also confers substantial protection. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/1\">",
"      Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/2\">",
"      Cruz AT, Starke JR. Clinical manifestations of tuberculosis in children. Paediatr Respir Rev 2007; 8:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/3\">",
"      Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004; 114:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/4\">",
"      Wallis RS, Broder MS, Wong JY, et al. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004; 38:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/5\">",
"      Bah&ccedil;eciler NN, Nuhoglu Y, Nursoy MA, et al. Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children. Pediatr Infect Dis J 2000; 19:215.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Tuberculosis. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/7\">",
"      Driver CR, Valway SE, Cantwell MF, Onorato IM. Tuberculin skin test screening in schoolchildren in the United States. Pediatrics 1996; 98:97.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Guidance for national tuberculosis programmes",
"on the management of tuberculosis in children. Geneva, World Health Organization, 2006. WHO/HTM/TB/2006.371 and WHO/FCH/CAH/2006.7 file://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.371_eng.pdf (Accessed on February 11, 2013).",
"    </li>",
"    <li>",
"     World Health Organization. Treatment of Tuberculosis Guidelines, 4th edition. Geneva, World Health Organization, 2010. WHO/HTM/TB/2009.420 file://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf (Accessed on February 11, 2013).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/10\">",
"      Saiman L, Aronson J, Zhou J, et al. Prevalence of infectious diseases among internationally adopted children. Pediatrics 2001; 108:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/11\">",
"      Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999; 159:15.",
"     </a>",
"    </li>",
"    <li>",
"     A World Atlas of BCG Vaccination Policies and Practices file://www.bcgatlas.org/ (Accessed on April 01, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/13\">",
"      Mandalakas AM, Kirchner HL, Iverson S, et al. Predictors of Mycobacterium tuberculosis infection in international adoptees. Pediatrics 2007; 120:e610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/14\">",
"      Jacobs S, Warman A, Richardson R, et al. The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection. Pediatr Infect Dis J 2011; 30:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/15\">",
"      Starke JR. Interferon-gamma release assays for diagnosis of tuberculosis infection in children. Pediatr Infect Dis J 2006; 25:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/16\">",
"      Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/17\">",
"      Lighter J, Rigaud M, Eduardo R, et al. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 2009; 123:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/18\">",
"      Connell TG, Curtis N, Ranganathan SC, Buttery JP. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax 2006; 61:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/19\">",
"      Nicol MP, Davies MA, Wood K, et al. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 2009; 123:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/20\">",
"      Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011; 30:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/21\">",
"      Critselis E, Amanatidou V, Syridou G, et al. The effect of age on whole blood interferon-gamma release assay response among children investigated for latent tuberculosis infection. J Pediatr 2012; 161:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/22\">",
"      Starke JR. Interferon-&gamma; release assays for the diagnosis of tuberculosis infection in children. J Pediatr 2012; 161:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/23\">",
"      Machingaidze S, Verver S, Mulenga H, et al. Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents. Am J Respir Crit Care Med 2012; 186:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/24\">",
"      Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999; 3:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/25\">",
"      Cruz AT, Starke JR. Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy. Pediatr Infect Dis J 2012; 31:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/26\">",
"      Lobato MN, Jereb JA, Starke JR. Unintended consequences: mandatory tuberculin skin testing and severe isoniazid hepatotoxicity. Pediatrics 2008; 121:e1732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/27\">",
"      Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365:2155.",
"     </a>",
"    </li>",
"    <li>",
"     Villarino E, Scott N, Weis S, et al. Tolerability among children of three months of once-weekly rifapentine + INH (3HP) vs. 9 months of daily INH (9H) for treatment of latent tuberculosis infection: The PREVENT TB Study (TBTC Study 26/ACTG 5259), Abstract presented at IDSA&rsquo;s IDWeek Annual meeting, San Diego, California, October 17&ndash;21, 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/29\">",
"      Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal Wkly Rep 2011; 60:1650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13143/abstract/30\">",
"      Finnell SM, Christenson JC, Downs SM. Latent tuberculosis infection in children: a call for revised treatment guidelines. Pediatrics 2009; 123:816.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8020 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-42B5A9483A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13143=[""].join("\n");
var outline_f12_53_13143=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Whom to test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Case contacts (5 mm cutoff)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Foreign-born (10 mm cutoff)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      How to test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Tuberculin skin test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Interferon-gamma release assays",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RULING OUT TUBERCULOSIS DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Isoniazid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10168047\">",
"      Isoniazid and rifapentine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Rifampin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUBSEQUENT MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/8020\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8020|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?11/24/11663\" title=\"algorithm 1\">",
"      Selecting IGRA or TST",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8020|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"UTD.htm?27/11/27826\" title=\"form 1\">",
"      TB risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/8020|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/61/17373\" title=\"table 1\">",
"      Dosing regimens for treatment of latent TB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/49/20252\" title=\"table 2\">",
"      Definition positive TST in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?8/46/8940\" title=\"table 3\">",
"      Causes of false negative TST",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10341?source=related_link\">",
"      Adherence to tuberculosis treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/12/40136?source=related_link\">",
"      BCG vaccination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/10/20648?source=related_link\">",
"      Diagnosis of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/18/37160?source=related_link\">",
"      Interferon-gamma release assays for diagnosis of latent tuberculosis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22378?source=related_link\">",
"      Microbiology and pathogenesis of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9432?source=related_link\">",
"      Treatment of latent tuberculosis infection in HIV-negative adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/4/23625?source=related_link\">",
"      Tuberculosis disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29096?source=related_link\">",
"      Tuberculosis in pregnancy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_53_13144="T-PLL morphology";
var content_f12_53_13144=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85962%7EHEME%2F64572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85962%7EHEME%2F64572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    T cell prolymphocytic leukemia morphology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 330px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFKAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6oHHFLTD0xS56UrgL+tNYBsZ7HNL6U2R1jUu5AUdTRcCld2W9i0JAbqRjqaqtbz/MCEIPQY6fWpzqXznCjbTjqUfzAqTjNBquZFJbS6kdt4+U/kK07aFbO2dm5Kgk8elUZtYWKJjsPA9aS8u3m8OXc2NrGJug6cU0EuZ7nNtK91LNcGNDLcg/vP8AZ6AV4V4ghu7bXbi3v3CyI+YQy8Pn3r0jxL4tttIttPsosTXs6fKjNjA7k1weqeJ7TXJjHcxwtJAeJMclvSvbwcakXzW0PSwkZR1toYVzZ3erRSwopjSPnJOOaTSor9tttK5RbZsNu/kPWuksbnZOst7GpijGUANSFLW+R7kczFs5BxxXZ7ZpWtodbqdLHM+LrpPsIt7aNPkU9Rxuz1z61wek6pcW975cpV4nYbg4yBzXTeOIHgkE6Su5YBc9Bmum0Hw1od9pMUIh82V4tzyKMMpxzzXTGpClSTetzVSUYpsv+Gdbgg1WG5gQQWpfyZip+Unsw96+jPDF/Jf6Urz8yoxQn+8B0P4ivjHT3NjJdae7yPCJSISOm8Hqa+wfACt/wjFozsS7KMnPtXkZpSUEpHmZhTStI2biyilffgK3c0R2MSqO49KtAeval9Oa8U83mY1FCKFQYHtSgkD5iDx1FLg9KTHOetAjBubx5bp0J4BwB6UqsoXnBHqOah1CIw3b5HBPGe9SQkEqG44x1/Sk2bq1tCRnG3A2rgjORnihyMgkrgjHK5pXQ5BDbh0PtSEEL1APueKVwGyA4YDORVvS7svIYWz7VRfA43E+wNJY5+3KV5Ge3+FNMJK6OjzntxSk00HPQ5pOcg84HUU7nOOznnFczc5hu3Vlx8xw3X/IrpazNWsTOgkhx5g6jOARQXB2ZREygAsqgZ6CoZZ/lYY596qyCeJ9joy44HFLHBcXLBVyOeuak30N3w++60bnOD1qHUZNt2yjAyO+cVfs7cW8CxjGe59TVTVrZ3PnR53AYIzVXMk1zDY5lKngUryAAnA+prLWVkB3Fgfyp3mu+B268HrU3NLGlbN5lwuAODWxmszTrcxrvJwW7VoAnrVJmM9XoPzSZ+tMB/CgNkZ7UXIJM0ZpmeuelKOwFFwHUGkzkcc0expgA6UuaSgmgBaQcUAUUAHpiop8hHI5GPu1LSZzn+VAHOxghiDtUnpzVXSr572AtJY3NvsyuyV1BDByCpx3GM56EEVe1XTYhfRX6wK9zEjRpL3RXxuA9jgflQiyOwyGAxgD0qToumiZyoy6jkds1HJIvJAOO3FSizcglmPPPAqZLJSpaQ8HOR6j3oFdIj0pMyFgMeuBwa1W9R1FQxGOICNSAoAxzUufmPJxincyk7sr3duswBwof1ql9hlB4KkjOOK1SfxpM5xtIznvQNSaKdvZLG2XGT71dA4x2oOaAQfpQS3cNo9M0zC8sBn3FSDp6UhXI5xmgCMEMyqwOOtFOCfvAScAdBRQgYBwzFFzuXBPHHPoad3wKUc4xR37UgAE1maw53Rpzjr+NX2mjTlnAHSmXMKXMfGCRytMcdHdmSMALjnjpTWQHPJOOvrQCyMVcENnnNPbB4Hc9/fvUm5RnAWM5AGQR14q9BELnQpbdchTEy89ckVWuQG49sE07SbyK3Jhk4jY8H/GheQS1R8w/E7TL6TxJNI/mNDGgJK8MFA7VxGi3Etjq6OV3Y6q3f3r6l+ImgCcBiGWGYfLcgZCN2Vj6GvBtWsbvTLh/O0/eY5csUTO4DsD6GvrMFiVUpcvketha8ZQ5TTS4gmjedWKuw/1OeD64qno2pwCV4SXjZzgZHFYZxc3v2zL28Lg/KP4D6YqXy5pltGYqHizwB2zwc+ta+ySVmb8qsdVqllFdqvmD94o4i/ve4qrB40/4R7RZbd7QtdqSsZxgEe9OnTVLhrOZQAyjCbV+b8a3ovA0viSWKS6VoU2/O7DCk+1c7dOKSq7GMpRStN6HEeFNMn8TeILMgMto0gkmIHUk84r7G0u2WysYbeMYWMY5riPh/4Lt9LEcwTCxjA4xvPrXoWOMDNePmGK9vNKOyPMxddVZWWyFBozyPQ0h4Xjr27UvPXODXAcYFh60A5PNIdoGGx+NIWUnAZfzpAV761S6jwx2t2IqjBZSxuN2MD07itfv2oIBzkUWKUmtDDSYo5xwAc4qZGWfOcCUcCo2mjM7hgMA4z9PSnExAl8FQDxj1oNSG4t5XbCKCM8H/Gr+l2Rh/eSA7j0BPSiG/iG1XG0nv2q+pBAIIIPSixEpO1h3HeijrwaTJ+vFMyF7k0nGSaXNIaBiFUYcgHvzSYVeAAPoKUDA45pDyRkHn0pALwc9MUcZwBXN3NzPBeOiORg9umO2asW+qygDzRu+g5oL5Ga0lrDIcsoJoS1hjOVQZx1qCHUYZHCk7G9DVwEHkc+/rQS7ocBgf8A16Ximj9B3oPv2oEO9KARTSOOTUbzImQzCgLEueaUHNVBewkcNyOvtU6Osg3IwPp70DaJKWmDmlApiHZxQRmkH50UCFOaD7UAetV7ydbeEux5/h7c0xpXJ6bgdu/U1z019PMc5I9hRFe3ELcsSO4NI09mzosAg56VDI0Nvh5DtotLhbiLevGOorE1ws18AScDgY7D3osTGN3YvyatFkiNS3oagl1CdwRGoWqkKg5ycEn0qfy/lOPl7nmlc15UinJPODu3Ec85610GmzNcWqs/3vWsSdNrHIJxzitdALTSyyDHy5AxTTuTNKxVvtUeOSSKLaWB+8D2/wAaoLeXZyyu3vz2qrBHuyx5YnJ461dCruxxz7c0N20KUUizY6owkCXPIJxu9K2xyMgjB6YrlrhcZwPc4PFbmkSebZg/Nxx81NakTilqi91H9KKQcdKX9KDIT+Oihv17UUANQ7lB555qtqcxjh2qcM3f0FWRxgDArH1J/wDTipxwOKRcFdkJjLH5iT0+pqS0uGtZQrZZDwe5FIAcqOi49OP/ANdNYBgTjkHAzxmkmavXQu6lCJAJIxnjqBWf5uACcHjnBqaG8WCDZPnGcA9eD3qLUYHi+eLlTznHWiwR00ZXnfOATgdTnj86rGFrklY03H0H+NMd5AAdjH0GOtb2k2rRREswIcA7PT3qoxtqym+VEcFm8lksFxgqy4Ze2PxrNv8Aw1A9m8UKIAQRhhkV0ygBdgxjHaiNcIVPJ9z2q1NrYy52jwTXPA66dcBUtJfLY7i0a5Un6U/R9E0u2kEbQSPkZPmDgH0r3Z1UK+7DA8EYrOfSrKTJFvHk88joa6/rsnG0jb6zO1mzidNtLKLZsMIccqmORV2yM15q8dlZgNEfmlO3hAOuT611C+H9OLq8lrGXHccVp2tpDaR+XaxJGp5wB1rCVVMzlUuSoioAq4AAAwKXHFKePTmj+tc5iGap6jeLaRjJ+c9Aat8k84/CuV1iZpNTYMeF4ABoKhG7FluZ7h87jg01RMpJ3s3Yc4zUtuoKgjgdc1aaMCPrjB79qm5votBLLVfLkWG5Ykk4B7j6/wCNbqkHoeorlLlAqfIFGOcKcVt6JcPPZDzCCyttyo7ds+9NGc49UY8gxeyZOcMfap1HYHg9gKNWQxX7NjKsM5x0ojYtjOSf1pMtbEUihiVzluvTGav6JckE27t05WqznPAHTnmq1q3lagh6NuHIoXYJK6Oq7DH60d+lJ0/Gj3PX1qjnFo5GTwDRjmkJ/KgAHXGeaDyPpRk4pD160AYOuxMt2sg5DL+VQogIwSD2A749q0tdg8y0Dd0OfwrJs3DhQT8y8gkdKlm8HoSvCMjbnd2Bqe0vJLdgjEsh7DnFAI5JGC3T1IpkiFgRxj6UDeu5vQyLLHlPumnj1rC0mfypmiZvkJyMnpWzM+IWIz06gVRjKNnYz7++KuyREHHXvVEhmbcSxbHFR5PmE5VucmplYhc4BB9KlmySSFZfkIHX1HNEUptR8uTjtTeMkk9P7tQ+ZzliOufcfhQO1zorWUTxK47jkHtUuPWs7S5MhugAGc1o59O9Uc8lZhS/lSZ5qO4mWFNzke3NMVrkwrI1jdJIqggfXvTJdRd87Oh4xUJcswMnrwc9KTNYQad2QbFI+vApsinHCnI4GTUzgoWzx71Tmftk49+1Qao0tAcrIyZ/DHena+As0TDgsMZxVPRJGa8+UfjntVnxR92AjJOSMCtEZv4yCBh1GN2cZAx0qfdxkE9+1ZcEjKo3DH9asickAljhuaixbRJKSM5JxnJB6GtjH2jTCqcEp2rGLDndtIPFTabe/ZnEcgAjY/kfaqRM02jOt22kBiflPI6VcVwSVU5IGc1a1HSvMcz2hGTyV/wrPW1uwNuxgeR9aGr6jUk0LcMeAG5zkkdSfat7SozHaLuGM81S0/TZAwe4wB2GeR7VpzTRwKN35ChIznK+iJgMZpaz/wC0U3cKcfyq1BcRyj5G5HUYpmbTQ9x8uSB/hRSt24opoEzK0y9ZpTDOxLY4Jpusx7JI5f4TwT6VQlYxN5qZz14rbYC807sd6fhms0atcruZYkEhGOQRjGelSEgDA4J/SqdvuAMcgIYcYPSpt5z1IOec0mrFkF2BgnGQB29auWV59phENw2NnGRzu9KpXLKd3OfUiobNGa4QpkKDz6Yqo66DaujfjtYtysFzxwT/AA1bVQqgDtSRjCfLxjtSK5DEbSO+TTMG7gWCAliAAK5PVPHmlafefZ38yQ5xlOcVkfETxUtvc/2dZvlwpMjA9D6V4/bapvnd7hQjFzgseCa78Pg+dc0ztoYTnXNI+k9M1G31GASW04kB5AB5H1FWpVdJQ6seRtA/rXgVnrUtu0Rtrlre4Y8sp+X6Gu503xxLayrDfzx3OQMH7pzUVMJKLvEmphZRfuno9vLuJVj8w6j0qck9O3tWNoms2WqDfaSq0h+8h+8PrWwpBHXP61xyTTszlkrPUXPBozzXPax4otrMzRWiG6uIvvBein3PrWVH4g1gRSTXAtY16qBzgelWqUmrgoNna8c4/Gua1+3aG9Myjcrfoah0/wATz9dQiQJt3FkBGK3dPvrLVbfMDrIMZKH7w/CplTlHcavB3Zh20wCnPQdecVeMqbAG69aj1HTPIHm22fL64B5FUVl4wPl9P/r1nY10lqixcP8AKSTwRwa0PDikWrntuxWTFFJdy4Ud8V09pbi3t1Rccdc+tNETeliHVbb7TApQZkQ5U1hI5jYiUENjoRXVY71TvtPjusnG2TGN1DRMJ20ZimUcnceahiDSalCMggN2q3Lo86NmNlbA4HrUemWcsepxtMhG3mhI05lbQ6RmC8kgDufSs99Vh3MIgX29WHSszxTqgiDWsb7doDSsOoFeZeKPiENKRYdHty7f89HGa6aOGnV0ihUqEqmyPXpb2RdueA2eRWTeeJ7G3DCa8UMvHBBH1rwxvGut6qJNzMBtx6AflWJcpf3cks9yPLiUcndxXdDLn9t2OyGB/mZ9EWviWF2AhuQ+4cZ/irWi12EbROrL2z1xXzppFzELYB7hhggbM8j6V6h4S1MavYPA5ZpIOAW6kds1lXwip6mdbCqGqPUA0dzAdpV43HUHNcs8b2dy8RyMcjv+NVdKvm0a8RW3iykzvVudh9Qa6TV7Vb20EsJ3Oo3KQfvCuGcOX0OWPuuxRiYkYU8DuTnNPYhuMEY9aowSNkK/BPB7VbD5HGPTFZWsaWImfy3BAPB71vsTLaNg4LJxiuekAJwxwTxzW1pcxaDZJwy8Y9RTRE11ObR2VjvYkgnk8c1YDnHUDHQVY1HSpftbSQhTG3YHp7VQ1ia30m1V7+YIp6DuT9KfK5OyNIvm2LcZdhljgDpzgfSqt5qFpazGOaVQ/cbs4rzXxV4pknc2lvcTR2/XzV4CiuHvLqe3nk8q+lnRsfM3c16FHL5TV5Ox108I5atnrmv+LDFGjabOrTI214hzuB9ahi8c3MP2R5ZYvLDbGjT+DHbFeK3N7c2LrcI+Xc/MpPJqxorxXrEyO6SFtzNnjNd6wEYx1On6pBLU+htJ8ay316ES1MkDN1TqPetvU5GknyThMcccVi+B1soLKBo0XzWX5m4NdHewhmBJ9+PSvGrJKVoqx5dRRjO0VYz4wMA8cnOe9Pc7cs5xgYx6VGT5ZwST+ODUcspKnOOOcDvXOLcn3Ga3LqRvXIIHaqaQTTSiNEIA6j3q5pEDmUtkbT1Gav61qljoVg11eyLHGvQDgsfQVai27Ilys7ILW2t9NQzTSKvHLtxiq1x4hsnLjyZZVQZyF4P0rwfxT8Wjf6oUjjJjV/3anoPc1BdfEnUbV9v2cvAQDnbkE16ccsq2XMtzdYOrLVnu6+IdPJCvZzKjDIbYMVatrvSdRby4JYxLnAQ/K34V5V4X8c2+r28McpEEnQjHX/CuykgjYqQF3feBUYYZ7g1z1MNyPlkrMynScHZm1qlo9oN4ZmQn73p7VnmTzWXY2CeORWjpuqbh9i1TncMJK3R/r71pwabaxT7lQ7h6muSUXF6kc9tGWrJWW0jV/vAVPmk4GBjFVtQm8izlkzyBgUGW7GXd+kRKJ8zDrgdKpbnnfMnINUIH3/OTkseM1pROd4BxgdRSubKKiMEQ7cdMGhWaN8oxB7irB27eue/NMlAKZByT68UIDQtZlniDA5x196KraWMKwGcA/hRVGElZmPMMqcg4z0z1rX0bIsQCcgE4rDkkB6DAP610Fmv2ewXd8uFJxUI2qbWKss0FzkJ+7kzgk8GojC8Y+cbgeCR0FUoF+ZnbHJzwasiWReGYlsYx6ehoY0rFDUEkg+ZkZ1buBwPqak0eDz+RvKA9ulOgm+yM8TlmhYZIbnH4VrWDxCBliC7TyMDiqWg5SaRYlnS3t3lmYJGg3MT2FeceKfiDHsEGmZTecebW/wCPpJ28OTJEwWNmxI3oPSvCYrGad5rxhJ9miONy87f8K9DCYeE1zy6HRhaEZLnkTxXkN14hd7243AgsxzgE1xHi/UXl1YG0jCJE3yqO9aOoTRwTtJIx8twSWUdDWfpsdpeXGXk3ntkda92lBQfO+x60YpajdHu7lt0s0u2TqB6DvWrf6kHkU2bl9qfNk5wafqfhifSrcSSbXglwS47Z9KraNpAZmVlQsW+VieoNNypy99DvF+8jV8G6zc/2pFLHePA6sBkZP5+1fQEet+dpM0ccqi5jiOdnQ+9fP9vpi2V4yRwtuYcBD1NaVx4un0bQ5WGEdUMSZ+8fUH6VwYnD+3knA5MTSVSzidnFqKWbEm6jhmyN6jHzZ710NjcadfSkR3KOQPnUMADXzRZeKTfF7e6VVVufMJ5z9acuu3WiXRljDSQPwjbiK0llsnpfUj6ndaM+qHjtZ41iJMY7FWBzVJWa3uluIMJJB8omQ8Y7qw714z4S8ZXzSYEzlSu5Y5OQfUV6XpmpyalaFoIvLZxl4ielcFXDTou0jmq0JU9z1TStRg1O0E0Lq3Z1H8Jp7WFs5J8sDPXFcZoobRpUu4W3wSYWaIdcev1Fd5GwkRXQgqwyK86pBRemxxSXK9BIYUiGEUCnjpSY64pazI3CjqMGjr0o4BNMAPP1phwo3Nzjuaf25qlqzhbF+Thjg47ULUaPPPG92bS3nnKlpDJnd6D3rybW3+0mRdgLk7gUPBzXd/GWYxaRbxRPtL9T3x6V59or+ayxFCWOPlPG7HevcwkbU+c9nCxtDmMZr82cD2Tfu2Y5Ixk59amWW71KGO0mmZIUblzx+dO/4R2a71NpM7yWOGzxVmUrZSm3vE2EkHevQetd7lH7O513XTcvy2NkZFRGI2YDyf1r0XwCsLXsgsz5sYXt2PvXmbSxPtax2SyEHMZPJX1+td38IpxZllnj2faPu5PI9q4sUn7Js5cRf2bPTLu0aS22sAy45GO/1q34WlZElsmbd5XzJnsp7Ushy3lo5yRk5pdKjEV+pA5KEMf5V4zd42Z5L1Rbv9OjuSXUbX6/Ws6WykiQgqcjn8K6InikwMc9KxauTGbRyTb2bG05HX1Fb2mQlEDOpBIwatmNOCVBx3xUgUAYFFhyqXVhpAryL9oG6lt9Ks/JIBd+cdeK9dkBKtg8kcV4v8WLOa6dTM5MUTEAeldeCt7ZNm+CS9qmzyXTL2e4Ty752Zey+vvXW6bdaS2mG2ubXefvCQcBfbNZdjoyExyGcxgnazEcDNZXinTb5dVexjfbbQAEMvRvc+te61CrLlTse1Llm7J2DVI7Oa6c2wkbbwnoBUltbrbTWbyEpBK20quOnrVTU9Nu7SGGNQX3rlSOhFQSLMlpAtw7CRB+7XHT2rVK6STNErqyZ714ca0sLm3El2qwkbnDnGOOK9GR0uYVaMh0b7pHQivle2vpVWJ5pHd3PzDOQBXvfw9N5NbLNONluFCxD+8PWvFxmHcFzNnk4uhyLmbNm+gK5IUk9PpWYxcybFzk8dP1rrnhSZSGXpxUUWnwRuGA3c968yxxKpoUxNFo2kSXVyQscal2JOOK+XviR44m8Tau8YldbYPwFPG3tXunx2u/sngSZA4RZXCH39q+bbbRTNq0LRW3znGV6owx617uVUYKLrT36HfgKcXepI2NG8P2yWUlxqJxDMvyP3z2NSWF2LeSOzURvIvQkZ3A0uree9hJDCGRY1wqEcL61xNtNd28yzyOCQ2A1enCDqpuTPRScrtnc3aS6ZNc3iqEdCCQBgEV6x8J9fGv2TiT/XR9D321wlvbLrWgLIvQoN4bnt2pvwnS60jxKIMsLdjs3AcEdga4a8VVpSv8SOWtFVKb7o92mtF2kPlgxHJ7VoaNdux+z3HLqPlf+8KRtjorSEhQOMetZ0oa2uIXRjuDfw814nxKx5D10Oo7n0rO1znT26nB5xWghyFbPBGaguoRNFInPzCsDOOjOctT+7wQAAd2PQVpRnGPbAyDmsrD20xikGCD1xVuCQFfnwPSp2Oh6mgoGTjHXg5qOVu2ST64/SovNA9CfXNSQRNM4GOAck0ydi9pqhYiR3PYUVajUIoA6UVZg3dnPaBBa6jZwahBIZraUb4mKFN3vhgCB+FXNavfLHkIAM43E9hWmDwCSDnmsXX4n8yOZclTwWH8NSjSL5pakFuNxwvTrzVhiFwc8+45FVoWBjO7BGQalL5OSTwOlI0K80frnAyB3P1qXR5CZWgQjcMsoJps7HYeRgdBio9HO3U1IOQc9qaG9jWvYYL2xezvVA85SrDHGfUV4jqOlap4N1C6iNu11p1wCN3JUr/Q178yK5wQPyqKdFZSrxh07giumjXdK6tdPoKjX9npbRnyJqtrHdzuYwyYPKdsVz8kclrM/wBnR0UHIGO9fTPjzwBDrEElzoiJBfddg4Vv8K8X1DwjqsWqtYXMDxSMu4eZwCR6GvewuMhUjv8AI9mhiYVEQx6zNe6fDHdTNJGpwIwe1R3E/wBits2ZCkHdhjVTRNJaLU9l6roqkhlIrotf8JXXkxy2St9lkG4M3pVydOMlG+hb5IuxW0zxBJfJ588QEkJAJVf881wvjXVFudXFptHlRnLAHqx9a9AEUGheHby7faRCqsFbnfNjgD6V5DpwF/r0P2p8eZLuckdcnJrfCxi5SmlohK17o6Tw14eW5OWXdhtwJFamveGXuZFjtXHzc/NxzXWWljDbh1g2kNzHzjt3qtql5Bb6dv3FJkOXVvb0rL6xOU7xF7RuWhwenWN7ZXEcruI5LeTb1613Gh+KnsNc053JCNmKRe2T61zFrqf9rnUnjhHmZDeYw+X6VVkglijWd90kvmAuvofWtpwVTSojSUVNWkfTT3sYs5ISpKlM5Xrg9812uhbjotoCCp2DrXk3hqSfVNH0+OB8mbbGwPYdOtewxolnZJGM+XCmB9BXy+Iioe71PAqqzsTn6UuawZtc3Ni3j7/x9TSLrM68vGhHfNcpnyM3++cUZxx0NUrLUIrs4U7ZP7rVc6DnAoJasGcnjoOpqvqSl7KQpjco3DjOcVXudSEW4BSTnjFUbLV3+07bkq0beg+7TRSg9zyb4k3EGpXsYRN4MOUbOAjd+K466khigtwflRhtaQcYHtXffEDSJf7faKGRI4F/fxse6nkj868s8QTsgEF0flDny2AwBmvoMKlKEUj2cM1KCSPSNL0m3j0NXjnxJ1i75B9a5jxVpN1awefchdrqdr+tVfC/iqbT7V7S5WKQqfkfNP8AEuuXWs6c1vEha3iOXfsKcKdSFTXYcYTjPU4jSJTaavGxLINwAY9K7GPU7jT/ABDDIC4V2G3HQ89RWLD4feOeDz3zExDBlOR9K2YY4bq5gMAOElESqTnHvXVVlGTvvodE7M+hdPl+0QIQCSyKQT1rV0yMmRpWA3AbQR6ViaYGSCJHU7lUAMD1rprRCsIHQnmvmZ6Hz8yf86M0UY/E1kYi5596b0paP5UAJXDfEXTDe6ZK8W4yw/OFH6iu5NZ2rQedC6AAZBByM5rSnLkkmbUZcsrnzJql7cpm3iJKzdY8fdxVhwJLQxygjZtJ55J9BV/V4BpnieUXCgojcGqTXcd9rLEBREvHPTHrXvp3SaXme7e6VkZVvqj6g80NxG37vIh54BqlK/2W6inkPnOvGw9BXTa1pttp6JJYS+YS+SO9Yt7Es2obxF8sgBYmtoSi9VsXBp7bEMVwrSBlGUc7hx92vdfhnfXM2kxcOwxhWJ4HtivLF07/AEWK1CfOzZTaOor3nwTp8en6JbQxnoASCMHNefjqkXBHHjakeQ6FPujd1705RgcnPuaFGO9L24rxzxjx79pUyHwpaxKMq0pJ/KvL/Bs4FnBHL0AzknJz6V718UNNTUtMiSYFokJzj+HjrXgVjbQabqs6GcNDHyMdCa9zBTUsP7Psevg5J0eU6vVJ7G/sGSMLI7LyQMFcV5vItjdwXFmpUOpyhB5Delbmul4t0mmqZEmTcW6bPUVz9nBHYW0t3egNKxyqnjFdtCHLG6Z2U48qOp8EXlzZaZOrLuAwrhhnArpNDufsOqRXQX9wzjHOetch4X1R3t72ZiBGF3Ee31qN9T8+OJLdnEgkyQTxioqUnOUtCJQ5mz6ZtnWRUc/NEVyCoq5PBGbXcEJOfX9axfDVysvhmwmZufLGcHitK1/0lhGC2AeQD296+fas/Q8WSs2jatv+PePPI2inYOefpS4wAB2FBHBFYPUxKt3aRXI+cDcOhHWs86TIGyJMjPFbB6DNKtKxSk0Z0Wm8/OTjuK0Y0WNQFAAp3FKBxTQnJsUDFFFFMkjRQqqoACqMADtSTRrKjI65U0o6Zzx2pSRjk9OtSMwbvTnhkLxDeo6d8VXRWA5GT7iuiM0eOXUfWgeUcEFOaDRTfU5qQSFcBCR6YrW0W08pDLJ/rG6A9q0MRYzlMD3FORlYZQgj2NFglO6sOzzQOfftSc46cUDr9aZmM2AEnjPtVXUbK3v49l1CsijkZHI+h7Vd70hAOcjIp3sNNp3PPvEHgKxvYZLizmMU2chup+lZ1v4R8Q2mn3FtFeQzQyqMGQZwPavTZmihXdJ8oz6UQSwyE+Uyt7Ct1iZpW3N1iJ2sfHfxI1V21CKBVVrO0bacfxyd2rgrW3abWN6Exc7wGr3b46/Dq5tVk1PSkD6eXaSVQPmjJ5/KvItDTdMkUyrNIVyM9VA7GvqsJVhOgpQPYw0ozppo6Ky1e5NgEwxmycHtj2rLktLy7uJFmZnLrvznJB9Kt313DaX0Sw/uggwMnIBPetiNrO2ltppLgERDMoPylj1zmp5uTVLc1+HVI5Jbm4ggk023jMbs+6T1yPWtDTLmRtTjtxsdwf3meeaNZ26reXGpW84gtd2CqD5jXWeCPDVskMepLG7swyEbqz9qdWpGMOaW/wCoqlSMI3Z6X4EgNvqOiWcRy0ZMkhx2xXp+vsRYFQ2N7Ywe9Y3gvw+ul2/2q7X/AE2VcsD/AAD0FWdauBPOI1yY068dTXyuIqKc7o8KT553KtvANnPQjvyRVhow2FwAAPrRAflGCcn2z/8AqqRiOCMDsMjNchZTCeVMJFYgA5GDmuiguBc2qv37jPesCfGznB9jWhoB3QTJk43fLkVa1RE1pcdcRAkBee/Xv7Vn3FuDHjHvU15OYrt4cj23dKsRIskfynGB1A5xQNaHO+JtIbxBpA8g/wDEwtlKgf8APRP7v9a+fNeadJZLK8jCRxkrucfMhBr6bmikgkWSFsY7gdRWL4j0HRfE0DR6vbeVcsPluolw34+tehg8YqLtNXX5HTh6/snrseH2VpaLbQyOI7hCOdhyV+tVLu+OmWbxMUNrKxC7T970zXe6z8KNb024Sfw7JBNCV2tjhiPcHisab4ea/JJFGdMmlDDDFlAA+lerCvRlq5XR2xr05auRynh6/W/1OSGWRl2DhV6Cu28C6XAb9X8vzRJNuU9WXHtV3wr8Gr6O9aa7KWcL/eJbc/4AV6/4X8K6Z4ctFjs0LOPvTScsa5sXjKSTVN3uYYnFwSagyzpunMGFxdqPMPRM8D0/Gtf8agkuYo8h5B6nFSKysoIIII7V4rdzyXd7j6U/lSA5GaU0iRPWjoP8aMd84o/SgA6Hmo5l8yNh6inMcAnGcdqQHI4H4UDPM/iX4VS7sxd22Rcj7y5++PavHHjuLNjGYWyeVBHWvqHULRbkjdz6Vk3OhwSmLzLeMtGODtzxXoYfGezjyy1PSoYvkjyy1PnnT1kuJZHfeWAJKt0qzDY3uoiJreJ3AbACryB617bP4Ss5LxXSCMA/Mdoxn610llpltZwbLeCOP12qK2nj0tYo1njorVI8w8H+Fb1Jrea9A3buMj7or1u2RY4wF7URxKgyepqVVwOK86rVlVd2efWrOq7sd3oxTevWnH64rI5ypqVml7ZyQOoII4zXzr4q8MjTNQnmdP3KNuBzgEelfSjLkY7GsHxX4atPEFm0U64Y+nc9s11YXEOjLyZ04av7J+R8qz+IreKVVZCkJONnXPNXJZIdfhaG1G+VMGQngAVr+NvhVfwXrfZbWT7OO6nP4iuVstPn8M3chkhuJ42BU7QRzX0cJUqkVKm9T24zhJXizcGmW1jZz26SMqsnzN7+lY2lWsEGpyJfTuhk+UMBxiqLahqmpRSbLJowjZO4/eHoK7vw14Z1LxAkU6WEnJGcpjaB7nrSm3Ri3N7hKagryZ6p4HWW18Pw2jkSEZIOf4a73SLfyod753t6+lZXh7QPstpALoKGjUAIDn8zXSYwOK+arTUpOx4NWfNJ2FNJ2oOPrUE9zFCPnfnpgdaxMrEx70dqxrnXYYm+WJnHYg00+IIlHMMg924quSQ+Vm6KO1Y8OuQOBvjdQTjI5H1rStrqG4B8pw2DgjuKTi1uJprcnooFFIQwCsXU5WN6Y1Y4wAQK2x39q5yLLzyyOcsWPtSNKa1ESDdncTxyTTTGM/ebGeOwq4MAcYx6+tRyYDYJXg8/4UtTUoSqwQASLzx36U7SJpItSVFYlGOCOoq0sfmFsEbf0NWNNjt4i8x+8vc002D2Nj6/nRwe9c/f3k9w22MmOP2/rVLfOrb0ldWHIHagzVNs609KRiFVmbgAc1l6TqbTt5U/EmOD61NrbMNNlK8Hoc0yOVp2Zm3dz9ulYKP3a8AVmFZracPE5Djpk1Y0/CMhx39M1ev7cOAyrwf0pXs9DoVloW7O4h1O0eK5iU7hiSNhkMPpXh/xJ+DS+Y934dBSNyWKDOVB7fSvVfnt23oTvHP3SK1dP1VppEhmjJdu4/qK6MPiamHlzU2EJzovmgfG1z4J1mG6WBwztnG9ckY7V01h4W1Vo5ILhIzEkeB5nDE19T6ho+mXY/0q3i69R8tVxoeiIuBawbe/fmvSlnEppJo6nmEmtj578J+CnaQ2bQNLKcFUThTnuxr3Dwr4QttIhha5IluYh8oxhE+graa8s7EEQpGvbCLjinWepwXbBFbDjna3euDEYypW9Dmq1p1NWW5U82MqTgH8c1gXto1vIcnPue4rpO2PX0pk8KTIVfp2PcVxmMZWOctpATtLcL+lWQwBOCTg8kHIp82nNC+Y/u5z9Kf5LbTkA/TqKVjS6ZQuHVMg4x9eRV7w4Xe2lc4HzcVXXTpp5GXaFAHX0rbs7ZLSFIY8YHU460yZyVrGBq5EmpP8oBXAzUtm4UknI9zWjqdkrK8qpzjn3rIjHlHBJB75/wA8UMqLujVIDqRyQOx6VlXUeG4GexFWhLjH3jjjn/PWq87FxwuWPTBzSGlYv+H5XaN43JwvIzWz/Os/SbbyIyxPzN6nnFX8k5qjCe5DPcRxcMSW9Kybm5nuMbTsUHJ7/pSavJvvBHnG3vzyaltY9yjOCfpQXGKSuUDAzE8nPXBqa2uJbQqCfk7g1omNO68+lU7qMYORg9DgZzSuy730Ni2nWePevbqKmyMj1rD0qTyrrYTkNxW3mmYyjZh6013WNSWOAB1pQeTtxWPq1xvfykPA9KBRV2PudUIYrCmffNVV1CdmyfwNRQxYIyOcY47VZNsSvA/PvSubcqQQao6S4mXK+oFbEbCVAyNuBHWubni8tvu5GepFX9FmAYxDA9BTTFOOl0a20ZyR/WnbQRgjA70A896XOT0pmIdOBQBUU88UEe+eRY0HduKqwatZXB2xXCbvQ8UWfQLF8/rS0xGUj5SDj0p/agBcUmBS0lAiOTYEzJjaeOayJrHRblyJoLdjnJ3L1pddlLOIg2F/HmssxlizEnJAzxz+dHNym0IO17l86boCSeYLO13D+7GDirR1OCPMdtEcAcYGBWSIOvzcdDViJ/K4QAdSc/1o5r7lOPdmvFdM23euBVwc1gG8Z2RBjJ4H1rYuJ1tbN5Zfuxrk+9C1M5xsQavfLZWrFWXzmGEU9/euVadjDyxMrZYtmmQu2p3Es14c7hlRnge1V5prax5nmjjAbdu7Y966Yw5dOpcYWNK3gUIGlOZR37Ul0AzMzEDI4PbFY9z4q0mzxIA0xHRl6VxviHxvPJN5MKBYXOFYda2p0Kk3sbQozk9jsrrVbbTkAmuI/lGRub7v19ai07xVpt1cyHT9Sijl6HecAn2rxjX5pLi5ZZjI5K5LDjNY/wBnhttLEnms10z4IA6CvQhgIuOr1Z2LBpx1Z9e6LqS38bKxUzRgbip4b3FFfPfwc8ftpvia00nUJhJa3TeSrt1Rj93n0zRXl4vCzw8+W2h5tehKlPlPpQ/dP0/Kuet8rI44Oe2a6IdK5+Zfs9/IpJ67ufT2Fcb2Jp9SfOBkgDuRnmoJMklieOme9SZB9eOcgVDM4wedp77f51JoiSH5I3bknHOe9KwKWiJ8u5uTzVm1iH2PzCMqAT9cVSEhkfd0b2NAlqOijyu3g89SaHQKR349alRdoyAMUrAMQT29qQzOlHk3KyqX4I4HI4ro5oxc2jKejrWBeZ8vIGT2rd0xi9jCSScDGT1q07oip0ZgwAhSgG0g4OK07dxINpPPtWfdA293IrDAPINOimKsvzHHqO1JvUtq5ZmttzcHk8fWoLH93f7IxyO+asLceaBs644HektYlt1d5Mb26jP8qBX0DVY3kj2l8MOR3rIjtX8sqWyPQdcVqSP5rEYpgTIJ6DOPpSbGtEZE1uQM++euc1XjjeKdHjfawPX1rZuUGGzuH5cU2ytcyDPI/lQmXzaG7AzPCjMcMQM1MAccnj2NZes6vY6DpTXupyiGFAAM9WPoPevK9R+KmqX88kei2sdtb5+WWQbmIroo4edXWK0M6dCdX4Uez5Uj52GBz1qot/YNMYVvLVps8J5gzXzx4p8R6hJA/naxM9wR9wNgCshL7SpdHiiCyJqRbPnbyCDXZHLm1dv8DrjgJWu2fVXCn7xBPYmhmVfvNj1ry34PeMjfk6JfTmaeNS0EjHJYDqpPrXqq9OlcNWlKjPkkcVWlKlLlkMHJ4bOR6VUudPSbLIcN9Kv80nU81mZptbGQNLcnl8+nNWYNOVCCzbsc4xWgfakH14osNzbEx7CjgZyeKd+FHvxTJOe1lQL0MM5YdcZzU1m67cDPHrzV7VLb7RBx99eRWPETHhWJ+Xgg1LN4u8TYVztODnHvVS44ztz0wPamGfKjgj0HpTWbORzk0rglYitTsvYwTyT1NdBjIrDsYDJcqwLALz6it3tTRFR6kchKxs2OQvaucRTI7M55PbPNdKyhkZeeRXNplXcEHcDgmhjpFyNctjkevNW8ZQk/nVNCOOTmpDPhCSeAMUkymrlS6J4yQGA5xyKXRV3XRYAYHINQzN5pUEA5PBra0218iLJHztyaaCTsi0M4/wAK4vxr4+0rw2fLkn33C8lEPT61yvxW+Ilxp0kmmaJIkdzu2NIcZz7V866oNS1HUWmvWeZs53LyB717GCy32q56rsjow2DdT3pbHsV98TZL66kJVXGfMQs2APwqvp3jeG7mCzKQVORz92vJdUa/TY9tFwiBWYDlverHh65d4QpwZy3zH0Ga9X6jTUbo7/qtNLRH09oviCa0ZZd5msWUEjrt98131ncxXcCzW7q6NyCDXzh4c8Rtp92LO7lVoZFCgZz+Vem6HeT6HfQ4dTaTkb1PcHoy14eJw3K/P8zzK9BxZ6StFICCAQeCOKWuA4znNWRhftkjB6HFNiU7R8wXnt0FaWs2rTIHiHzLwRjtWWrGN9p+XucVLOmDuicoxTBbrx061HJFIZtwkHl4I8sKOT2Of6Unnj0wcdTzkU2SQvIoUHdjkHipGWdNgaW93k8KM5xUfjaST+ykhhb5pHHbqB1rV0uDyYASCGbk5Nc34vvv9MNurD90oL+oz3FdFFe8jO/NM5xb17WDzVf5UHIA4/GvMPFWs3t7eEyErBkhUx1r0LxnE58KXFzbgq6MGyowNvoa8XvtcuhcABA4cYXcOle1g6Sm3JI9PCU07yOr0mGS/hjVZ1Nuo5DcEH0p8un/AGLUxNdBikXzDGOfpWBpNzdRQyrHGWDDf05BqeTVLm5VEulyxOFYdh710OEruz0OhxdyfxTIk1uEt2IU+nauWkBtVbz0l2rH8rqOM13ljYLIdsmWO0beMhvrVy50y2LeXOBtYY+7jA704VlTXKEaijoeQJcpMEubNHjnjcbyORkdxRWhr5tNI1mWKx/493yCOvPqKK9NJSSdtDfkU9bH2np9x9ptlc/e6HHrTNRsxcx5XiQdDVTw4GFs2Rx3GMAH2rYr4Q+afuy0OZeG4g+VoyQOnGRSxWs9y65Qgdy1dGR64pcClYr2rIo4FjtxEo4AwK5+M+VOyMuCpI/+tXS8HrUFxaRTHLr8394daLCjO25lrICBnuc8Ukki4xkkfyqeTSjgbHGOuCKi/sy4LYZl2560rGilEo3DtKVjQHcTxgdfeuis4vItY4+eBzUNnYRW/OMv6ntV3iqRnOV9EV7u1juUxIMkdCOorL/sZt+N67eua3PpSfhQSpNFWzs0t/mBLHpk9qy9ULQ3PIO08j0re/lVW+tVuowDgOOlBUZa3ZjxuWOSMKOcU/epyVIPpmq8sE0L4wePbrSwpKzp8hxyOBjFQbaFhOXAX25NaEcSW6NK7bFVdxLHgDv+FLb2yhQXGCByAKxfiNK9t4F1l4iVfyCo59eK0hHmko9yL80lFHz58YPGi+JPFPlWUjNploCsQ/hZu7Vz0V9JbaS7ElTLjoOfpVSLS53WFrmE+ROwVWHY5rS8U6Nb6TaJ9qvImKsB5cbbsmvq4Qp01GlE+gjGFOKpok0Kx0/VYpLi9u/ImzhVJzn3rSj07TY5ERpxO3cr1z6Gua8PXVnZ3RnnxLAwIWKTvnuK6DTTALqKZo9kJJ/eZzipqxkm9XYU7p7mtZXCaZ4jtL2ziEKROuSo6+tfTMbB40YcKyhvzr5k1LWbNxmIISrgZHf8K+ifC1wt54d06dFKq0KkD04rx8fF2jJo8zHp2jJmrn1zS9qO9HHIrzTzQ70AdaXsM0fSgQZ70nNBODUV1MsMLMSM9BQNK492VfvFRj1NV5raG4j4xnswrFYT3DHzCc56Z/lRbyzWTAocjurE9P8AGjQ15GtmSz2k8GSMsOxx0FJFbyyPjZ14z2rbtpluIQ6dD29DUuBx60rC9o1oV7O3FvEAfvd6sUvFJxTM27imsfVLMh2njBII+YDt71r9cc80dfpQOMuV3OYSUqpwMHuOppjzDBIwT0B6/hXRPZwv1QA98UiWUCHIQHHrzU8pr7RGZpNkzSiaYfd6ZHJq3r1zLaaTcywMFlVflbrjPtWgAAMDjFVdVj8zTrgMuQEJx64q47q5m5cz1PiT4m301xrs25iCGPJPJrN8Oa7PaM1vOzNayjDDuPpXUfE+ztbjxsdhMcbuA5x27mq+n6BAl0IYSs0JbG7vg96+1hOHsYprofQ07cq7WNDUvIm02SWxlDsoGMHkj3qhbKzWUs8SxqzAAvt6MK6HX/B1vp3lyWM7gMuGXPBrl9HMgupbC5lCdQo/hf0z71lTlGULxY4yTV0aHh/ffpmRAjQn5Se+T+te2xXMWo6DBg5MEe05ODkV43H9nh06MWxk89WKyDHCmu/8FXiXtjdKykTBBwe/rXHjI83vrozlxUeaN+x7roE8k+j2kkmN7IM4rR7Vl+GUkTQLISgCQRjOKS/1MxMY4VDN3NfOS+JnjuN3ZGofr+dVLmyhmbeVw2c5ArMj1Kfa5ILBeMYx/kVYg1gFwkyY4+8KRXLJbCnSEZ92/k81at7CKEghct61aQhgCpyp5BFOOOecUEubDHpXBeN4jbawJz8oniCq3qVPSu9HFVtRs4r61eGZVII4JGcH1rSlPklcUJcruecTTR6rp7ad843qd+fUdq8T8ZWlxZXKziNAseVA28YBr2me3fStQaG5iXep4cj747EVynjvT11PTpJ7MAYOHj/u/wD1q9bC1FTn5M9LC1VGVujOK0DXbeVYpplUN0kCYG6thYY7yBpUjGQ3HHbtXHaPaLHOFkTDhsYxxXTq91ZROZCEVm4I6EV3VYJS907ppJ6F+LUvJmgWePBT5SQOoqfWNUsIoJhPMF3KTGV5rLW4gaJ7i4UyQqMcHnNc893FcpKkESiTkKrt90HvUQpKTv2JjC7OYeRb66klRC+2Qgbu3vRXX+GPC17q12gitHZQwXzMbVT1NFdtTF06b5WzadeEHZs+stMi8qyi+VgzKGYMMEE9jVvnHpSD1FOyPyr40+abuNPH1o60p9jSCkIBS0nWigAHrRS/zqtfyGKzkdW2sBwaBrUkmnjhUtIwXFZ8urAAmGPcMck1lx+ZcDdK55HUmpVjUcbTj0HOaG7Gyppbln+2XU5aJSO+Gq1b6rBI21zsc9N3T86z5I1LAYz6iqc8CjBC8nnjv+NK4+RM6vsKXqOKy9FvDcQmNidydz1xWlgEgng0zFq2grAEjIz9aTaCchRkUp/M0poENPvXO+P7Jr3wZq0CZLeSWXHtzXR8ZqOdBLDJGwwHUr+YpxlyyUuxUJcskz5U8O6dHrEs1o12IJYImkG5vlOB0HvXJjSTdQ3TXPmmBQdkg6Fs9PeuyTQpbTV7ssREglkRXJxnk8VRsNOvLm/W3ufNjtbTdKCgypPavqYVbNtPQ+jUrXaZw67lSK3MUm+InO5eRXXabfRzWXkyDlV4HTBqDxRqkM6cxRi7Y58+P+L2NZj2s8NpHcXMi+U64XYefxrdv2kVzaGjXOtdDRgghTT5J2kG55gqrnkV9YeDI/J8K6UhGCLdT+lfKvgfRrrWNas7CJNweTcSeePWvryzgW3tYYY8CONAoGOuK8bNpJOML+Z5mZy2iWOx6Uv6CkHXqaXnjH61455IZGM0Z559KOvSmlQSOOhyOaBCk49OKyLmQXFyV3ZA6DNadyT5Eu0c7TzXOWEhM53Zyex5NBrTXU2Uj+Tkfjmqd2oC544HHtVsyAZbnPeqF1OrL8hG3qCKllxvcdo05S4MeRtYcDpg1u5wMnpXN6ajNqCEDvluc10fTvmmZ1FqKKO4ozQDTMwGBnjHrSEdByaUkAZJAH1qCW8toj+8njXnH3u9O1xkwoNU/wC1bEvs+1R7vrVqKVJRmN1cDupzRZoLD8n8KbKokidGHDDafxpenWlPXmgD5q+MXhqSPU5buODEaKVkwOPZvf615lpN5JHcxzGFgYcbip6gdDX2Xr+iwaxatFKMOQRux29DXzf8Q/Ams+H7mWawiJt2b5NoyMV9DgMbGpH2U9z18JiYyjySIbjxNps1sTO67du7OcmvOtY1a3luC8Ctv35Vv9mqerafM21o7WWGbOJM8c/Srek+HZ7lQZI23Kf0r1adKnRXNc7YxUS5p2pSusjxI7mPl1B+8K9f+F6HUdTEfleXEQCAevuK4bSPCk8kjeWrwwAbd7cA17l8MtBa0nWRgzCJcByODn+debj69NQfLucmLqx5bI9AvZRaacTgZUbRWBBGs7fMO+eT+tamvysqrGOh56VS0ziR+oH1r5pnmw0Vy5HahIyDjgcGs65T5+MceprocgpgHqKwrzDOUOTStYcXc0dAuS8bxP1XpmtG4uEt4i8pwO1Y3hxPnlYknsKl16Zcxx598VRm43lYqS6vcSE7WAHoBjNTWeqyI6rNhgeKpwqCCeAP5VI6gY5Bz39fep5jRxWxp6xpdrrVpslPzfwSr1U1xE/hTU7WeVh5M0B4Jz94fT1rpor5rUDHPY84pyarczZPCRjqc8AVvTqyirLYlKUdjgr7w3YGdQYQJHGCyrnaa52/+HmsTSKIFZoScbs9R7jtXfal49soLma20yOO4u4ly5fjFcle/F67aKdbWOJZl4UEdCK9Gi8TvFfedVOVf7KJYPhjqFwEjlCJFjG8nH14qXTvgpDb3glmnjdQ27vn6VhRfELVLi7tkk1GUByPNCjAX6V6NofiZo5BF/aMd4zc7JOo/GnUniqa3Cc8TA6bSfD1pp1skMSAKowQO9FaFlex3SKQQHI+7mivLlOV9WcEpSb1LGcAZ4zxS4po3ZB4HsaU59cZrMkCaM+1J7dPejkc0AO/lSZ445/Gk696M89DQMUduc1n662LA44ywFX8Z6j6VXv7YXUBjY45yOKBx0ZhW7jyzwTjr7VYU4bJ544J6VQBkt5XSQYPIPGD/wDXqyJSRj0wM1LR0MlZumfvY61XnYBCcHd6VI78EevANQNH5wwGPXBGM0rAWPDm43crjO3aByeldB68mqun2qWluFU5J5YkdTUrXEEYw8ijHvVGEnd6E3bI/OlyKrpdQSH5JFP44qYc9O9MmwYHoKUgZFJn2OOlLx9aAPnz4weHptM1zzUeU6deHzF54Vu4rhzqVxplpMttI80bttwTwB3FfU3iTRbbX9Jmsb1PlcZVu6N2IrxKf4Ya5arcQRfZ5hztbfjd78969nC4uDgo1Oh7OFxMJQ5Z7o880XTrHUtPv3vphahPmiDdCfTNVYPD1xqk0UWmSGdVODgdq9W0/wCGF5f6XZ2moW8NksJPnSB9zS+49K9H8O+GdM8PWQis4FL95CvJrWrmUad3B3f4GtTGRhfl1MT4R+Ek8OaT9rvQxv5+P9xfQV37ajCjhW3DnANZtzPtTaM9uaxrtt8jHdkjr2rxKtWVWbnLdnlzvVk5SO3ikWRA6MCppxPGe1c54dklWcq2QjDoTxmuhzgcg1BzyjyuwqnPNKTzmkA9AfypDxj0FIkdjIKk9a5C4WSzvXVuAT37iutbOeOtV7u2iuFxKuGxw2ORQXCXKc/Le5TGc9zk9aLRXv5MR9sFvT2pZPD1wZxicGPOc9xWq7Q6RZLGoyR90eposauS6Fmyso7UHby5GM45q3XKT3N3OC4c7eoHp9abpupzW94iSsTGxw2T0p2IdNvU60n8DVLVNQt9Oh824OSeAB1NT3M8dtbyXEh/dou4n2rg7mR9Vuo5rgHYWyoHPXt9KunDm1exMY3J9U1O51Ixi2JML5yicY+tYN1qtjpkbCfMkx64bJAHarHj3xFb+F9Dk27BcSqdoHr714fa6xqGpl/szRjzATJu5z9K9PDYZ1Y820TuoYfnV+hp6z8WCsslvZWwQKSqseSfc1q+HvilblIlhlkiuOjdRk+1eeX+g6xJudLSIxsvXZyo+tZFrp95BKshUCLzNgOMDd6V7H1TDyjZfmd/1ak1Y+wvCHjOLVoYkugqyNwsqnhvr6Gux9c4zXyX4f8AEk2neIfsQIjVEHmYbKkf419KeCdW/tnQ0mb7yHbkdx2NfP4zCOi+ZbM8nE4f2TutjoD068VHcQR3ETRTIHjI5BFPx17fWjp1zXCcpx+p/D7Rb2YyGNo2/Aj9aoQ+C5rHdFZLamLHysyciu4vJvs1tJO2WCDOKw38QM3+qhwD0yea2Vepa19DaM5tWMzTfCch2LeNEbdW3FUGd5rsooo4ECRqFHotc9JrM8kJCqEb1AqumoXKyYZ/l6VEqjnuDjKW5r69aGZFmXny85BOOKyoA0UgJ3An/PNbWn3n2hZEZXVkIUsyYB4zweh9/em31vgeYDtHX/8AXUBF291lN7zClQSD6DtWbNIc5fduHYU++v7DToTLdzrwN2xfmJrzTxD8VmtvNTT9O2qMYafqce1bUsNUraQR0U6Mp/Cj17w8u2JznOTnGc/5NV9dybvfuyAOR3rwu0+JfiHUpHkSWK1SMbl8tep/GtDQfi7cR3aW/ia0Z0c/LcouGx646GuqWW10nZXZo8FVT5j1yFiGwFyv16/41MZRtOT7jPOap6VfWGrWnn6dOk6f7B5H4dqlbcHPQgdfevOcXF2Zg1rqEcW+YKo3Hr16VxvxD8YWWmQnS4pSsoBJwcHPpXoEQSzspro8YQkAjG33r5p8ax299q09804+98mec+tehl9CNWd57I2w8FUnrsiHTb5JWlWGPdcyMTnOGz9a0v7Ot3sw8gf7QD+8I/h96z9E0xba6gu5mySu5QoyP/11o2UUlzJLtnyGPOPrXtTav7rO+bs9BRb2ljp87PJEWfjDckD1Brm72HU7DUIZ9PkeS327tyk8CtnVtLuPtUcYZSpHysFwK7C2FnpttbQhg8U8Plvxkqe9L2vs7Pe4ufl87m78PvGDPpVjBqjJu3Yjlzh1Pv60V5fcXs8a3Fjbrv2NuQ45AorGWXxqPmvYwqYOM3zLQ+tEYMARnn1GKV3WNSzkADuaTjt0rB1+5Mk6Wyn5R97nFfOnkRjzOxJd6wzErbAAf3j3qmL68yPnJ7j3FEMQVRjsO/ORT9gPIHqev9aVzflSJrXWXjKpdDOTgso6VuRyLIivGQVbkGuYuEBVgMc8dOlXPDMxImgblU+YZNCd0ROCtdG4Dn2pfxP1qORyo4BNUZdWgiieSUkIgyT6fWqSb2M7XJNQsIrxcnAkAxu9frWDJBd2rMrxkjsQMj2xVr/hMtBGd+owJt6gtWtp+o2WqQmSxuoLmL1jYHFNwlFaotOUd0c1umlZlSItnjgda29J04wIzTY3N2PatMIoOcBfpQ3AYhsEDjNQDm3sZ8033gOq9gOayrmAu245x2IFNS+BuGj3guD2INXPMSZOSd/YH1oehaVjOMPyEg98c+vtU1ley2co3Nuj/iHWpQNrnJyOmajnjTnPDEdCfSlexVr7nQ2l1HdwiWLkHqD1FTeuc1yen3P2O+XOSkhwc11eMdCMYzVGEo8rGzOUjZsZIHHbJrnopmllfecck/SuguE8yJlJ5I4rlrrdbTMnzAjvQXTSNQSggDcMnjB4qF3RR949fWslp3IwAeeOfX2pwWV12qMgdeKRpyk91OucZ3DsDUdjaG+fodvc460+z0m4ndjP5YXdhQufu9s571tymDSNOeRuAoJHqTQlfRClK2iILq9sNChRZ3CyH7q4yxrG1Dxgn2cmBRAM8tIefyrzfxtrzMZbqaVReZ/dqTwBXnltr1/qyTPfkzKjbQudowPevVoZfzR5mb0sI6i5me+W3iiG4nD/ANonavUB+Pxqtf8Aiq0nufs6akMg5JDEYrwO21yF7uV7hZLaJR8iL1OP51RvtQvprlpLeUCJjwrDrXVHLVfex0LAq59L2fiK65SzuYLiNRkeYc5ArpvDusjWLVnMLQXEZxJE/b6e1fLlnfajaW64csVX76tyM/0rrPhR8VII9cktPEUio23yxN269/8AGsK2Xy5HKGtjCtg3FOUT6MzxnIPcmuR1C5N9qWM/IpwK6aC5hv7HzrOZJYnU7JEORXEWhaO7ZZD8yk59a8lLc5aS3Z0jxbbXHAyKw0i+0ahHHtBBfHFac9yrQ7c847Gs3TX/AOJzbliPvc85z7VMTRbG14wkC6C8RGRMwj9P89K4a41aHT7BZZirXGCFUHOTXYeP4Vm0iFXZkxOGyp74PWvDfitqCWt1bQSszMsO5SnA59a9HBUlVtAeGhzuxxnjLxA+varPBNPJ9oZ9qZ+7jPQVa8J3Npo2qfZZwruUKnvXEWlle3YuLhTsaH5sucZ+lTac0rTZuMRSociV6+llQjyezT0Pa5Eo8qPd7AmSCTzlVYCMLg447V5n4hkh+13kUT/6ErF3A4w2Ov1q2uo30+lf6PMHWMYY7scetcedQSaG9gnAMWflC/eZvX1xXLh6DjJsyp03FtkEV0sbwi3hlkllOfNYnO3NfWHwWRF8OyNFu2sVByehxXhnwX8L3XiPUlUwtFZRfflYchfQfWvouS/ttHtfsOlpGoiwMj1+nrXHm1ZSfsY7nJjqil7i3OsoPsPyrhTqN5KN7TMAcglau6JrDxTmK8lZoWGFYjkGvFdJpXPNcGjotTG+wmQHHHauNRSnBwPYjrXao8U8WY3Do3GBzXP3+nTwNJIFJjHOc54rLyLpu2hUjBKjBGD2AxmlKndtHT6VBDICPlyRnBAqyW3KSMEnjFZ7Go+Od0dVQ7WAx0rmfiRrlzbXMdrHLiAQeY6L1Psa6exh8yfI6LXlvxG1eGXxTObV1kKIsOMZAI613YKHPU2NaEFKpsZDakwi/fysd2HUKOcelYWvLca5r9vGqLBG+FUMeD706+1B7nSp4TCgeE8OnX/9VY63dzZva/aHDhfmUj+HNe7Sp21W56kIW1Rv3WlR6bdLHDCGUMF3Hoa3b7ShBpct7f2yyWIXapX70TetcLdXly8M1s7uBu3BmPXvwa7rQNU+3+GGs7udnBUjbjkelRVjOKTuZ1OeKTOd+GfiObQteeZHE1jIfLlTpwehx7V9BjM4jmtSskMgDo3bBr5isbGWK/uPkaOOPJ6Yr6a+G+oxap4QsJYhzGvlsNvIK1yZpTjdVEc+PilaaJ/FaIfCd3Ez+Xuj4xXzBrsktrb/AGYxAlHIzt6jPrX1d4isl1HTWicMdh3bR3xXg/iPSo7NrqQs7wb9zRt1zUZbVjC6Zhg6ii7MynvoLTw8kawhZJE5x2rM8Gaikmo+W53GQ4Xn8qx/Es7GLNm7KAuw5HSs3whFc21yJSnP3lJPUV7MaK9lJvqej7O8We2a5aGe3AW3LKoznPzIcV5ne3VxFqcTWU7FchWRu1ex6dI1/wCHQRt8x0xu74x0ryrxFEugar9pmj3xup2uOx+lceDlq4Pc58O9XFhFbK14Hst5kkP7wt2orF8P6os1lqU0p/f5yW3c49qK7HRm3bsdLiz7PB5rldTRodWlZs7WIYN68Vt22rW07BVba3TnFS39nHeIN3DD7rCvkNj5+L5XqYsbYYKcn3OaeVI4xlupqKWOS2kKSg8HOaXcCMjjPb1qWajZciMliq8epqx4ei/fyyEYAGBzVOdvk44Hqe1bejoItPDkbSfmP+NCFN2Rl+K9Zj0yzkJcqVGXIPQV83/EHx9fanKulabKsMU4+Yo2CB7+9dR8XPGMd3rMejWjhAV3Sv1+gNeD3tuINTkchniV85II3819LluCikpzWu6PRweGSipyRtw6fq1opXTLlJnm+8Ry305rLsrnXNAvWntL2ezuFOGVZCpP1r0r4eC2urpso1uMbgo7fjXNfEiRZb6WKPDkHlsdvrXoQquVR02jrfLOXI0dF4Z+OviPTSkeqPBfRJ/C68t/wKve/hv8RdG8cQOLNWtr6MfvIJep91PcV8SQRJJcqu7BJxmui0/UdS0C/t7q0uWt1WQYMZwMjvWGKyyjVXuLlkc9TBQqRbirM+ztZ0xIJftdsgCH74A6fhVe3fcowfyPNHw88W2ni/w9HcJJE14ihLiIEcN649DUup2v2G5BiyYn5x2Br5WpCUJOEt0eYm0+WW6JtzMVwMN09qR2AVtxA5/KoUlXjHJI/OlGZCqjnjqO9ZDKiwm6uURcFs/pXYKNoUdSBgc1R0ywjh/ekZkPf0qrrWpeUTbQsQzDll7fjVGcvedkact5BFgNKm7pgHvUDvZzrudk57njNcxGhYsSxyOpqTadp5I4xmk2ilTsbM9xpsCHO1sHoozT9NvbO9YpCCGXgA+lc5MmSd+7Hp2NXfCaKLyfHULn6inpYHGyvch8c+JZtFa3stJjjk1G45AbkIvqRXMX2uX99aRw6g6ibdjI6A+tSa5Mbf4mX32j5fNtk8gsOCO+Kq2yw3F3KJH6NkAjg/jXowhGMVp0vccYpK55341t0m1OS48xJPspC+SP+Wv0rlbpGvrgRwQyC3yMeWO/0qbx2s9rrcnlyNsWXIA9zW3oepR6fBA8Z3o4O7A+ZWr2o3p01Jansw92CtqRGOxkHlXCnZCgGWX5s96yVkMd6ttDhrUtxkdB9a0X1GCbUZJJwYXc7WYrkD0OKiZVN6kSFN5fgL/EKI3W4031LOpaXdzWsU24EEbdyDp7VwnjDQbi0kinWM5CfO0Y64716zLceRp6wRuoiY7vm6/hXPeJ7uNLWDYxwY2SUHuD2ow9aakkRGTejPUv2YdafUvA1xZzPl7G4KrnrtYZH9a6/wASWkttqbTRg+VL82QM4PevIf2b3fTPFl1a5JtL22ymeNrKc8j86+jpY0mTZKoZT2Irw8ygoYmTWz1/r5nl4heyqs8/+0EqoGMnPT0rV8N6bJLeJdTBkSPkf7X1rpF06zWTcIEz16VZ4BCggE9B0rhMpVbqyKWu6cmq6bLbOSCRlWHYivnz4oyiJobx7FZfIRrWdWHDehFfSQ+tcT8QfCqavZStEoKyDEyAckdmHuK68HXVKa5tisPU5Jq58uLqf24Jb2MKyRxqC4I2lf8AGr+oQGfTFXdCzAfNFtww/GoPFXhK/wBG1uVY0kaORP3bhSA2O1ZN9fNc6TF5AnW/RtsiuOg9q+oSjPllTeh7aakk4mBMl7a3MpkSdIe+Mge1dL8MPCuq+KdaKabDtUH95cP91AetdD4P8Nar4ijisly0Ui5ct2PrX0V4e0jT/BujRadZbROVzI/dj3JrnxuY+yi4R1kznxGIVPRbjrays/CWgR6dp7Ism3LyE4LHu1cZrfiCx09QlrJ59xn52J4BrG8feKne6eGBt0ak59Se5riINWs7k3MkikMw+Yue/avNoYSUlzz1uYUcO378zrJ/FtzFKzPIx9lHyn8aot4uuvMZ3cmPH3c8g1jWkbXsaCf92i/cycLRrVxAqBfs6LMqgBlHDEV1qjC9rHV7KG1jtNF8QyahP5Uc72t6BlTG3WvTPButz3VqbPWpE+1q20SdBIB6j1r548PXobVReRxmORgFIHYjvXstpbvcwJMhblRJnH6ZrjxlGMfdZxYmioPQ7DVtP8kNNAuxe6+9Z0WfuncRj6Vp+GtRbU9PeC4VluIvlbI6jsaJtObcdoJIORmvIlFxdmc0ZdGV5rpLDS7y5cgCOJjwehxXzbBN5hvpnDC4kYkHuc19Qz6bDc2Ulrcr+5lXa4PXn0r558TWb+DvEt3aGAPG5/cSspIxXqZa170VuduClG7XU5rQUuFuJGKlvnAOR1zTfGNs1vdB1ICnAx0FdDF513aLFLIqMGLkoP51lazE+o2wsXlQSRABXPc+9etCd6nMeipe9cr2cq3do0uN7x4yvcitPSNdtrEXBtNphfAbPB/Cue8P2V7p93LC5EjlSvHPX0rZ0qy062ScXayMT91sU6kY6rdBNLVMNevlN5I1oCyygbm9K9e+AmqCXSLzTHQAwMJAQeueteKCZ5VkjKbIkODgdR61658ALOVbnUrgZNsyBVYDvnpXJjYpYdp9DmxcV7FpnshAYfN6c9q8u+IXh+eCO6ZHzaXKkEjnYe2a9SzheuMmobq2SeB4pV3RsDkH1rw6VV0pcyPGhLld0fIF7Dd2INpqqOHUYUheHX2Nbmk2FgLbiYG6IGyPOOO4Ndz8W/BWoJYxXWmKbmGJz8n8SivJZJZjEYZEkiucDewGCPpX0lKosRTUou3c9qlU9rC6Z3cHiS103daElCvGFPH/ANel1XVtF1GOOxv5VZWI9iM+9eUXAvXuwYWeQIR879a7iPSk1W2t1ERWSMjaQuST3xTnh4U2pNhKnGHvNnTWPw70+7AltZNtoW3M3c47Ciu40HQr24e0t7a0ubWyKjznm4PTnFFedLGSi7OZ588VO/xHTS2i4G1QD1wBwau6bqMlq4iucmEnAJ6imkBmBznPcVFNFuT5sNjvjrXipmLV9zfv7ZLyD5SC2MqwrmgxidlcEMvGDWpoN2wZrWbORyufSl1nS3uJfPtjh8cqe9NroRF8rszEuJHaEjeV6ZI5/H6VvzTeT4ZmlUNlLZm984rNg0Sd5AJmAUHsetbOqRBdGnijBx5RQADPb0ojbQc2nZHx9BdxvrFzdCF2upCRLK/IX6VqX8VgojcsJrc4P3fmB9ak8c+FdQ0ozajaQu9vO3z/AN1T3rDUWs+kxvHdf6QchrdlwM/Wvrk41Epxeh7sGpRTidBpt/CIjDBH8p7KPvD69qS08MHxN9pXcqrDk5PBx6Vi6XBc2kaSQblbG1vbPvXQ21xd28RuLGUebg706ZrOd4N8j1FK61ieb+IvDk2jai6IfMjHIZe31rotO0i1ufDheUPLdb/lA5AFRpZ3uo6pdXbTCOReSkh4NUjry6VLIlsMzk/Mp+7XW3OcVFPVGuttNz0f4S3Fjo3iyxGiSS7rhdl2rt8p9MCvpK/tVvbUxsOSMgntXyD8KIr3XfFxeRBCsbq5dRtwc8D8a+xI12wopG7aoBPrXz2bRUaq11sePjklUTW5ybaXexOyrHuB7g1paTpc6TeZc8D+6OhrcJP0/nRzx6+leUcjqNoz9Zma1tlMfG44PbFc/Ed4LEZ3dcjJNdRqNqt5aNESd3UfWsBIUtSWuZCCO2eT7UdCqbVhFTAGASMZ6cGpGtZSrNtI9AKQaoRnyYhyMEsaT+07ph8qqo6AYpWL1K1yhTIdCPU46H6VUtrxrDUUljGR0bI6itBtSlBPnW6tn8Kih/s+7uB5n7ps8hxgEU46bj6amj4m8PWniSzhMrNDcR/NDcRjDRk9vofSsU+E59O0uUxTm5mA3HC4NdrHt8tQhypGBt6U8FuOhx1rSNaUVy30MFJrQ+c/GekxiT7a0BlVxhiOqt71zml3ECiYWv72aPLhW4GB7V7F4u0m/wBP1G4nS0W50i6fc/l8mEn1Hp715lq3hdhO01sMRPkxjPzj1Fe3h60ZwtJnp0KyceWRxEuoJNdSG5UjcclvQ+tLFYOUMsk7bwCUePnGPWqF5bXRuJ4pEcR7hgFTlsVOmunRlnBsyJ8bQucqR716vK7e4d3TQgOrXI2xTSiVfveYOv41Bqd091YzQi4y4G5l96fo9819cO91ZIlsx+Z0GAK3rPQYpPNMUcsonX5HA5/GnKUab1Q7xjqy98Epru21iC6kc5iZcbu4J6V9c5DAHpnke9eM/CvwUVWOedCkKkNuI/1hr2bj8K+bzKtGrVvE8TFzU53QvSg0D1o74yfwrzzlEz7UrD0/Wk596UY60AY2seHdP1VcXMQHfI9a5yb4X6DIzMsIVm6nH513Zx0o7gcVpGtOGkWXGpKOzOf0Dw1YeHo5mtEOdvJbriuN8Q6kRZXVxNJ5by5RSew9K9LvmCWUzOfl2nrXjnxEv7X7HDbjAYHcqdiK3w96k/e1NqCc56nFatp4m+yKjqWYbpHx0rButDVrh3gKyQJjeU43ZqxrGpy2ka/MoMiZUL1UVDY6qHtpQ0biMpgEdM17sFOMbo9iKkkZMV9PYTXNnC/nW7DgHt9K1dLBksoTKDvRs7G6sPrWHMxnuQjRLHgbmfpxXRC8guvsQhDZVdrLjn/9VbVNtEXIpQlW1p4opCu3LA4wGPXBr6E8KBbvw7p8gBKmMdD3rwTRvJTXGEiIwGdysefwr6D8LRKmhwAKQpUMpHp6ZrzMyekUcWN+FIuaOGstWaOZgDKeP8K6gqAGI/xrl2CzaxCp52YxjjFdN2/CvIqb3PMkRhcgZJ474zVDVtHsdVgeLUbaOdexZfmX6GtQfzprLwNuevpUKTWqEm09Dy7V/hPZvbyDSr6eBnP3X+YfTNcP4x8D6loloPKtftMafMZoxnj3r6HCYXCjGT9ajYZXEm0r0we/4V2U8dVg9Xc6qeMqReup8n6da3sN2145MexcqGXr7YrYivpLdJRNCk0cq5JwCVJr6Kv9E03UYil3ZxPGOnyjj/Cuck+G2hSyfKs0adSqvwa6/wC0YT+NWOpY6EviR4dpljc61q0On6YnzzED5h27819J+FdDg8O6LDYQ8lfmd8Y3MetGi+H9M0YAafaxxueC/VvzrVycgMOfX0rjxWL9vaK0Ry4nE+20Ww/qeemPSjHBGOKFOB83FDHBrjOMY67shgCOvPeuS8V6b4Wtz9r1Szge6wSgAwzfWtDxtr6eH9Hkn3J9pcbYVJ6n1r5zsdQ1TW9YuL7VrhjM+Qkf3toz1x9K7sJh5VE53sl+J14ehKp7ydkd/f63omnSKttotupdd4YpnNNPja70q0hvYrGIWzHC4iHymvN9R14Q3koAxGi7FPrWto2qRazaLBKSnzZXdwob/CvTeFUUpSV0d/1aKV2rnsfhr4ipqJSO4EPmHHyqcMfoD1orwu5i+w6tCJpwJVk/dvGfunPt2orGeXwesTCeAi3eL0PphvuqSdp6f4UzKheCB35p5ACgtx2+lQyyFUOTxnkNXhHGV4Nyajbsp4LjPtXWYz+dYejWgeY3LdB0+tWdbu3hiEcJw7jkjsKryM5+87I0PMjL7d659M1X1ZZGsJBDjeBnB71y/lsDksQ397NbekXhlU29yeR0J7+1HmgcOXU52JLW+V4p4hLa8rJGRzn0xXG658MNLuJjLpEjKeuHHGfTNd/rGnyWN4Lq2Vnhc4cD+GoY72NTuGApP8PY12U6s4e9TZtCrKGsGeZweCtXt2UFFl2D7vWs/wATaFqLqpe0aB4025VcZHvXtC3Cjk8kjcMHrVO8vAwczDthtw6j0raOLqc12jVYqV7tHz/ZaVf27PcIOikEsM/jiuT8OeFb3UvEyz3MDvF5hdiRjd9K+mPs0cy7RAm0HG0Ln8M1VS1j06OSRLdfNY4SNBg7j7V2RzBpNJas3+uabakXw48LQ6dOEIAk3edIR2PYV6meTnv6ZrB8J6ZLp+nf6W4e5l+d/QD0pmtas0cht7U/7zD+VePXm6k227nnzk6krs3y6BthdQeuPanHPUnkivPZBO7bjISWOevQ1p6Nrc9vKsN0WkibjcTyKxtfYTpNanUXc6Wto80vRR0NcoZ/tkxkmILMc/T8K6PV7cXumSxjnI3Lk1yFk2FwSAw9D3o6FU1pc0/LBAORt7ZP6U4oT9ccHoaridUUZx17kdadJPno3ygc81BYkmFyWIOB37Vk3eSjFRnP51dkIV8gnJ6Hr2qheTxQQyXNzhY41LNk8gelVFO9kUkaWla7DoejyS6jJhCw8pOhY+1Vbn4g2awFklVTzwOfwrx/VtYk8SajNM8pjhiUmFWbC4HYe5rIt4PtqmSAtCS3G4nFexTwEbXqbnVDBxesj0fUPE99rNyYobmaKEjPH9a5+W7ktNUFmT5+efMRuFpNOEK2EqXjfvIyAdp61FBrDfbGkitIt0a7VJ7itowUbqK0NVTitEtB9rq0J1BySGZG6yAd66S407SvEFk3260gmjH3vLXDj6GuM8QWjXKJL5axu4Bcx9Ca2/C+qRwXcMEj5UhVJPY+lOpD3VOG6JnT05obmjbfCDQr62xoupyRzZ3eTJ0B9CK6fwt8NZrFo/7Uu4iqfwQZG76mtZYY1MbIm2QHhwcV1emXLTQKsn+sHTB6j1rz6uLrONua6PPnVm1qy7DGkMSRxKFReAPanHgE4HA4pQM+ufXNJ2znH1rhOcXtzz60diKy7vW7a3kaMBpCpwdvaqjeISc7YR+JosxqDZvjnpijsfasnTNWF1OY5dq5+7g/pWqTwSCAQO9GwmrPUUE5pPy+tYdzqbiQsvGOMZ4NOg16Peq3SFM8bh0osyuRmtdQi4t5IX/jBHvXhnj82kVxvvLV2kiRol2now6GvdUcPGGjIKHkEVxPxD8LJrFs00IzJgCUAcn0YfSunCVFCfvbGuHmoT1Pl+1jk1LxJHazlgqjG09cV6vpGgaeLJoiFI+8Ceo9iK4GWOTTPHHkai67Yzt8xuOMcc12c1xarpUl9b3sa7eqlsZ+le7ipSly8r0aPWrSbSsclrmnQWGqSeXOqK3IU9x6VXsp4FvTFuwhAAIH3axdX1W11PVuZx5rMNpLYX6Zra0VUlvVG5Hu/uqByF+prdxcYe92NkrR1JIYpn1yHzIwilsBwMlvSvo3QZfI0uGJ1Cssa5HavK/B3hyOXUxdyXPnwwNuUKcqDXpclykUZ8sqXPGB3PpXkY2oqjUV0POxc1JqK6GvpoWS9GzDY5yR0HpW/jLE8DPU1maJZ/ZoQ75MzDLH0/CtMHJ9QfevKm7s8+T1AjBO/Bz2puDvJOAPr1FP6gjBzQMnacHNSIZJwueffNNbODwfx71LjqfwxQR9fwPWgCLk9Rk9hSDGccH1JNP2cjAIGKdgZ45/HpTC40DJ6DB9qci4xkDHYijHzcjt37UEgHDOKAHAjmo5pFiiklkOFjBZiT0AqC5vIoBy25vQGuP+J2tyWfgW8lt/kkuFMak9gepq6cHUkorqVGLk0jwb4leN5/FGt3b2X/HpaEpGGPBPcis3wpdm2s5pLlzBLJzESM7j6VjaFc2KzmFx+7J2n3Y96m8URTWGqxpFFKbaMDbzxk19aqUYr2MVZH0EKcYxVNGrNp9tczwTS3IZmPzLtrQvLKOImKRvJt7cgnIxn8RWTp9u+oPAiMVfOcAYx+NbPiOd5Yvsy2jF9oyWPccZrOTfMo3G272IbeOzuW3WO5nJGCxPA9qKp6Auq2lz5yQb1C/u8r8hPtRRO6dk194pXT0PqBfMKlQp57Hv9TU1np8tw2ZkKJnkMOTitxETgqgz0zipBx26V8kfPufYidktbf0wOFHeuelZriVpJhkn1HQU+8ne5unG7KAkAelSKuMc4APYUPQqMbajBENoDHgn86rPGQwZAcg5UenvV3bwcghvWo26H0zjp096WxVzQsLxLyIxynD9DkZzWHq2jTwiSW3CyRs2dnQj605w4YlSQ56AGrkGrywoqXCbwONyirhNx2J5WtUYzeXJaP8AaHYbTgA9R+FQxYlXym/eYPLtxkV1UDWOpoQsalxyVI5qxBYW0Y+WFFOfTpWvtUg5rHIxma6wtlEcj5RxgfWtjQfD4tJDcXjma5Y/xchR7VvJEiHMahfYCnHnOf8A61Q6jasiHPsUtXuPs1g8in5sYGD+tcvZxGVyWI3HqSM1veJY2fTcrkbTnn0rBsZgmAvXocjrUdDSC0NFNO+XBQAEZFZWp2whJYkHHqMV0KXKeWRwGHvWHq0nmsUUn8O3vmpW5UW7nRaNILjS4mI5xtOetclfRm0v5YmT5dx25HUeorq/D0Jh0uMEnJOev9afqc1law+ffeWFTgMeapb2RClytnL21vdSgCKEg+pGAakbTr4g7YjxnIHSsHxB8VtO0vzI7ZELjgVyNr8dDNO0T27fKeSRtrqhgK81zKJtGFSSuoneXYntl2zRso9dvFcD8TdSlj0yGyiIX7Q3I6Zx2rq4filo90Fiu1MkL4yjLhl/x+tcT8Zre1u9Gtr/AES5E0KSjaQeU3djW2Ew8oV4+0jY1op86UkclZXVtqDWsEMbbYh8zY/iHau1sPD7XFmrSMscedyKP4j/AFrz/wAOLLpul3BuColkkDEkZ4H8q9Q0PWLa7soyWzlflU9q9LFc0fg2O6s3H4TJ1DR1t5luJFYQRrzg9a5h7uI3h+zMTEzZ2jkrXo+oqLiymUqduMKnoK82gs3sLqW4t/vOpUrwcZpYefMnzbipS5lqa39v29qTHvWWFiASeoNX9OihbVEuVKpHdDCKo6Y7+1cLDo+25SW4O6OQ5Cqec112l3Ej3kMcCMgChV4yfpirq04pe4VOKS0ParQNJbrjDAqDk8kmrlpcNbTI7fKOm3HbNVtBhkXTrdH3eYigDH+FOv3lWWMSjknC4HU14T1djxnvY67IIBHfpWNr2piCLyIjmRuCw4xWugKoo/iAxzWD4ptENn9oRDvHXaOorBbmcEr6mRbQiUklvvevWr6WPoOoznsPesG2uQpUlnBHOTXQWF4OkhJB4BzSaZ0S02Kd/GLdkMeQxPBHP410mku0ulqzkhsEZNYetrmPIIBPoK19A2nSI8HnkZ70dDOequc/G5MzhuoY8VBdwAc8Z7YFWYs/bZAp4B6VLcphiR3PWk9y0Lomptayi2uN3ktwp/u11R6YHI+vauHaBpZVK5BznmuvspCLRDKQCg5NO9zOpHqjg/iV8LrDxjBJJbzfYdQIwJAvyt6ZAr5z8XeC9b0KBdMvrWRZ0YncjlopF7Mpr6c1TWr6W7b7K/lIh4AAPHvU1w2m+ILSGPVoiksJyCOhPf8AD2r08LmFXDpRlrH8jpo16lJWeqPjix8N3l3dJHtKkHBIHSvWvDngt2kDsSvHLAcmvc7K18M2UTRx29vhgdx8vk1qada6Y6GWxjj29DtHT8K2r5tKpsrGlTHSfwqx5/o2nw2UUUNqjvIP+WadfxrqtD0h3uftF2hEacorDBz6muhaO3tImm2LGAMlgOTWLJrTTsyRjC9P8mvNnWcrnHzOZdvdUWKQrDtYqOeM0ltrSSuElTaTxkCsgRFnLNndnPUUhj2846dxxmue6HyKx1ysuAQQVPQ5py+xGPTrWPoM7sjRuc45UjmtfkccUzFqzFPIyccfpS4OOO9IDxkcn9KDycDgigQHsD17nFJgcccZ4oOexwR60MSoZupAoApX18lthCR5h5/yK5u81K4ldjuODwBjGBTb1pbq/ZiuCxwuP61M+lzvC21TkDBGODTehvGKW5nxb5ZAM5JP4CpPibYfbdBtbMEASgqOOrY4H41KdOuYGSXy2OCOgx/+urfjqGU6Jb3KAk28quw9B0Na0ZNTixt2kmj5B1CxuNN1BEjVYlDtgledw7V0wiu9Qgtbdg0k5PzN1+n0r0rxP4OF7cPqFskbXLqQI35Vvce9cBbWN5pc7EpL53QgjB/AV9LHFRrRTW6PXhXVRXW5uadp88OjzyRzQxzwHaynrWZdedcWHmeYp5wxPWqbWNyZfNaX5JjgqG5z71ftraC2jCybiw+93FRbld73GlZ3OktPE9tZaVawz2BTavdM7j6iisue4kmDKgjkh2ceqUVnGjB6tfiSqcXqz6dXOBnjIpc56DHY5pq/d5wKdg557CvmzwDm5wYLx0bHXPSpN59QSPetLUrJbpQwwJR096xJVnRtrIdw4x60mbxaaLG/5dvYZB4xj6GnPDKM7QcH0qTTbV32vOhGOmf61auruK2k2Hk9wvr6UWE5a2RjszKxBGefu+lVZXB+8uD2reiks7kZwoOed1SCztXwQF2jrg8ZosPnsYvh+F2v/OAICg5x0rphwvTHPrUcCRxqEhwB6DvU2AoPUfjVGcpXYmQOScDHpSg5HGRn9aGxjpQME844pEkVwizQPE65VxgiuN1HTptPl+UFoz91l6D2rtWHXODTWQMhGMqeo9aC4T5Tg1upFBzkeg7irOl2kt9cjepEY5Jaus+yW5zmFcjrxUqoqABAFHoOKexbqdiK5mhsrJ5ZWCRxL9BXzn8RfiBeXuoSWunRtIXcxq2eF9BXp3xh1t9O0WcI+FVcZz/Ea+Z7C0udR1Oa6llYRg5IU46D+dezlmGi06szrwVBS9+RXlheO5VtVuGaXkt5Z+6fSq8lrFdaj/obmeRvmO/gGtDS9PW61aUTgsHG4AtyKtXVrb6d4ht3hm+QHgMMGvc57Oy3setzJaGfaPdabfl9QtpBEBxnqPpXaaTqh1bRri2EAWTdlWHoOQaPFclrNpc1xMVB2DABzg+1Z3gbzZ7mCODaIWBBboTntXNKSqU+dqzRz1LSjzdUWk0q4nWVZpF/eDPytwWrOfVLjQZYHjRt8ZwQeQa7i40uLyXeEYlQ5Uhvv+orH1CG1uFSUwu1ox2scdDWUKqk7SV0OFRSWpp6T42jbTZ3eL/SJunGQtUUQSosu8fvMhV9zVGGyt4EkWCEuVb5WPerRnSGAJK2LjqAPSo5Ip+4g5Yx+EjhtZQr+bxIh+VVPIHrXqPw98Np5a6lc5ZnGYw3GK574e6BLqF21/OXWP3/AIvavW4Y4kiQKpAXpxwD9K4cZXfwROPFVre4ixkW4zn5iMA+tJZx/a7oyNjyozkk+vsarztvmjiU+Y/cA4qh4i1VLG1FjYzKkn35ZOu0V58YuTsjg9C/qvi2zs3McMclw6nB29B+NcxefE4W8hW50ljE3pIM4ridb1uOEuyFHY9I84Lk/SuC17R/ES239qySK8ec+SvZfWvRoYKnKymddPBqXxOx9C6N4x8N+I5EtGVrS7cfJHOuzP0boan1XS5dPJkj3SW3t/BXhngqeLU47e0v5COf3bE42H617X4f1a901YbTVW+16e58tLhuXTthvaufFYRUpWh93+RlVpyou245rtpYcEqfT6V0PhaUNp7IMfI+MelYmvaXJZymS1UyW7c4H8P/ANarfgxnBuFKER8H8a4baXM52cdCrMTHqMqsCCrnr6VYnYHBwOeDjmq+t5h1aTIYB+eTwRUBnwRkj0yTx7ZFTLcpao0LEGScAAmr+ukw6aoBxubp61S8OHzLh9+cYznNO8WTYmt4R0ALAHuaaWpD1kkYscW4A4IOemKl8gf3c57EVJAwCrzz/OlaVQvUY/l6VJrcqSQLkk55GDxV/wAJOYtQkRc7HHI7HFU7iUkZGc461u+GrJ4YjPKPmbhfpVJu2pM2rE/idyunrtbbl8H3rFtosgcZ+nQ/Wt3xIrNp2Vz8pyfpWHZHCg5+Y9jSexNN+6XVUDqoYdCQKSVcbRjnnOBmlViq4PGO5qOVgB0A9eeKgY/R3H9oBe3Paukz19657QITJdNOxYgZHWt9iFRi3AHOasyqbjyevXGKb5i9Cy5+tc1e6z9onMdvKFA4G1ueO9VZWlk5LMePXtQNU2zr/wCEn8aCeM4GOnsK5a3vJoCp3kgDODnpXQ2V0l2mU4P8QoJlFor6jNBZgN5amQ9OKxnuJ5GzuIBOeB29qveIFbzUJxjHHOKrRRhgoJPHXJoehpHa4wahdQEYJdO4Pb2zW5BJDqunukiAxuCjpWM0QbBHK9j/APWpluz2c5kiLYzkqG4NCdwlFPYzdS0yXSGRJAZ7IHEcw5Mfsf8AGkk0uy1OL99GrEDCOOq12dtdw3abGxkjBQjg1Ul0SFp1ltj5OD8yAZU/4VuqvfclTaPJvEHgSVUkfTcM5+Y59a4mTTLkOba7321yqnDbeCfQmvomSznifDAlAfvL6VDPZWkxVmghbPGWTmuynjZRVnqddPFyirPU+cPD9vqN1qS2traNKd2HdlOBRX0lDYW1uWEFvHE2QeF6/TFFXUx7k7xVip41t6I3lPyjAyPWgnDLkf8A1qao+UeXt59DxT1zjnGa8k80Mg+5HrSYy3IOKU9f64o9Mk0DILyXybSSTPIHH1rmBueRpXLEtzjrXQ60u7T5Bj6isW3YFRg44x1/kKTNaewjQjJJXBxySc0eWc4DMMfjVk4wAcAk8Y7UMo3D/wCvxRcopESxndG7Z9a2tJv/ALSDHKR5oH51mzgYPO0kY4qCxcwXsW1t3IHtTTuEo3R1QO0ZPXHbpTcg4xlu/WnEZPGR74oHfj/69BgJ2z0HpSHHp+NDY4wTnHaq8l0sUmxjzjmgEifo3TqOTmjA3jA4PeoUmhf7r8n1P86mGc8HH1oGfOH7QV3NLbkAyGJZznA9Oma4nTr03dnHIbaNITHtyhxg+pr0H462U8ltcxopUebnP97PSvF7KbULFLXZE4jAIdSOHFfU4OCnh0ke5hFekrHQWlzbZlhQCOYDIlfvWNqMMtzPJNdklIjww710mgx2upzLYiBcbslSfmx9av694US1mR7eQpZy5XDHI/KtlVjCdnozbnSlZnP6dHHf2sEUZ86JThy7YP1Nd/4G0m0gk4O+OPOFHr615TeWL6O7mG4VmLAgBuor0T4c3V0uqRpg7duQBzkY5rPFRfs24vQzrp8jszqI7cCSeOchVY5jyema5bW7C+0u4yI3MBbIxnBFeiXlob7WLOyhUKzyqS+M1pao1vaW8tnqCq2xtqg8kfnXmxr8jWl79DgpV/Zux5Q5kmgUxKyAnhcdMVt+HvDx1/VI45NqxofmfHQdwK7Sz0zT5miNuodz93HOB3rrLaysbWJRAFQqMuRwD+NRUxbStFWZpPF6e6hdNsbawhWCFcKowDirpBBC8biPwP41BHtEW4sSM5HfAqxax/apwqH5VILc5Arz33ZwNt6sivrgWNqXRQLiVTsz1QDvXi2p+I45Z7y1gZ5plJd5F7mul+LfiKW0lvIoCRI48mLaMkDua8l8KxTtcFJbgxO77pgRyfYV6uDw1qbqSO7C0bx9pIisdchbxBHPcjZGjdx0rsNd8YWb2jQ2DRSF127j0X3x3rB8W6fBdAPbRIrQ8MAME+9cvDpq2+SXAyMlf8PevR9nTq2k+nQ7+SM7SOmi1SBZYIkCFlICsBjB9fpXv2jxrd6PAtyn+sjBIxgH3FfM9rYwyPHdJIUk4+QHtXv/AIF16K80mG3mzFcxYTnqw9q4cwp2inE5MbDRNHW2+pSafGtvMPPgUYBzyPY1uWbwywCW1ChG9BjHtWAwWYbyMYJDA1NorvaakYs7oZh26Bu1ePKKevU8trTQ19QsIL1AJl+YcKw61ljw6g4WTGeOn6VvkZ46/WjHQ9axEptFOxsorSMpEBuPUkVU13TmvkVoiPNQYAPUj2rXxxj9DSDB6c4H1oFzO9zhra0umcRtCytmt6w0mO2/eXRBcngE8CtvA7YyT1rN1FwJkzlgvISmtS3NskW3tJSWWFcKcZ7VdVQq4UDjjAqjbPtQmPKknpjPNWLaVnX96VL9wooasS7kroHUowG05BGK52+06W3cvAu6LOcDt7V0h5Az9aGwRnI60gjKxyfndAVYfh0pYYZbmQqisueue1dQYI2Odi8e1ORFXO0YHQUivaENvAtvCEQcDvVHxGCdKlRGKmX5d3XGa1NxLY2ED1zVHXYjJYNg8qwI4polPXU52ziSOKNFULgAYA4HFXDGuPftz1qK1Yjndz1561YyNrchR3qTZkLxqQcMCPenaXMYL5ct+7bg+nNPYZUnPze3XFVGybhdo+bcMYOPxpoN0dFq8O+zJwMpyCKx4CCBnGfY10bIJINpGQww1c3NA9pPsYbQOh7YoM4PoTjIHOfXkdabIq+w65B7UiyZI+bnng9qcX4A/wAmkWVHVkdWQsOeMc/5FdVExMSEjGRk4rCs7c3MwyMKTyR7V0C4UKoyTVIzqMcP8mmSQxuPmUVIKUVRkQrbRKcheR3oqbBx1oouO7IEHyKR+gptxOtvEXY5I9utLCgByvAI6VmapIZLgLxsU/r61KKSuyCXULhzlWA/2cU6HVZEcCYKVP5mmiNSpHU+h5/GoXiLlgBgjue9FzblRvI8V3Cdjb0YYPtXOXEDWVw6nhf4GHpVrSZjDdeVuJRu3v8A0rV1Cyju4tr/AHuob0oIT5HYxRIpIzt56EGhyFJ+Y4IzzUc9pPA5Urx2IGQaZGshADB846ClY00HSPk8gg9gBRaQ77iMAg7jT1sy+M5OTxWxp9osC5Yc9vahIUpJIuEDgZ4HFKe/69qAwywGeDg8UjAH6/561RgU9SuRbw8ffbpiufmkeVzhmx6Vq60D8q8ZrKjT5cbhx70jeCVrjAHQZAOMdelaulXzOwilYMexI7VRZQWORkDoSar5ZJN6uFI56c0J9xtJlf4j6JBqGm3Buc+S6bG29VbsfavlHUbTVtInubS4YvaRHdtkOcj1FfatrPFqFq0UoRsjawI4NebfED4X2+qafMbd3QqMq3Ugeh9q9bLsaqPuVNmdGExCpPlnsfPnhe/urW8EtqqZ+8SeQfxrqLrUbjUxI9zJ5YGdqjkVnv4S1HRJDbzWzT2knUx9/cGsrxDaau8yRabayW9uF2hc5Y/U17UvZ1Z3i16nqPln7yN6+0mySytLhV82Y/8ALM8lq67wfblZnu8G3B4Ubfu1yXgTwlrAzd6jcSRRLgKrHJ/CvSEt57lBa2akvwOB1rjxE0vcUr+ZyYipZctzpvA1tcz675khEkEY8wydOegH9aseMoYTrbEKpZlG70rptEsU0HQUEpBnCZc92b0rl5Fku7uSaQcsefUCvFlU5puS2POi7yuc6dG8t2ksbl7aTuoOV/8ArVZWHUwQkt6jgdRjg1uLa5znAwOMDqKb9m+ZueSBg4p+3l1NNGVkvDbRjzmdyPlAU7Riuw8IanbajaOkEPkSxfeTrn3rkbm1ORk8dhjineHLv+ytYDfdim+Rj6eh96iXvp9yZwTWh538Rb8X2sXEkZDeU5XPQgg9axdJgjljWTeJbvG4YGMnPet3x9pbWOtX0DLm2ebzfMA7Hms3RoTpkjyW+y4jIyDnkV7VNr2S5T0qVlTSRnuJpbhtkZiuASCjHmo5NMhS3Bun8ySTJ2jjbVu+eW7vDeFMEthvL7e1Q6tcLcpCYleNuhU9RWyb0saq+ljkRbyLfSmMsFT16Cut0DVprW8S4DvI+3kKOmPasa4nFoGdoWZi/PHWtHQ/tZb7PaOitcA7t44X8a2q+9G7LmuZanv3hrV7TXdLjuLWTaT99T1U47+la+nKVuUZCpXd1NeLfCXzbfVrqzkmJZyQ2DwcdCK9o02KM38AiZlZTuZf73GOa+fxNJUpuKeh4uIpqnJpHR46kU1iq8uwGf7xqhrV7JaRIsKjzHJ5x0FYg8+f5pHJz171xWOeMG9TqgoKnBz+uKQKACB/+uuZRbiJt0UxU9h2+uK2LDUBJhLnAYjAbpmjfYbg0aBBrPvbdmuUkIzGBg4rSBwO1GOc44oWhCdjKSBmfJbIHX3q3bREZwQKmMAxwSvuKeiBRjtTY27iEHPJp2B/QU4Dj/GggVNiRmBxxwOlJt4PTB7U7HzDmggYosA1gAM44+lJJGroyseCMGpO/X8aTAx1oGctcWr2cpDKSh6E96FlGAeBXTPGsi7ZFDexrPk0iIkmNiufyoaNVNdTIcgADp7Cl063a6vEcphUOSQO9aqaTHwHbOOoAwKvQQJCm2NQB3x3pIHNdB5xjOeBTZoI51xIgI9fSpAAAMUoxnHPrk07GVzLfSkONjkDryM0+PTArfMxO7qK0uAOlLgUWHzsjihSNdsYwKkAxSAZPU0uD65pkscPU0hG7GccUDmnYpiG9QeoopSccnpRQBDHkqCevvWG25rhzj5cmtqP+GsV/wDj5k+tI1gPzkHaf/rimSDJHBCgYGKkH+rc98nmo5SfJJzzgUjQqwqzXsapjIYc4xXUHr09jXP6f/x/2/uD/KugHSmZ1HqNYZXBHXsaieFcBlXZ67cc1Ix+cfSlP+sFBCdhsSjGSgD47daft555xQCcn6UrfdP0FMBrBs8AYzSkEA46mnfxsO2KT+I0CMrVIfMjEhJKjis1VYrheecYA5ro7kZt3B6YrnEJ+0MM8YFFtDaD0GhmG7dzxUMykqCcD6d60X9P9jNU2/1//ABU2LTLPh+NjIXHCY4PT/JrfCHHJBP8xVbSFAthgDrV48EYqjGb1MTVNAtL4jK+Wy9CBx+VYFx4L3P8kkW3OfmWu4T/AFYpV5HPpWkaso7MFUkjhF8FTMV828JUHPC9q3tN0Oy0lWeJAZDyWI5re71VuOY1zzwetDqSkrNhzt6HM61eteOIhkRA9PWqcduQcZwQOvr71YbmV/Y4/Wnw/wBT/Kl0N1otCtIrFuo9gO5oWEnkptY9vSp3++h9zUjElIsk9TSC5TeHdwRn8OBWZfW3yk4BGMdOlbhJyvJ6VRvfu/gKa0Y0zG17QbrxV4bZ9JmWPWbNdu1+VmT0PvXg8q67FqFxYTW5t7iE4dcYxX034F4vL/HHArk/jPGiatG6Iqu9uNzAYLfN39a9TBYhwm6Vrr8jpwtdqfI1oeMC/lsmEd6XCscuPXHeta3EEsQuYv3gJ+UMeg9azNcAezQsNxDEDPNX7EAaGmBjgfzr1JJcqkei9rlu7+zpbIqxpLJ1+Q559TVeEG3gWa7j8lVPy54DVp6YqrcptUDKjOB71R8YklwpJKjoD0FZR+LkIvrynWfCjTZLq+n1UjaGBUA8AV694YgIu7yQBiBhFLdvUVyPw+RU0G1CKqgoc4GO4r0XR/8AjyU9yT/OvGxdRynL7jyMXO82ZWtFpdSVMfKi8fWpIIwAAwx0AJ6VDec6jPns3FTwfcWuFma0iOlUEkADPTp1qpNDgdMH1XtV+T7kntVS4+4R2JpbDRpaPO8tuVk6ocde1X+grK0D/USfhWv2qjGe405z1oGRnmnfw0g6CgkB1o57mlPSk/8ArUAJilwaXt+FHYUgEH1FIBgcUpFC/doAQD6/jRgYp3emnoaADHWgDnj6U4dfwoPWgBuPzoweaVec0d6AE6AhqXBzQeM4pT0pgJ3pQMfWl7UfwigQdqWigUAJRSmigD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    PB morphology from a typical case of T-PLL showing medium-sized lymphoid cells with a regular nuclear outline, single nucleolus, and intense basophilic cytoplasm. An occasional cell shows a cytoplasmic protrusion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     This research was originally published in Blood. Dearden C. How I treat prolymphocytic leukemia. Blood 2012; 120:538. Copyright &copy; 2012 American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    T cell prolymphocytic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 231px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADnAgQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5l8P6Nf8AiHWLbStIg+0X9yxWKLeqbiAT1YgDgHqa7DV/g5480cRHUtBaAS5CE3UDZx9HNT/s6232v4z+GoT08yVv++YZG/pX09rtvoNt8OfEPi3xW+s6g1pqOpBYf7cvIUYpfTRQxqqyhUGAi8LwOxoKjy/aPks/DPxcOukH/wACIv8A4umn4beLB10n/wAmIv8A4qvpbS9O8LeKPgz4o8S6fpmsaPrOmWl8klrJrl7K1rcQxsyg7pBn+E4K+xBxXoHh/wCH/l3Cz60yyIvKwqep96n3jeKoNNu/9fI+RLX4GfEa6to7iDw4zRSDcrG8txkfQyVL/wAKF+JX/Qtn/wADrb/45X3sqpGioihUUBVUdAPShulWctz4IPwF+JQ6+Gj/AOBtt/8AHKT/AIUP8Sf+hbP/AIHW3/xyvvXvQcdTQFz4K/4UP8Sf+hbP/gdbf/HKU/Ab4kjr4bP/AIG23/xyvvFiO1IBmgLnwf8A8KG+JP8A0LZ/8Drb/wCOVBefBH4hWcYe58OsiHjIu4D/ACevvoA02WFJojHKoZD2oGmr6n59f8Kl8bf9AQ/+BUP/AMXTW+FHjVeuin/wJh/+Lr7nuvC8TsTA2AexPSo18PWljG1xekNGnOB3PpSN7UbaN3Piq1+CfxCurU3MPh4mAcb2vLdR+sgqH/hTvjrft/sRc+17b/8AxyvsXVdRlvSsZAjt14WJOgHvWbImGCKo3lSwHfA70Fxw6e7PllPgT8R5FDJ4c3Ke4vrb/wCOUv8Awob4k/8AQtn/AMDbb/45X2D4Pv5RefZpG3I3A9jXaYx1pmFSDhKx8F/8KF+JWM/8I2f/AAOtv/jlJ/wob4k/9C2f/A62/wDjlfetAFBnc+Cv+FC/En/oWz/4HW3/AMcqG6+B/wAQ7UKZ/DxXd0/0y3P8pK+/RWT4jgZ7RZVP3Cc/ShFR1kkz4Ob4PeOwcHQjn/r7g/8Ai6lPwX8fhN58Pnb6/a4P/i6+up927OOlKdQZU2HnjFQ3Z2OtYZNaHx4/wk8bp97QyP8At6h/+LrSt/gT8R7iBJofDhaNxlW+223I/wC/lfUwVpnHy8E16ToELQ6RbxvnIH6U09NTKvSjTSsz4T/4UH8S/wDoWj/4HW3/AMcpf+FBfEv/AKFo/wDgdbf/AByvvoj2ppHBpo5rn58XvwY8fWUpjutAMbjt9rgP8nqo3wp8aL10b/yah/8Ai6+9/EelHUYPMgCmdB93P3h/jXnl1bmJ2SUFSOMEYp27HVRpwmtWfJP/AAqzxln/AJAx/wDAmH/4uovF/wANPFvg/SbfUvEekizsp5BDHJ9phk3OVLAYRyRwpPI7V9faZpguZS75W1i+eWU9Av19a8z/AGqdbm1TwVp8Z2pbLqSGOMDkARSAEmlYKtFLWB4Z4P8Aht4s8Y6fLfeG9KF7axSmF3+0wx4cAEjDuD0YfnW8PgR8RzkDw6CR1xf23H/kSvSf2bLYX/hPRtOlnvIbW88UTxzi0u5bZ5FXTZHCl42VsbkQ4z/CK6S58W6DaeJ9R0tdL1Njba0NIMUfja/+2Tc489bfdyg7/Px60znPE/8AhQ/xI/6Fz/yetv8A45Sf8KI+JH/Quf8Ak9bf/HK+w9E0+PRvH+uabaXOoyWQ0ywuFjvL+e62yPLdqxUyuxXIjQEA4+UV1gHHNArnwiPgP8ST08Nn/wADrb/45R/wob4k/wDQtn/wNtv/AI5X3TcTw2sRknkVFHrWUfFWmh9paQc43beBRYI3lsj4muPgd8RLaEyzeHSqDv8Abbc/+1KpD4ReOD00M/8AgVB/8XX3brUkd/oRns3E0SsGJX071xgISQrn3oZtSpqe58jf8Kg8c/8AQCP/AIFQf/F00/CPxwOuhkf9vUH/AMXX1+H4OetV7xJzaTfZfK8/b8nm52598Ujb2Ee58p2/wS+IVzC8sHh4uiDLEXlvkfh5mapN8JvGyttbRGDehuYf/i6+3/A5lM4DkbhHiTb0zXWPBExz5Uef90U7I55JRdmfAlt8DviLcxiSHw4xRjgFry3XP0zJU3/ChfiV/wBC0f8AwOtv/jlfenyllOB8vT2p9FjO58ED4C/Eo/8AMtH/AMDrb/45QfgJ8SgOfDR/8Dbb/wCOV97Z5qHcBJg9fSgD4O/4UL8Sf+haP/gbbf8AxymL8C/iMzui+HDuQ4Yfbbfj/wAiV97EbjuHpinIMA5xmkFz4KHwF+JR6eGj/wCBtt/8coHwF+JJPHhs/wDgdbf/AByvvRvmxikC0aBc+Df+FC/ErOP+EbOf+v62/wDjlB+AnxKBwfDRz/1/W3/xyvvQLxxQQRTC58FH4C/Er/oWj/4G23/xylHwE+JR6eGj/wCBtt/8cr71xXC+OfEE5u30vTH8sIMTyLwxP90Ht70i6cHUlZHxzcfBfx5bvsn0aBH/ALrala5/9G1Zi+BHxHmj3xeHQ6f3lv7Yj/0ZX0SLOIgh13MepJ61a03Ub3Q7hZrCT92Pvwkkq49MUrnU8Lp7r1Pm/wD4UH8S/wDoWj/4HW3/AMcpD8BfiUOvhs/+B1t/8cr7t0q+h1TTIby1OI5RnB6qe4q1TOLVaM+CD8BPiUBk+Gjj/r+tv/jlZ1/8HvHeny+XeaA8TdebmHB/EPiv0IPtUc8EVwuy4iSVPR1yKdhxa6n55N8LvGK8nR+P+vmH/wCLpus/C/xjonh6413VdEkttKg2+ZO80ZxuYKOA2TywHAr7/lstH0uGS8ltbaFI+S+wdfb3rxL9ojxfLq/ws1u0gtBFZuYPmc5c4njI47dKGaKHMrwWh8c0UUUjM9R/Zkz/AMLx8M465uP/AEmlr6D1WPwr4n8OQaFr/jfR9GgsfE2o3l/YS3ccc1wq39wVjJMitGCGznBPII7Gvnz9mT/kuPhn63H/AKTS19d+KpnOqzgH5Qdv04oLpwc5WPPtUTwX4Z8P/E6fQfH+j3lrr+lTmPS31JLiUXPkOpYStKzyM5J4IySRycCuysNfvraXcJXkXurnIrMUh5MMcY71D5YjnlkWRyXx8pbKrj0HapUrs7qeGUU+bU9W0y/jv7NZ0BUnhlPY1c6gVyfgZyyTqTkcV1npVM8+pHkk0hh60dTTiKTpRcgbtAJOBk0oHtQOetH0ouMWlpAfWjv7UriDBHNc74nndjFBtYIo3k54Y10lZOvWJubcSRD95GOQO4px3NKTSlqcLKwEgB6A1p3F9b/ZQkar5hGCx7CqtxbFicjHrUNvYSSy7FBYntinbqd75bXZpeGoGk1SN1+6vJru+D0rN0TTV0+2+YfvWHPtWiOKDhqzUpaCAVFbxzrJOZpRIrPmMBcbFwOD685Ofep8U5aTZkNKksD0A/WnNGHRkcAowwRTxS1NxHK6hoTo5aEGSPtjqKzv7GmZhiFl56twB9Sa7vIClicBRk+1fMfxW+Il34k1SbT9Ple00q1YphW+a4bPUn09BXfgcFPGz5Y6LqzroupN8sT0+98Q+FvD8oGp6vbyTLk+TAwc59Ca3vDnxD8Oa9JaxabqEPmyZUwSHa49MDvXyIfNjIYxRmMjGTzSRzvCytuKyqQ6NHwVIPr617zyChy/E79zWeFlLVy1Puw4LYrj/FOr3Baa2sHEbICAzDgt7+1cn8FfiF/bGnvp+v3SLqMDrHEznBlUjj8eP5VpeIUktNWuEk6OxdWB6g9K+bxOHnhpunU3Rhh6fvuMt0Vf7RngKsJWEoHLKT1rrPDOox65C6XcMUlxFjLFQcg96wk0dpdP83AJIyaZ4BkMHiWeD+FoTn8DXKpNnRVjGUG1uil4p1J7zU5beL5bKBtiRoMKSOpNeJ/tHxsvguwYnrqCcf8AbOSvYvEUB0zWrmGUFEaQvGT0ZTzXkf7Sbxv4H08pkn+0U/LypKq+ppNJUdOw79m/UbHSPC3h++1W8trGyi8WT+ZcXMqxRpnS5gMsxAGSQPqa7PVdA8I6kniawm+KvhRNF1/VhqlzCjw/aEIYMESY3G1fuj5thPX1xVX9j7/knOqf9hWT/wBEw171Hw2TwKqx5dzldB1rStc+JGv3Gh6lZalappGnRNNaXCzqrCa9JUspPOCDjryK6+R1jieSQ4RFJJ9qHABBU1neJA58PXzDP3OcDtQ9ioq8kmcTqd9Lql28zsfLz8i+gqqYwR60lqylPSp8Y68VDPUjFR0Re8L6kdNv9koP2aX5JEzkY9aveINMNjdb4vmgk5Q+3pXMznaS2enpXp2jQi68O2S3ibsx9/0q1qrmFb93Lm6M4JWwpBX5qdEkksixorMzdAB1rsz4ZsS+d0irnoDWhZ2FrY5+zxBW6FjyT+NFjN4hdCvoGnjTbQBv9dLy/t7VpHO72pGBPrQaT3OVu7uGOM0ZzVe/a4EKraKTIWyfp6VMN5VTIoVyPmA5ouJi0YBPIGaKMGkUHbgUKTjkYPpS1T1i/j0zTpbqXnbwq/3mPQUAld2RNPNDaxGS5lSJB3Y4qhH4h0d32i/hznGTkD8688vZrnUpzcX0hlduQvVUHoBTTbqY8bQRjpii6OpYbTVnrKMrxB4nV0PRlORR1ry3RdVuNCvFaMsbRiPNizxj1HvXp6ujJG6NlJPmUk9QeaasYVaLp7j8kEHGRXjTMZr26mkOXeVifzr2YH5gcdOue9eU+JrBtI1y4VlPkzsZIz2waDfBtKTRSyM4prAckjIpA2Tu9eahnn2jYvzO3AA6k1LO+1jvPhfIzadqELf6uOcEe2RyK7H+VYngrSpNI0NVuFIuZ282RfTPQVusM9OfWq6nkVWnNtDaQ5xx1pxBAJ2k47UhwP8ACqMziPiTPI72Nl0iIMre56CvGvjXGF+Fms894P8A0cle5eONOl1Gziu7ZGaW24Ze7KfSvCfjXID8MdYXBBzDwf8ArslSzvpNexaR8sUUUUHEemfs2zpbfGrw5NJ91TcZ/wDAeUV9k+J7U3Li+tP3kLDDlf4TXxJ8EGKfFHRGXqDN/wCiZK+v9J1u506YMw3wscOh53Ci62OmhTlbniUJIjkEdTTorWSVwqjJPpXoKadpOqQpdwxLtfnKnHPpVq00y0tGDQQgH1PJp2W5pLF2VupW8N6abG0/ef6yTkj0rYPNIaQUnqcMnd3YtIaWgjmkJDaKU0goHcMUtLRQIAKcKRR+VOAoC5Vm061nO6SJcnuOKkt7SC3/ANTEqe4HNZHiTXFsEMFsN9yRyeyf/XrkZNT1CRt32iTJ9DRzW3OmnQnUV0el4xmkArh9I8U3FtKsWpDzICcb+6+9dhqF4lnp8t3kPGibhjofSi9zOpSlCXKyaeWKFR50iJnpuOM0QukqbonVx/snNeWXrT6rdR3Ny7tKrFlwSMe1SwzX+myLNBMysDnDdCPcUuZbHR9Tdt9T1MU4VR0a/TU9OiukGC3DKP4WHUU671awsn8u6u4o5P7pOT+VFjk5Xe1jhPjf4qGg+FpbK3lKahfgRxlSQUTPzN/Svlp02iSRQC+7kD0+tfXvi7wjofj61iaadi0IISW3cZHsR9a+T72F9N1W+sZS2+3laKQBfQ4r67IalF0XTj8S3/4B3YSyTi9yY3DSaWsRWNUQ7eOrH3qtEC42eVkquP8A69PmmDIIIUAjDbgxHzH6mo2kSMxmHcGAIfPUmvfR37bl/wAPOsOokMT9olwkagHOdw5yPYV9LeN7doZdN2g+WIdoPqRXjvwBt0uPHnmTQiVooWKl1yFz3HvX0rqdlFqFq0E6gg8qe6n1r5HP6t6yprojzKlSMMRzHJT61FbaOE/j24ApvgPT5Tc3OqzKUSVfLjUjlhnJP0rXs/Cmn27h7jfcuOcOfl/Kt0DaAqgBRwABjFfPxVkTVrRScYdSlqem2mpwGG+hWZO2eqn2PavnP9rHw3ZaN4B024s2my+qIm12yAPKlP8ASvpaR9p6Zr5//bH/AOSbaV/2Fo//AETNV7mCqSS5U9Bn7HYz8OdV/wCwrJ/6Jhr3cgkYAB+orwf9jsf8W41X/sLSf+iYa96+6Cx7DNUSxRjgd6l8pZopIpV3I6lSPUGokcOwAxz71ZUHZ2J+tJiPMda0qfR7lwylrcnKOBxj3qiLlCgGeTXraKrho51Vw38LDIqsNG05X3iygDZznaKmx1RxdlaSOB0HRZ9WuFLIyWqn55DwCPQV6aoCRoiDaigKo9AKRVCqERQqjsBwKcB8pp3sY1arqMb3pSoo70FqOhmIDzg9aDSnrmkpDEoJJ60UUAFGeMUlLQMBXJ/EN2FrYpnCNISfqBxXWfWsrxLpv9raU8KECZD5kZ9SO340F0pKM02cFEoKDipcDbjpxVNGeBmjuEKSA4KnqKV7hcE7sD3pWPRIr8DyWBAPFenaAhGhaasoBcQqeecVwvh7RJtau1kmDR2EZy7H+P8A2RXpQ2hQEGFUYAHYU9jlxNRO0UKRiqWp6fa6nam3v4xInY9CD6g1dBz2ptByJ2d0cbL4BhZh5OoTJGTnaUBP0zT44/DPhR+9zfp1J/eOD/IVt+J719P0S5uLc4m4RD6E968vtodxLMcs3JJ5JoO2ipVl7z0O+tPHGmzy7Zo7m3z/ABOAR+OOldBbObgNLHko/KsrZUj6ivKJYU2Diuh+Hl9JFqcunMxaCRDIqn+EjrihairYaMY80DvUUoOTk/WlJoUEnGCfel2jfjI3Y6ZppHEtdRFwowvFeR/tPafZr8GfEV0ttEtwDbYkVcHm4jFevEY4NeU/tP8A/JD/ABF9bb/0piouO76HwXRRRQM7n4J/8lP0T6zf+iXr7NtrCKa0BAy2O1fHPwEtHvfixoVvGMu3nkD1xBIcfpX2HpF21qTHMhABx7g0jqov3HbcteGrl9L1P7LKcW05wM/wt6124OWI7ivOdUuBeXMZgTkHg+9ehw7vKjL/AH9oz+VNbGeIWql3Hg8kUUYpnnRicQbh5u3ft/2c4zQc4skiRIXmdURerMcCsSbxXpkb7fMkceqrkVh+LLx7q8eAOFiiO3Znqe5Nc0sBdzg5HtSeh20cMpq8mem6fqtnqGfs1wHb+4eGFXlOT0INeQjdbXCyRF1deQVPNem+GtS/tXTEmbiZDskGO/rTuZ16Hs9U9DUVec5NP+ooA9KMGkcwuRQTjJPAHJoApHxtOBkkHj1pAjzTUJjPcyTOS29ycmtHQ9MN9Kcj5R1rKvEkt7yaCZSjxtnaecA9K3fD95bW0gnljBlVSqt3AOMj9BUvc9SbaprlKHiGwS0nMXUHrWpPIX8ARB2LAMIyfbdWVr94LqZ39TXQ+GrEXng820uQs5cqT254P504sio+WMXLuc9ophS8XzDlc81N4kmilf8AcABR2rIvYZtMnMN4jRyLwGxww9RUMDvqF0lvArSSNwABSN+VOXtL6HV6HM2neCr27jyjM7GP68DNcpIxlP3S0h5LHkk12fiizksfBcMCjPkFDJj68/qaxvB32eTUA84UjHG6nJu1kY0pJRlVt1MrSdRuNH1SOdFPl5xIg/iWsn4n/DvTL77f4ustTe3hmVXlhEW8MxIBI9D7V1/jK3txciW3KgkchfWrXw9cX2najYXkay24YfI4yCD1BFdGDxVTDVOaL9fQms7x9rDRnzDfaTc2swZA08OSFmjQ4Prn0NXNL8N3F7p9zfzSeSkLDZiIvuycElRk45FfW9roOk2aOlrp9tEjDDBUHNS6dpdjpwIs7WKHJJyqgHmvdnxE3G0Y69zF4yfKo9TjfhX4Bh8I2T3FxL5+pXABkcDhfYV3cjhFyzAZ7089eKx9csXvEQqz/L2U4zXg1Ks8RUdSo9Wczbk7s0wwIyCD9KQ1BZxGGBEJJKqBz1qZjWTWorjSAeoFeBftlY/4VrpWB/zF4/8A0TNXvp4FeA/tkn/i22lf9haP/wBEzUIaIf2O2A+HWqj/AKish/8AIMNe6zSAIxU5GK8M/Y7Xd8NtV9f7Wk/9Ew17Pq9/aaZZT3d9LHBaxL87t/T1NaRi5OyFq3Yg1fU49H0u71CYjybeJpDyMnHYfjxXjY+NOuvcJLaabaPGEO+Hcxz6H2xWN8Q/H0/iiL7DaW5tNMV8t82Wlx0z6D2rhEKeYxjlMS42nBOelfT4HKYKnzYiN2/wPVw+DSj+9Wp7n4U+NXmX3leJbOOK2lI2T2oJEZ/2we3uK9phlingSSKRXjkUMjqchgeQRXxTwrLHKsihhnI6EEcV738AvELX2kXOh3MrGayO+3D9fKP8I9cH+dc2a5bTpw9vRVrbozxuFjBe0geu54HNOUZXOaYsDFASaRcocE8dq+dR5o/tSN0pxHPHSkII60xick+tHXtXLeKvEjadKLOyA+0lcu5/gz/WuOmvdQmfzJLyYt1zuNNG8MPKSuetbTxSDB+6QcHHBrz3w94ku7O6WO8kaW3YgEnkiu9toIoEItkVY5GMvy9y3JNDRnOm6bsyWilIoxUkjT6Uo46UYoxQBn6pp+n3e039urlyF3quG/MVVh8M6RDJuFqWYHP7xiwrZzQRmgrnkla4oVVjCooVQMAAYAoFAGBRQTvuOFIRxR/C2Mbu1ImQihjlgOT0yaAKWt2H9p6VPaDiQjKH/aFeXlHtZ3gnQxyrwVI716/jmq1/p9pej/S7dJD6kc/nRp1N6Fd07pnlMxwmSwx7d663wFpEtvJLql4hi3oVjVhyF7sa6Cz0TTLRt0FmgYdC43Gk8SStDoVyyHDFQm70Bp+hc6/tPdXU5DxD4mur64kttOkaC1Uldyfek/H0rD8mT77Syhh/FvOaW2QKuR0zirvbHapu1sdUYRirJGn4f8R3VpcxwahIZrNvlDtyyH6+lZP7T4/4sf4jIOQTbEf+BMVQXIyjf3cVW+P0rTfs4ao7klilqCfXFzGKd7nLiIKPvI+GqKKKZzHqH7M3Hxv8NfW4/wDSaWvuDU9EtL3L4MUx6snf6ivh79mf/kt/hr63H/pNLX3pQCk4u6MWw8P21rOsrO0rqeNwwAa2xxSYpwGaGxSk5asDik5Pp6VBe3UNlbNPcuEjUck/yrlb3xdJ5ZNkkJPpJnBH4UIqFKVTZGf43tWtdU+0lf3Vxzu7Z9KybaZQgIx0rp7fxLpusI1hq8AhSTgOT8pP17Gsy+8HXtu2/TpFu7ZuVO7DAf1pSWuh6NGoopQqaNGDdSjd0Ndx8Oxvs7qRQQm4Ln1NYVh4Q1C7kAuV+zx9yxyfwArv9HtrWzsltbJlaOElWIOTu759/ahJpGeKqw5eWOpcAp2KBSipPPALShQO9AYHIBGRXm3jz4uaV4Xvn0+C1m1C/VcssbBUT/eb/CtaGHq4iXJTV2CTbsjrfE/h9NXiEsL+VeIMK/Zh6GuGk03WLOUxy2MxxxuQblP5VyunfHm8N/nUdJh+yZAPlSElB689a900PV7LWtOivdPmWWGQA8HkexrbFZdWw1nVja51Qrzo+7JHB6V4Z1DUpla9RrW2z8xf7xHoBXo0EKW8CQxKFiQBVA7Cm3d3bWkLy3U0cUa/eZ2wBWQvi7w+Y1f+2LFVbJXdKBnHXrXNGlOSvFNmVWs6r1Nie2guE2XEMcq+jrmm29nbWoP2a3iiz/cUCvOL/wCKarrEcemaa91p+fnnLYJXuyj0HvXpFpcxXdrFcW7rJFIoZWU5BFbVcPUoJOorXMlLoLcQxzwSQzDdG4Ksp7g155feGNS0y4Y2Cm5ticrt+8o9CK6rXtdFjP8AZrVVkuMZfJ4Uf41zbeI9RDbhO3+6FBFYWXU68PGpFXjsZv8AZmq3b+WbWffn+NcD867vwzo6aNYGLdvmkO6Ru2fQVztn4vuklUXqLLFnn5cMK7O2niureOe3ffE4yDRaw8RKpa0lZEpppPFV9Qe6S0kNhHFJdDGxZWKqeRnJHtmp2H5UWOIzNb1hNMiHy+ZcPysecYHqTXE3us39xe2121yYXt9+xIiQh3DB3Do340/xfLK2uXXzYChVUe2KwANzYyacnY9Khh48t2dPa+MLqFgLsxTJ9NrV1enanbalD5trIGHQjup968k1K3YRMU5btUfgnUr2w8Q26OT5MzeW47YP/wBfFSpXHWwsXHmhuj2o9K8C/bJ/5JtpX/YWj/8ARM1e+HoB6cV4F+2R/wAk20r/ALC0f/omaqPORF+x6SPhxq3oNVkP/kGGsD4neJ73xD4lns7gNb6VZyGJIGOCWHV2H8vatz9kAP8A8K61Mq3yjVnyP+2MVanx38Ooirr9uioRtiuFx9/J+Vvr2r1spnThiFz9fzOvBOKq+91PKYrdLmVLeJAv92RWzj1zVTU9P+yaiyMQY1TcGz29aYpZZSTlWzgbeBUrlpwFVhJITnJHQY719io26nruLcr9CG5vjd4VgFC4AYDgj2q9pFxdabONSs5mhuLeRWXY2D16H2NVBEDKxlAeNBkmPv716J4J+G+o+KLeG7lQadpLkMGfJlnHqB6e5rDEVoUYXqOyJqSjBXm9D6H0nUGv9Js7oDZ58SyYPuM1cVfly2cmoLG1jtbGC3hGI4UEaA9gBirQ5FfBStd8p887X0FHKnFNTPmL9acpxim5IcnFT0Fex5RrG99evpZRw0pwfpxSDBHGOa6PxroM5c3+nqzrnMkQGSPcVx32sKCHDKw45qbXPWpyU4qxJcgAcGvUPDUrzeH7F367Mc+ma860DRb3XbkFQ0Nmp+eVhjPsPU16tFDFa20cMS7YolCqPYVSehzYuafuoXJzS0nQihQc9e2KGcYtGKXFITikMaRjpS44oLYOKCCRyOKdhXAUYpBw2KdSGJ9acwAHFNIyMevFNhVliRZHMjgYLkYz+FACurPDIittZgQCe1Nt42ii2PKZGz1PbjpUlFAESxkS53HHpReWyXdlPbP92VCvPapgRuK5BYdR6U7vmgNtUeSSWslhcPb3GVdDjkdR60NIgbI5zXpuqaVZ6kgW7iBboHHBFYY8F6XC5lubidoU5Ks4Ax7mi1zvjiYNarU4+ytbjV7sW1ohJJwWHRR6ml/aWt47X4Ca7bxfdiFqo/8AAiKuqn8W6RpK/Z9HtDMBwTGNq/n3rzD9oTxf/anwh1+zey8ppDb4YNnGJ4zz+VMyqqpNXtoj4yooooOY9P8A2Z/+S3eGvrcf+k0tfelfBX7NP/JbfDf1uP8A0mlr7yBPagQ+lAzTA43bSfmIzinA4pCOB8T3TXt64dswxHaidvrVHT7NZ3AUVNrlu1vqVzG543lgfUHmodNvPs0oYgY9aT3PWhdU/dH6tpXkjO3Bra8BXrb5bF3JTbvjBPTHUVnatqouUzgZq18P7dnvri6IPlxoUz2yacTOteVJ8253eMkEUyCCKEMIY0jDMXbaoG5j1J9T708cjinKOaGzzBwFK3ANKK5fx3q6abZxwvKYfODM0nQKqjnmnSg6k1BbsDj/AIn+PYvDsDQ2uZp5wwVVYgHHXJ9K+cJ55L2eS6mJa4nYs7E5P0ruPH+tWmt2YMEBE1qf3c45LKeufauK0u2E8oaVgkKcu3Tivuctw0MPS2s+p6eHp+zim1qyCUCOQpGu5c/McYr134La0uiaPretXksn2SxiWP7OpJ8xj93j9M15FdFAZBCxKhs7j1IrrrSFrf4ez3atMnm36KvYShUOR7gE1vjKcatL2T6tFYimqtlLuHjjx7r3i28l+0TCGwVsraRj5VHbJ6k1ysOd4dY1JHYdfwq24QpFLboN5GHjYkknPWqrqftIDAxqSPbArelThShyQVkjeMIw2N7wpqUcOq2cU77IDuWQO2FCkHmvor4Q+JLPV9Faxs545XsflAXI+XscGvmbUVtxM8LkMvG2Vf7v0rpfhJc6hY/EbT49HKSvIPKkDcK0RGWz9MZ+tebmeDjiaTlezSv92py4ugmvadj1+4czXc0sxO95GJPqc112l6VbPaRtgMzLkmsHxnYtYan5sKMILgbuOgbuKj0vxDJaQFFA4Bx7GvhnuU1KpTTgWPFOn21sw8plV8crnmtTwA7tpdwhPyJL8vtkc1x+j+Gb3xGtze3l0EdnJDbske2K9B8L6T/YujR2jy+bLks7+pNVypbGVeSVP2bd2avWijNITxTOE5fxjoct4BeWC7rhRh4/749vevPFn2SskgKSKeVYYIr2qszVtE0/VR/ptqjv/wA9B8rfmKTVzroYrkXLLY8ulmV1+ZhipfC1kdT8R26wqTFAwlkcdAB0Fdg3gLSd+fNuwv8Ac3j+eK39M0600u38ixhEUfU46sfc96Si73NquLjyNQ3ZZZtzGvA/2yP+SbaV/wBhaP8A9EzV74eprwT9sn/km+lf9haP/wBEzVR56ZD+x4cfDnVR/wBRZ/8A0TDXsXiHRbXXtMuLC9UtbzrhsHlT2I+hrx39jxc/DnVf+wtJ/wCiYa94CBxg5x14rSEnF3QJtO6PnjUfhJ4kga4a2NtdQoSIyJNrsv0Pf8ax5PAXiy2gdjok2wjkxsrNj6A5r6iVCQNxw2aeq4yd3FetHPMQlaST/r1O2OY1V0R86eBPhtq154jsP7c02e10lT5kvm4HmY5C496+j44tiqEAVF4VQMAClROmRkVLXDjMbPFyTn0OavXlXd5AgxnPemucHPWlPtTJH2KWIyFBJrkMSlq+sWulqHuCTI33Yl5Y/wCFc5/wm828lNOXy8/xPyawr6dr++lnkYsXbOPQelQpNbtcNbI+ZVGWUDoKTZ6MKEEvePQdB8Q2mrOYowYLoc+U5zkexq5fJp9tDJd30NuiJy0jIP8AOa8suHeyvLe5gYrJG4OR9a6f4qTySWOlxqSIpXLsB34GKbaaujN4dqooxejLLfEDTUkEcVnctCDwwAH5Ct/Rte07WU/0KXMgHMTjDD8K8mhhG0Z6fSjMtpOtxasUmQ5DA45qFJdTaeDi17u57XtNNIxgd81n+F9WGtaPHctgTj5JQOzCrt5dW9knmXc8cS9ix61bPOcXF8r3H0AbmwKpW2sadcvthu4iT2PGfzo8QXD2uh300X31iO36mkNRd1FnMeI/GX2O5ktNIRJZVOHmflQfb1rnh4p10SbzeZ77dgxWNZpgfMPmOSatHG3mk5NHrU8PTStY77wt4oj1eT7LdKIr3GVx91//AK/tXRt7V43Zs8Gr2MkRw4mTGPrXtLgFskVW+pwYqkqclbZjFzjBpaU7R1wKUCpOcZikRWGdzbh2GMVJik9eaYDSqh84GSME96kFJx6UgyD6igQY5NcR8RL11nt9OjO1HXzJSP4vQV3H1rhfiNZOLuC/Rd0e3Y5HYig6MNb2iucukYA46VwvxxUD4W6yR6wf+jkrvQw2jpXB/HNl/wCFXayB1zD/AOjkqbano1fgfofJ9FFFWeQenfs0/wDJbfDf1uP/AEmlr7xr4O/Zp/5Lb4b+tx/6TS19496BC8de9OHIpg6808EdBSAztX0mDU4sS5SVR8ki9R/9auPufDOqwyERRxzoOjK2P516FSg0GtOvOmrLY4Gy8I6jcSA3rpbxdwp3N+FdvYWcVhaJbWybI1/Mn1NWAacDzQtAq15VHqKgwKeKSl4xk8D1pGA8V578b9JvtT8E3D6chkltv3jxqPmdP4gPwrb1PxjYWcrQwo91IpwShwv503TvGun3Mohu4pLUt8oZ8FfxPataFV0Kkakd0bxo1I2nynyI91Otlt2eXE525KkfhVKa8uW+UZAXjCjivrbxd8L9F8SBnV5LR5Du3w4Iz6gGvOz+zq8l3mXxIRbZyQtp85H13Yr62nneGlG8nyvt/wAMdP1q613PD7KO4u7tYFRpLuZgkSDksx6V7v4/8LxaB8LtEtbgt9rtyGfbn5XbJY/TJq9ex+EPhBaj+ybddR1yTA33Lh3QDqc4+X6CsXVPjBpuvWD2HiDR5TZuQd9s3Kn3B6ionXxGJlCrSg+SLv5sy9rOc04ptI8ohlit7hg7tjPynGfrUOoXIuXIiRUjXoO/413TeCdP8RzGbwRqkV3k5+xXP7uVfXrTLL4UeMHmTbpqLuYqWlkUBPc8816X12gvjlZ9np+Z2+3pvrY4FgAyMCChUHB7mvfv2f8Awc9pLc+IL9NsrL9nt48fdXglv6Vzui/BHxAurRf2jcWUdmpyzRyFifoCK93sbSx8K+HzGrOLa3UsWc5Zj/8AXrxs3zOnOl7KhK7lvbscuIrObUIbGncwRXELRXCLJE3UMOK52XwfpUzl4zMg7qkmRXI32uX+szOw3JDn5IgcAD39aqCXUNPlEsLvGw9Cf5V8veKKhhqkdFKzPTNL0200yForNGUHlixyTVs1heFfECazA0co2XkQ+dezD1FbuR3pnHNSjJqW4hpM+lKcEU3oKCQzQ1IaU9KBWG0nbrS4pApz0NMdhprwP9sj/km2lf8AYWj/APRM1e+kN3rwT9sn/km2lf8AYXj/APRM1AEP7HWD8ONWAYbhqsh298eTDzXvC56jNfNP7IFw8djdwgkpLdyAj/tnH/hX0xGcHmqeg3FocASRmpAvbGaFHQ052wuRyfSpJFjG0EZPXpT80wH2xS5oAcelLJGJImToHUrn60DJGB9aUjjDHFJh1PKGja1u5oJQQ0bFealiYDc2MN64rsvEfh46jILm0ZVuAMMCeH/+vXGXNjqNrJsksZ8+y5FSenCpGotGUtTIMRLZ9q6vxdbzal4O0y9VDuhCuwx2Ixms7SfC99qk8bXaNbWgPzFuGb6CvSkhjWAW4UGEJs2kcY6U+ljOtWUZRt0PF43wg7d6SV1KNuI/Ou01vwpp8c+Y9UisgxJ8uUjj6c1Rt/AKXjK51mOW3zyYVBJ/HNS6bSubLFU+rLPwsLfY9SuGJECsAB2JAyTWBc3U+sX0tzcNuDMdi54UdgK7vWrRNF8G3NvpcexI48e/J5JPrXD6Qi+Wo4qmzOk1NyqDJLYgbgeRzXW+Gbr+1tIutLuZP3oUhCT2P+FZM0AERGBVPTXa01m0kiOG8wDHqKIvoOoudX6ozLizltLuSGVWSRGwQRVecmJTuH6V65qul2eon/SogXHR14YfjWfF4X00Sq8qvNjornj8qckmTHGJLVanHeB9Hl1DUU1C4jK2lu24Ej77egr0plkMibVXbnLZJzjHGPxp6IqKERFVFHCqMAUnltvjaN9qgncmOGFCZyVarqy5mSYpGUMMGo4rq3mnlhhnjeaI4kRWyVPuKlfaAC5AGe5xzU2a3MhADn2qhrGq2+kwCS4OWbhIx1Y1okcgdjXlniS8N94juS5O2JvLQegFNOxtQpe0lbsaU/jK+eX9xBDHH6MCTWjpnjFHmSLUYVi3cCWPp+IrlVjVlHGKhnixnPoaFO53PDwaskeukghSpyrDII71HcQxXEDw3EayRNwQ3Q1i+CLp7nQlWQlmhcoCfTtW3dTx21tJPKfkQZNM81xcZWW5y134HsnbfBdy28f90gEV5n+0P4d0vS/g5r8sd2ZrsG32AuP+fiMHge2a63VNRutUumklkdYc/JGDgAV5t8eIFX4Way46gwf+jkouup2OFTk96R8j0UUUzjPTv2af+S2+G/rcf+k0tfeNfB/7NH/JbfDf1uP/AEmlr7xxQIjD5dlIIx0J71IvWkxT16UgFoFFId2eMU0IcOlPQ+o5pqc/e60rOiY3uq5/vMBSsFh5rm/Hd/Ja6XFbwtse5faSDztHWukHzLkHcPUHNcr8RLOSTTbe6jG5bd/mA64Pek9DbD29olI5bStNe8lWOJcmp9d0ZrRQkyjOM07w9qYtJBKmD/hVjXtWF4WdsDjpWLStc9Tmqe08ja+HWovcWM1jMxdrYgoT12HtW54n1aLQtCu9QmPEKZUYzljwB+dct8MIWabUbvnyztiB9T1NdT4o02PV9CubOUkK67s+45reny80efbS552Jio1WkfGevX0uralNe6hOWkkYtt9yasFYbqy3M6NJGgJYfLx6YrY+IPhOPR4TcadG7WjSHcG5Kn/CuL+0Lja3AGAOK/RKVSnUinDY7aUo8vu7Glp13PZahHNazvDcxHzIJITgg1758Lvirf65qVnomt2IF5Kp2XMJ+9gZyy9ulfOkUymXfwjofl55rt/gveNbfEvRRhj5zunHoUaubMsNSr0ZSmrtJ2IxMIypuT3R9chlbOCCRwcVy3xIZh4eVQcI0yh/pzXToipkqMFjk+5qlrmnJqumT2kmBvHyn0YdDXwJwUZKM1JnFeFYYHOXwCBmtHxX9na1TaqiT2rzzWdW1Xw3fpZHTLiWY8b14THrmr02rTXaRqVYzOOEX5jn0qVpoem6TlPnvoa3hE48RWwiBMmSWx2XHOa9KPtXK+BdDnsIpb6/G26nG1UPVF9/euqIx9K1WyOHFSUql0MYdTTHYrE7KpdgCQoONx9KkIz0PFNxig5xqMWjVmQoxAJUnOD6ZoAJJyaG3Fkx0HWngZYCmBg+JdaXS1SFXAmYbvpXC3mu39wT5V5PEP8AZciqmvrG3izVJAH3mTb8zE4A9KaluG/KpnO2iPVo0Iwim9Se18Ta1prqy3DXMWfmjm5B/HqK479qzVLfWfhJo95bDbnV0V4z1RvJmyK6ie3CofavH/j/ADunhG2tAT5R1FJMf7XlSD+tCbe5OJpQcOaK1R2P7Henu3h3UNQbHkx3skY9d3lxf419FIPmz2NeCfsfE/8ACuNUxjH9rPnP/XGGvfV+9kdMVoeY22TdOKQmmg0o4Jz0pAPHNMHWngglgO1JkBTQIcO3J6U4AEEEU1eQKXODjOKAHAeWQy/lU5J39ajjGRnqBTwcmkIjuLiK1tpLi8lSGFASzyNtVR65NfMXxi+JGoazrJtfD+oXFppEAID20hUzn+9kc49BXS/tC3WtRypZT36nTLkl0tkGBhcY3HqTmvGrdNqKXCnb1XOM19RlGWw5FiJO7e3l/wAE9LC4ZNc8ipJcSunmS+cZA24zTuWdvzrsvCXjrUPCWtx3qq0tk4AlslO0MCOo9DXKCKW9nSIyIE6Dd/M1oanaC2ZH87zAEAQr0P1r3qsIVI+ymrpnRKhTno0fSVn8UNG1SeCzmtLmO0vFVVnfBTLDofT0qpcadJpmoTQISYwcpnup6Gvn7wt/aVzqEVpG8lwlywjjRf7309q+wDpcN1YW0V4mZYo1XeOCDjmvj82wFLCOPs+tzz7yw1TlezOCeWUptwa0fC2lSXmpJczD9xAd31PYV0kfh2zVsuZHHoTitaFI4kWOJAiDoAK8jRDnXVrRHZyc0ooApwqWcw2QqkbO5wqjJ+leY638XtAjnlstKuVkv1OxWYfIPcHoa7Xxxef2f4P1m6x/q7Vz+Yx/WviiWzCQeed+PX19q9zJ8vp4qMqlTZNHRRoe1TZ3dz8SNU07V7u90Roree5cq8zqJGfnqc1S1X4heKNbmhm1TUWEUJzFFEgjXPqQOv41y9rFbCNFzlyecDNWJtr7ERNpWvq44Skpc/Kr+h3ww8F0PpH4Q/Ea117TodP1aeO31WL5FVzjzR2IJ6mpPEWmyWeuXZIBSVvMQ+oNfMK3txb3cFza58yNgVbuCDwRX2TYz2t34P0281vYS8KMSOu4jtXyucYGnh5KpT2l0OWUfq9T3dmcOruowQTUErMzbVUszcADkmuq3eGxyzXfPY1JZ6v4e0+ZWhs5h281lyVrxFC2qNfbu10mbXhTTm0zRYophiZz5jj0J7VH4yZl0Jgn8TgH6Vr208V1Ck9vIskLjIYU3UbRL6xlt34Djg+h7GmmcCm3PmkeaxYIAHSuG+Pyj/hUmtkesH/o+Ou4nil0+5e3u0KsDwfWuC+Pkm74T6yFbjMH/o+OptZndPWDZ8g0UUVR556f+zR/yW7w19bj/wBJpa+8ulfBX7NsqRfGvw00hwu6dc+5t5AP1NfepyGIPUGh9xMr3Vylsu+Vwq+9FldxXUbPE4YA4NR6lZpeW5jfGc5BxUOkaWmnhtjNhh93tVpRcfMOhqUgzgY9eaWjOwZHOOazBbnKeLNfktbr7FpxxcAfPJ/zz9h71yLRPOxe4kkkc8kucmnb2lvLqWU5keRifzrS0+IPICenepbZ69OEaUVZalKxvb7SZBLZXDgDrGxyrD6V6Romowa5pImVRtb5JYjzg9xXFX1uiq2MVe+GpZNQ1GD/AJZlFfHvmhO+jMcTBTh7RaNE2oeBVM7SaXd+Qjc+XIMgfQ0yz8DIrb9Vv96D+GP5fzJrpPEerjSrJmjQSXLAiOM9/c180fE/xhrGpahLp8d9KBb8SMhIBb+6PYV34LLZ4uWmiMKdetU9xM+odMXT7aBLbT2hWJOiRsDV7qCvFfDGnalqFm5kt7y6huF6SJKRg/nXv/wW+J1xrVzFoGvNvvdhaC6OP3oHVSPXHfvXZjMlqYen7SD5ktzOrRnBc8tRvx30qTS/D9zd24DW9zIiN28o/wCBr5ynbHGPmXk59e1fdWt6VZ61pk9hqUSzW0wwyn+deI678BpZbndo+qQxxZ4WaMjj04rqyrM6VOl7Ks7PuaUaqiuVngkQYmPzE6sMYGSxr6B+Bvw2u9O1CPxNrJaCUoRbWrD5gCMbm9OOgrsfhz8LtL8Is93csuo6o3AnkTAjHoi84+vWvQScVjmOce1i6VDbv3FVr8y5VsL0GKaTQTTSa8BI5iO4hhnXbPFHIPR1BqK3s7S2bNvawxt6qgBqcmkp2HzPa5ma/rlpolqJ7rLu/EcS/ec/0FcHcePdZmkLW0NvBGOildxP41R8dzyXXjC4jkYlYAERfQYzUVpZiWPA4bH4USk07I9OhhqcYJz1udLoXj0yzLDrUKxFzgTR8AfUV3QxgHIIPII7ivD9SgVSYyM5OK9N8KXV7J4JikjRZ72ON0iV2wHIyFBPaiMr7mOLoQglOHU6M0nQ5OR3plos4tIftRQ3AQeaVGFLY5wPSoraFLOARJJI6gs2ZXLtyc9TVHCeb+OdOew8QPdBSbe7+cN6N3FUbe4VV5IOa9WvrO2vrZre7iEsLdj29we1cde+AFMubHUXij/uSLux+NQ1d3PRo4qLioz0ORv7pApJYAV5Z+0Dpkkfw60/UrhHVp9TRY8j+DypOf0r6J0zwLY20yTX88t86nIUjamfp3ryf9si0jj8E6Vc+c3mNqMcaw5+VVEUvIH1FEUTWxMZLkgTfsdKD8N9VyP+YtJ/6Jhr3peDXg37HP8AyTfVf+wtJ/6Jhr3kDJrQ4BQeGwRntmsrxTcanb+HruTQoUm1IIRCjdM+v4Vq7RSSIWidUO1ipAOM44qoO0k2Bzfw1bVz4ZRvEN2brUTIxdiVO3/Z49K6ojIrK8N6Sujaatr5zTyFi8kpGNzE5PFaxGOlVWmp1JSWxFOLirMdgYA9KjmmitkMs7BI17nvTxkngZriPFepvNqDwRMQkPyD696yubU6fPKxs3Pi2JCRFb7l6ZY4zVvRfEVrqE4hYNDMegY5DfjXArGWxvOT71DKXtyJIid6MGBB9DS5kdbwsWrI539pW8jbVNNs2X96BuBz2rycSQ/Yw0nMynaEHQj1r3T4weDn8caFZ69oMbz6tbqEeFWGXXuPqK8DmWbT5Wtr6zkgv14ZJQVK/hX2uT1ac8MoJ6rc3wsko8o1maVyeFAHYcAVa1COK3t4mjlMu9d3HArOgkmjdk+9uBLADpVmCGW/cQ28Zd24wOcV67d9To5rK9z079m63S78YXM86HNtbkxAjhWY4J9jivpcnBH0rzL4IeD5vDOhTz38Hk3t2wZiTztA4zXb3Ov6ZbP5c14hdeoT5q+Gzauq+Kk4u6VkeNUbqTbWppknPtQPWqtlqNlf/wDHpco567e9WiQD1Ix2rzGZvTQdSgnOKbk+macPWpEcZ8X9WtNM8C6pFdkl7yFoIUAyWYj+nWvkVlAAEshCqM9a+y/GXha38U6fHb3UrRPGSVYDPJHpXzv4t+Gcmg3ohTcZCxKSMf3br9exr6jI8RRpU3Tb95u524WtGHuyPMp40jxLExjHUMe1SQlggndizk/KPWum1Hw3fWtk7z2iCM8bw+QRXLKpe7S3K5OdiqOST2r6FST1i7nZeO8Xoa+iWFxq+r22m2aF57hgo29Fyep+lfTniBDa2+laWxBNrCAQD36Vk/An4et4asW1bVQDqd2uEQ/8so85x9TxVzW95129M2d5k4+navks5xyxFRUobR/N/wCRzqftat+iIhahgDjP40ksAVDhcVftiix4OB3qrfyqqHHH0rwbXNVJ3N/4fSORfRHmFSCPY1Pqni6C3uXgtIjOUOGfOBn2punRNo3g6eZ1KzzAsQffgfpXIWsIArXZXOdU41JSk9jqV8S6bqCeVq1ntGMbsbv/AK4rzj9orRNOT4Na9qOm3Dsim3wmcjm4jH9a677AxXcEJFebfHeaW2+FXiC3HEc3kBlz6Txn+lLcJwsnyM+QqKKKZxnd/A5Xb4reHljBLmV8Y/65vX6DNxNz1r4M/ZqVX+NvhoOMgNO34i3kI/UV96D1OKAb0sLiijIoBpEiO2xSSM4psLiVQwHHvUlAFAI808SWMmlaq52kWspLI/b6VHbXIT5lbivSrq1hu4HhuY1kjbqGGawJ/BWmPKXjkuIl/uq2R+tS0ejDFQcbTORvtQymASSTgAdTXbeCNJk03Tpbi7Gy5uMMynqqjoDUukaBpWmzK8UXmXA6PK24j6CtHXrn7Lo13OTjbGTnFVCN2l3Ma+IUlyQ2OO8QTpqV+RJvKR/KhHAxnrXzZ4mkR/EmovIcj7S2QOM4OK9Q8X+MhptolrYt/wATBhnBOVjXHU+9eO3Uizz+ZINxdiSxOSx7mvtMpw0qUXN7GuDg4pzfUtG1iSOWU7A5G5Y92QB71b8J3TWPifSriNhE8c6HeO3OPy5rJYmQeYynbnbkcZq5o1m+o61ptrZqxmnnSID3LDn6CvUqJcjvsddVfu5J9j7cjOY1PqAaUgGmxrsjVf7qgU1sFSxz19a/NOp4nQcetNc1G3y7Wj+7/EM0rNx7U7DFJpuaYHB5HIpQcjI6UwAnmlpCeKYGX1FMDi/H3hqe8nGq6YhedQBNEOrAdxXCDVmtXeF1kSReqsMGvcWlREZ2YKqjJYnAArkdT8X2EUpW0sBesP8AlowAH6jNJxvqd+HxE7KHLexxOnaTqOvXCJbQyJGTl5nBCqP6mvXNPtI9PsILSD/VxKFBP8XvXDzeMNWbH2a3toEH8O3dW14c8UpqUwtb6Nbe6bhCD8r+3saaSWwsVGrNXaskdK5JwPU4pHCF+YwyrxTmBGQRSdqZwjVGBhfu9vakZgvWnHqO2Khu7u2slEt7NHDGO7sBQgSu7IesmR8ww3pXzf8AtmGT+xNHHPlfaEIHvskr6Di1jTNRwmn30EsoOdgbk/hXh37ZKIfh9pMh5lXVET3A8qU4qtil7rd0L+xyD/wrbVcD/mLSf+iYa94XrXyz+y/qNzp3hi8lt5GCf2gwZP4T+7jzmvqOGVZI4pU/1cq7lxR00CULJPuS0o6iilpEioNwzTj2oXgYpQaBAh+cV5rqKH+17xX6rKa9Kxk9cfSuT8W6U4nN9ApZG4kA/hPrUs6MPJRbTMNUBOaS4gBQ8ds1XinwxyMAd6lnu1K7QSSemKhrod12aXge7ey1SVZZAtqyMz54C4Gc1p+MvAmieNZY5NShkjkj4E0Xys6+mfSpvBely26ve3aeWzLiNWHOD3rqS5bGOnet6dWdKSnB2aPPrT99uJ5nJ8G9FISO3nmhhA2naAXYehNdZ4d8EaB4fhRNP0+ISLyZXG5mPqT610SnGaRmwK1q47EVY8s5toxbb3ZyPj3U5Y/K0+Byodd8pHcdhXFxQKe2a6rxzbt/aCXGPkkQKD7jtXORFRwT07VyvZWPUw6SghgV7eRJIXZHXkEdRXonhnVxqtiVlI+1RcOMcketcCT8pHQe9bXw/wBzaxdFfuLDhiPrxTi7qzJxME48x3wNOHSowadu4pHnDiO9VtTtra7sZIrxIWRgQBKBjNWAa8+1rVjdXUokydrFVXsMU43vcunTc3YyrLwNp9rbFde1nzRuO2G26Bc9O9WtN0nwLpF0JLTRg8qtnz3TcwPqMmqxZ3OQABUbxfKSSSK6Z4+tPeT/AC/I7IYVJbnqen3lteWqy2jh4+nuPasnxD4fTU28+3cRXQ6ns31rn/AM7rrMluufKaMlhXW32sadYy+Xc3KrIP4RyRXN6HNKMqU7RON/4R3WUl4iVu2d4xWzo/hcRzrcanIsjg5ES/dz71v2V/Z365tZ0kPdQeR+FTg80rWHPETatsVdZtTfabPb/wATLlfqOlecW7mKXyplKyIcEGvUs45rD17w7DqrefEwhuf73ZvrTHQqqN4vYzotQiS12YByOteOftAv9o+G2uGJcrGICxHYefGP616uvhHUtxDXUKp68n9K5L9obSINI+AviRIcvK5tt8h6n/SYv0oXkaSqQinbVs+GaKKKZyHp/wCzRg/G7w1npm4/9Jpa+59U1K10y1M102B0VR1Y+gr4Y/Zo/wCS3eGvrcf+k8tfUfiC7fUtcmkkP7qJjHGvYY70mbUKXtJWexpzeNr8yMYLOFIh2ckk1s6F4pi1B1hukS2nI4G7Kk1xgjUA5HHU01oN6k/dY88dRSU31R2yw1Nq2x6yhOdrfezUgrjPA2qyOr6fctJK8Sbo3Y5Yr3B9a6iG5Fw+1MgA4JYYqrHmzg4S5WWx1p2KiJMf3+R1yKEnSQ/u3V8ddp6UWJKw04NfC4Zzkds8VbvbZLyzmtpf9XKhQ/jTwc9CPrWdres22kRqZnLyt92JOp/wpLRgouTtE+ZfiT4Z1qw1+432bSqAMMiYDKBwR26V57A8hiZrnadp+X/Zr62PjSG9R4rrRy9ucqQ5GT+BrnrrRfh3dP5lxoDxyE5KpkA/gDX0mGz1Rio1Y7djvp+0grSTPm+CbzjswFdjgKD1r6C+BPw+m0tYtd1mEpdOpEEMq/NGD/F7Eius8FeGPAkN79o0TSYI75fmBmDM49xuJ/Su5v7uGxtZLi4bEaDnHUn0FYY/OZV4eypKye7/AEMa9aVRchOCKYT83tXBan4s1ORibNUt4+w27m/WotM8WatBIPtwjuIc/NkbSB7EV4Nl0ZP1Wpa56A/XpVV5/wB6EliZV/vZGKckyX1iJbOXAlQ7XAztP09qcVyoWT5jgAkjrT8jDYfIsZTdHwR6HrTBuJx27moHt0JBQshByCpqXknIYqenFOwDuQcE5pGIP8GaFAAxThSGcx43eWWxjtoAFU5eQZwTg8CuU0q0E0iqozkciux8a2nn6clxGoZ4G59dprltFu1tbgSY+XrxSlqehQdqXumtc6R5EAOOMVyuohon3RkrIh3KR2IrsNX1iKeDEORn1rkJo3ublIYyWeRtoX3NFknoXRbcW5nq2nzm6061uG+9JErH64p8kscZUO4Ut0z3pmnwm2sILcgjykCc98VDqOnx3zRM8kkZjORtPWrVup5kt3Yh8Qai2maTNdRqDIMKmegJ6E147qzXF7cl7y6e4lJzljnH0HavY9c07+0tGu7JeXeP93nsw6V4lGXtr0pOrLJGdrq3XNTJvl0PRwCTu+qEktZbYrMpeNlIKuvBBrG/aX1c618F9EuZceemrpFIR3Ihm5/Gus1fUY5rIRAAHFef/HaB4/gbpUjrtWbXVZfceTMM1MX0LxivTUmtbml+ytBYN8O9UmuuZxqbhRnt5UX/ANevoPQ5BJpluY+UGVA9ADXy5+zjJL/wil5DArPI+oNhV6k+XHX1RpFr9j0y3gbBkRPmP+13rVKyPPmrQVy8vSlBwegxTY265z9acTk4GOKRkxx68UCiigQueOBk0i5ZPnTr1BOeKVabIxBGDgUB5mbeaBptzJueEqT18ttoqWx0TTrJg1vbLvHR3+Y/rV0ZJJ9KeM4yeKLF+0lbcfnPWnZAFRjk04+lKxA8HPSgjnJ4pg46UpOaTQEN7awXtuYbmMOh/Me4ri9W8HXKSB9LlWUf3XbBFdnH54uJjI0ZgOPLABDD1zU4wOaGrGsKsobHmy+GtclOwwJGOhZnGK7Tw5pEejWphU+ZNJ80sp7n0rSdtoyAx7YHNOH0JHvTTKqVpVFZig0/PA459hVW8u4LK3ae5fbGv5k+grkL3xfdyORZQpDGOhb5iaGkTClKfwo7lcAgnNeb61bNZ6rcI46uWBx2PNX7PxfexSAXsSSx9yowRW5qtha+ItOSe3cByMBv6Gi1jWmpUZe/sziRKD0PSklfbGST+taMmgXluCPs74Hdec1ZsPDdzdSqbhTFbg5Yt1I9AKnlOt1opXuS6Qo0Tw1c6pJxc3I2x56gHp/jXOJC0v72XJLcnNb3j6Rhe2VqBtt44wyr2J6VmQEFQvt0oe2hNK9ufqyBTJYyrPbyFZFIIxXo2i341PTorkDDn5XHoa88vGAU5rrfAQZdIlLgjfIWXjjFNbGWJinHm6nSDnrzTQCAdzZJPp0ozQfU0HEKMnpXkX7Ud/aL8G9ftPODXLm3wg5xi4jPP5V6P4n1I6bo8kkfEznYh9D618+/HRCfhdrUjklyYSSTnrOlU7I2p0uaLmz5NooopGR6h+zP/wAlv8NfW4/9J5a+ntUga0129iYHHmFhn0PIr5g/Zn/5Ld4a+tx/6Ty19reI9CGpqJoXEd2owD2Ydgf8aTN8PUUJ69Tih06UySUAdOQOakn0/UbN8T2cpx3Qbh+lFtpWpX9wvl2cip3ZxtA/OpXY9Dnile5peBIJJNfNzgiOKM5PuelehFmByCM+4rO0TTk0y0EKkNIeXb1NaQq9jy61RVJtorXKyv0C7CCpIPSs/R9LexvZZmlLBhtVccAVsHrSjpVKbSsjMdGoHvz3rzXxAyT6xdLcAtIJCufQDpXpJzjIHNcl4p8PzXd0b2wAM7D54ycbvpUPY6cLOMZe8YFvaGQqgZceuOa0rrQzBCrnHPSsYTz6fOEvIZIJPRxWrJrPm2+3fkVFjtnz3VtjFmllsbyCaFtrxyAg/jXZfEWdodMs2BwrzjI/DNcakb6rqdvaWyl3ZwW9AAeSa674mRs+iQSICywzAtjsMYzVR2IqcvtYX3Oc0mJbubLnO48Zq34k05LS3LLjOMisexuTFhkOO9WL++ku4ysjE1CaZq4yc7rY3/hvdSNBd2z52Jh19s9a7F64P4ao5utQfBMaqEz75runYIOTxWvQ87EJKo7C4pKSlpGId6DRRQAjKGUqwypGCD0Nchq3hKRpDJpMiopOfKfgfga7CiguFSUNjz5fDOsyOEaOGMf3y4Iro9A8OxaW/nzSC4uj0fHC/QVvUtCRc8TOatsITnmiigUzAAcHNch4v8Gprly13DKLe6A6heH+tdfQaRcKkqbvE8xsfhrMblTql+pt+uyIHc3sSelcX+2BFHb/AAu0aCFAkUeqxqijsPJmr6AZc187fti6ray+DNP02ElriHU0dyOg/dSjH15FCjbVF1K1St8RL+x3FGPh/qc3lIZhqkih8fMB5MXGa99BIJPr614N+xuyN8PNViEiecdVkYR5+YjyYa97CkNgjFWYu4KxyR607aeCAMVznibxINHlNtEkc10QCoGcIP8Aa965k+JtZkff9q2g9lAA/Kg2jh5yV0el7j6UpIAXPc4rkNB8VtLKsGphdrcCZRjB967DHlnjkHkGhqxnODg7MXnArG8Ua3Ho1qpCCW6l/wBXGe3ua1wfm+tee+PtzeJU8wnaIhtpN2NMPBVJ2ZWbxFrczBzeGPuAigAVp6N4wuYZ1i1cLLATgygYYVz8WFUbu/SkuUEigEcelLmZ2ulCStY9b+VkV0YMrcqR6UquwGCc1zfgSWSbQ3Ms0kgjlKoGP3R6D2roUfLkEcgZ6cU7WPNlHlbiiQNkUvf1pq9KHYKCWKge5xU2JHZozRSUDHZpDg9aTNFANnDeOLtp9VisgcxRKGI9Sax4kBIAFa3jW0eLXEulBaOWMZ+o4rNglAI9fSkz0qdlBco+W3IT5h1rovAEjeVeREHYrAjmufu7pXAAYZ711fguza202SaVSrTtkA/3R3oWxnXfuWZ0QbPfiggjr/OmZ4B9aJGCLk0zhMnxJpCatbrtcJcx/cY9D7Vx8mkajbNh7d2x3UZzXoqYdOOPeglmB2Px70G9OvKCstjg7Dw1eX0qtejyLccnPU/QV3dtEkECQQrtijACilbLHPNKSf4RQRUqupuLSOMgc9KTJpQee9Bmc944t5J9HR0GRFJuP0rwv45Nn4V6yO/7jP8A3+jr6SuIo50KTLuRlKkZ4rwj9pHw7Jp/wt1y6tpA9pmDIPVczxj+ZpvU6adRKDiz4yooooOc9O/Zq/5LZ4b+tx/6Ty1955AQZGa+C/2a/wDktfhv63H/AKTy195hlKgGkJi7wRgZFOQYHzc81Gq/MCo+WnuSGwDgUCuSU1VYE5PFLg00yKW2iSMN6bhQA48Ammku7L5YHXnPpT8YwGNY/iN/s9lcXaLIJYIHCMGIA3YHToae2pUVzPlMTxB4wMFw9rpapI8Z2vM3QH0ArFi8X6zFIGaSOT2ZK5+xJMeT1OT+Nben2QuQSSOBUub6HqqhTpqzR1Wma/p3iJBZanbpHO3RX6N/unsaRvA2nbyUuLpE/uBga4fVbb7MweNsSIcgjqDXqWg3pv8ARbO5k/1jrhvqODQrNXOasnRV6b0Y7SdJsdJiK2MIQn7ztyzfU1YvIIry1mt5xuilXaakJqJYytzJL5rlWUKIzjaMZ5Huc/pTONyk3zPc8z1Hw3qekzOIomu7b+B4+Tj3FQWmkavqLiOGxkiUnBklG0AV6vnrSeuSTU2OtY2SW2pQ0LS4tI01LWI7j96R8ffb1q8yhvvDNLRVHJJuTuwOMUgqpfW91NNC1tdmBEbLr5YYOPT2q4etAgoopsjrHG8kjqsaD5mJwBQHWwqsGzg9Dg0tc3deL9OhYrAk1xzyygAfrVrTfEunX0ix7nglJwFkGAfxquVlulNK9jaopTwcUlIgKBRUVzPHa2sk8xxHGpLH1oAl479Kak0TkiOWNiOwcGvL9f1i61aQ/vHjiHSNTgAf1rEMLhd0bMMdwxFO6Tszsjg3JXbPXtdvG07Sbq6VGdo0JAXrmvkv4/yi48G2c+8vI+oqXJ65Mcma+nPBF3FqOiC3mneaWJisiP12nt7ivnn9qvwy+h6RbXFuf+JfcXylB/dYxycfoaOlkTC0Iyg9zL/Z3mmtvDF3PbOUlS/Ygg/9M46+r/D+ojV9Mt7vGGPyyAeor5E+BOo2Vn4Qvku7mKF2vmIVzgkeWlfT3wsYP4fuJEfdGZsqfXimr21QVIr2UZdTidUkebX9QkmB3+aR9B2p6EAfpXSeNfDdy94+paUhk3/62Idc+o9a5ETPEv8ApME0bZ/iQioT0O2ElKKaLTrujO3g9a9O8K3LXXh62eU7mTKE/SvLLeSS9lWCxjeWV+AFFetaJY/2dpVvaE5dFy5/2j1qlscuKtZFz7vzHpXN+NdHfUbaO7tFLXMHVf7y10xAIxTSQvQ4xQ1c46c3B3R4/wCftwsoww9RSPKZiIoA0kj8KqjJr1C80fTb191xZRux53Yx/KnWGlWOnsTY2sUTH+PqaizO361G2iIvDdgdM0eK1lJ84/PJjsT2rSAx0OfenZyeefeg+1WcTk27sQsEUu7BUXkknAArGuPEml7vKaR5QDnIXIzWP8QNRkQwabASocb5Tnr6CuagtQ0XPOPek2up008OpRvI9Psb23v4t1pMJD3HcVaGcc9a8otrmfTbpLm3dlZTyB3HpXqNldJe2MFzGMLKu6nZPYyqUuQmoPKkUZoFKxlYr3lnBfQiO5XcOoPcVzl14R2sz21ySBztZefzrq8AnPejaPSkaRqShszn9L8N2NvIr3LNcS4DYYYUf410XHAAwOmBSDA6UUEylKXxCk4xwcUEZ680gOKXNBIdOOMVn6vq9npMYNySZG+7GvU1fGMnd0rzPXHkudZuJJcnBwB6DNNI1pU+d2ZuT+M5GXFtaBT2LtmlsvGLK4F9bqsZ6uh5FcyE3gYHAp0qrgZHFHN5HX7CB6fDNHc26TW7h4n5BFPHK4OeeK5HwFcSZu7TP7tQHX2rr+ccnmhnFOPK7EaRBI0RSdq9MnOa8x/ae/5If4i+tt/6UxV6lXln7T3/ACRDxF9bb/0pipEHwbRRRTGenfs1c/Gzw39bj/0nlr7tr4S/ZpOPjb4bPvcf+k0tfdx5JNAmPjboKLl1jheSRtqICxPoBzSLwwrL8S6laWthNb3UuHmQqI05Y5/kKLDhFykkjhtd8R3er3DCGV4LIHCRocFh6k1mPZXKoJWWVR2Yk1Z025isJEkW0STYc/Oetdslxp3iTSZgHEDgcxltpU/4VL5nqj1HJUrJR0Oe8L+Jrqwu4ba/lae0kYLljkoT0INegana/bdPubRjxNGV3e9eUaVp8uoazDZoN22TLsOgUHk17CDz7DgfSqTutdzmxajCacTxSJDA0kTBg6MVYMO4q/Y33kDqRXe6/wCG7XVJPORmt7kjl0GQ31Fc5J4Ivw+FvLYr6kHP5VLR0xxFOa95nO31y11IAqksTgAdSa9S0O0ew0iztnGJETLD0J61meH/AAvbaZMtxPJ9pul6MRhU+g9a6I+vemjkxNaM7Rjshc0lFFOxyhRSUtFgCiigso6sB65PSiwB060oIPQisC98V6bbSGOMyXDA4Pljj86it/GOnv8A62GeIepAanys0VGo1dI6Ji2cDFcR41v3urw2SMVt4jhgD95veuzsbm3vk820mSVcdAeR9RXnPikNbeJrpZOA5Dr7g0ndJm2Fj+816EdpZAqBgYqG+tQAccYq3FdKo4OKpajexohLNk9MCs9T0LO/kdz4L1B9Q0UecS0sDmIse/HH6Vv4rnfA9hLY+Hw06FJp3MxU9QO36V0KHcK0R5FW3O7C1z/jUunh6VlGQrqzj1Ga6CoL23ju7Oe3mGY5UKt7e9C0FTfLJNnkUJEh39AemK3dS0iCPSIrmCQtIRlx6VlXWk32lXbQTxM0WfklAypH9K1i/l2yxzOApGME1FrM9ab2cWYXhy8ksvE1oYcgTMEZR3zWL+2Xn/hXGljt/a8f/omavR/C3htFv11S4KnH+oj9M9WNeb/tk5/4VtpWRj/ibR/+iZqpeZw4qcZzvE8D+E3gLUPGRRrEnYtyUYAdMKpJz+Nfc/hjR4dB0Kz0q35EKYZv77dzXif7Gzbfhtq2BydWk5/7Yw17jq96NO0i6uM/OikJ/vEcU0nFPUzlUlVUYdjH8ReLrTRZzaQR/a7xTllBwqfU+vtWPD4+mcn7VpUTR+gb/EVyFtAxkeW5JaaQ7mJ7k1bwuPu8UX7o7I4aEVbc9K8N6zp2qxv9jiW2uAMvHtAbH4da1QCpOMk15Z4cla18RWTxZ+ZwhA7g16wwxKwqrdTir0+Seg0dM0xlDdaNxLf7NDNgHigxsHSlApqtkZpyndSGI3AJoPFNdmw2wAuAdoPc9qz/AA/d6ldaTDLrllDZahkh4oZfMXAPBz7jnFAWOX8fwNHrNvcgEpJHtJ9CKy4JFVOeCa9B1Wyj1O28mX5Sp3K3oa5C78M3ySHYgkXsUNTY7qVVOKTMK/mUxMFH5V6N4Xhkt/D1lHNw+3JHpnmsPRvCpEqzX5ARTnyxyT9a7AgZGMKBwBVJWM69RStFDscUmR2qC5uGhMQFvLMZJAn7sAhQf4jntU5wDxjHtQcwbsdcUFsA9KZy5wBzUcs0MR2zTxRkf3mxRYErk4Ye1LUUWH+aN1dfVTkU/PqKTQDxSU3NLmlZgKTg5rlfEmkSu7XFqm9W5ZR1FdOH+Y8e1L0JI709SoScXdHlTkxHa6lSOuRT033DBYVaQk4AXk16bJbwyn97FG/+8oNLHHDbr+5hiQ/7KgUWOj6z5GT4V0s6bbyPLxPPyw/uj0rczTVOee5pTSOZtyd2LmvLf2ncf8KQ8RfW2/8ASmKvTyev4V5d+04f+LI+Ivrbf+lMVOwj4PooooAtabf3ml3sd5pl3cWd3FnZPbyGN0yCDhlIIyCR+Nbn/Cf+Mv8AobfEP/gym/8AiqKKAD/hP/GX/Q2+If8AwZTf/FVXm8Y+J5pDJN4j1mRyMFnvpSfz3UUUDTa2Gf8ACW+I8f8AIf1f/wADZP8A4qlXxd4kXO3xBrAz1xeyc/8Aj1FFCHzPuS2/jbxVbZNt4m1yEt18u/lXP5NU3/CwfGf/AEN3iH/wZTf/ABVFFBO4f8LA8Z/9Dd4h/wDBlN/8VR/wsDxl/wBDb4h/8GU3/wAVRRQAf8LA8Zf9Db4h/wDBlN/8VR/wsDxn/wBDb4h/8GU3/wAVRRQAf8LA8Zf9Db4h/wDBlN/8VR/wsDxl/wBDb4h/8GU3/wAVRRQAf8LA8Zf9Db4h/wDBlN/8VR/wsDxn/wBDb4h/8GU3/wAVRRQAf8LA8Zf9Db4h/wDBlN/8VTJPHni+RCknirX2U9Q2ozEH/wAeoooArjxb4jHTxBq4+l7J/wDFUf8ACXeJP+hh1j/wNl/+KoooK5pdyS38a+KrZy1t4l1uFjwTHfyqf0ai58aeKbp1e58S63M4GA0l/KxA/FqKKBXd7kf/AAl3iT/oYNY/8DZP/iqaPFfiLeH/ALe1bepyG+2SZH60UUD5pdy7/wALB8Z/9Dd4h/8ABlN/8VR/wsHxn/0N3iH/AMGU3/xVFFBIf8LB8Z/9Dd4h/wDBlN/8VR/wsHxn/wBDd4h/8GU3/wAVRRQAN4/8ZMpDeLfEJB6g6lN/8VUH/Ca+Kd27/hJdb3ev2+X/AOKoooHdjj448WE5bxPrpPqdQl/+Kqtq/ijxBrNsltrGu6rf26PvWK6u5JUVsEZAYkA4JGfeiigVw0bxT4g0S3eDRtd1XT4Hbe0dpeSRKzYAyQpAzgDn2q5N498YTx+XP4r1+RCc7X1GYj8i1FFAFc+L/Ep6+ItYP1vZf/iqT/hLvEn/AEMGsf8AgbJ/8VRRQPmfcWPxh4mikWSPxFrKSKchlvpQQfruq0fiD4z/AOhu8Q/+DKb/AOKoooBu+4f8LA8Zf9Db4h/8GU3/AMVR/wALA8Zf9Db4h/8ABlN/8VRRQIP+FgeMv+ht8Q/+DKb/AOKpP+E/8Y/9Db4h/wDBlN/8VRRQAf8ACf8AjL/obfEP/gym/wDiqP8AhP8Axl/0NviD/wAGU3/xVFFAB/wn/jL/AKG3xD/4Mpv/AIqj/hP/ABl/0NviH/wZTf8AxVFFACjx/wCMsf8AI2+If/BlN/8AFUf8LA8ZdP8AhLfEP/gym/8AiqKKAD/hYHjP/obvEP8A4Mpv/iqP+FgeMv8AobfEP/gym/8AiqKKAAfEDxkDkeLfEOf+wlN/8VVWXxh4llcvL4i1l2PUtfSk/wDoVFFAXJIPG/iu3/1HifXIv9zUJV/k1Tf8LA8Zf9Db4h/8GU3/AMVRRQAf8LA8ZYx/wlviH/wZTf8AxVH/AAsDxl/0NviH/wAGU3/xVFFAB/wsDxl/0NviH/wZTf8AxVH/AAsDxl/0NviH/wAGU3/xVFFAB/wsHxn/ANDd4h/8GU3/AMVR/wALA8Zf9Db4h/8ABlN/8VRRQAf8LA8Zf9Db4h/8GU3/AMVR/wALA8Zf9Db4h/8ABlN/8VRRQAg8f+Mh08W+If8AwZTf/FVW1Pxh4l1Wyks9U8Raze2kmN8FxfSyRtggjKsxBwQD9RRRQBhUUUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blood smear from a patient with T cell prolymphocytic leukemia. The tumor cells are medium-sized lymphoid cells with moderately condensed chromatin and a prominent nucleolus. In T-PLL, the nucleus can be round or oval and the cytoplasm is slightly basophilic without granules. Cytoplasmic protrusions (blebs) are common.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Kindly provided by Sarayu Chandrashekhar, MD, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13144=[""].join("\n");
var outline_f12_53_13144=null;
var title_f12_53_13145="Contrast echocardiography: Clinical applications";
var content_f12_53_13145=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Contrast echocardiography: Clinical applications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13145/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13145/contributors\">",
"     Neil J Weissman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13145/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13145/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13145/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13145/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/53/13145/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 7, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrast echocardiography is a technique for improving echocardiographic endocardial border delineation and providing real time assessment of intracardiac blood flow. Agitated saline contrast provides contrast in the right heart and enables detection of right-to-left shunts. Opacification of the left ventricular (LV) cavity by contrast agents developed to traverse the pulmonary vasculature permits improved left ventricular endocardial border detection, thus improving the assessment of left ventricular dimensions and wall motion. Contrast echocardiography can also enhance delineation of Doppler signal. Additional uses of contrast echocardiography include assessment of myocardial perfusion.",
"   </p>",
"   <p>",
"    The current and potential clinical applications of this technique will be reviewed here. The development and safety of microbubbles for echocardiographic contrast and the optimization of the echocardiographic settings for visualizing contrast are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/49/23318?source=see_link\">",
"     \"Contrast echocardiography: Contrast agents, safety, and imaging technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS FOR AGITATED SALINE CONTRAST",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Shunt detection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first clinical use of contrast echocardiography was for detection of right-to-left shunts [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/1\">",
"     1",
"    </a>",
"    ]. Agitated saline is well-suited for this purpose because microbubbles of air formed from agitating saline persist long enough to opacify the right heart chambers and diffuse into the lungs when traveling through the pulmonary circulation. Therefore, microbubbles will not gain access to the left heart chambers unless a right-to-left intracardiac or extracardiac shunt is present.",
"   </p>",
"   <p>",
"    This technique is used most often for the detection of atrial septal defects, although it can also be used to detect ventricular septal defects and arteriovenous shunts in the pulmonary vasculature. The appearance of bubbles in the heart early (within three to five beats) after right chamber opacification suggests an intracardiac shunt [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/2\">",
"     2",
"    </a>",
"    ]. Later appearance of bubbles in the left heart suggests pulmonary arteriovenous shunting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/48/5896?source=see_link\">",
"     \"Identification and assessment of atrial septal defects in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=see_link\">",
"     \"Pulmonary arteriovenous malformations: Diagnostic evaluation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Contrast agents such as Optison, Definity, and SonoVue that traverse the pulmonary vasculature are NOT designed for shunt detection and their use is contraindicated if a shunt is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/49/23318?source=see_link&amp;anchor=H7#H7\">",
"     \"Contrast echocardiography: Contrast agents, safety, and imaging technique\", section on 'Safety'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Doppler signal enhancement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agitated saline (and other ultrasound contrast agents) may be used to enhance tricuspid Doppler signals for use in assessment of transvalvular velocity to estimate right ventricular systolic pressure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14378?source=see_link&amp;anchor=H30#H30\">",
"     \"Echocardiographic evaluation of the tricuspid valve\", section on 'Contrast echocardiography'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis of persistent left superior vena cava",
"    </span>",
"    &nbsp;&mdash;&nbsp;Agitated saline (or other ultrasound) contrast can help confirm the diagnosis of persistent left superior vena cava (SVC). This venous anomaly is usually detected incidentally. A persistent left SVC is suspected when a dilated coronary sinus is detected in the absence of a cause for elevated right atrial pressure. A persistent left superior vena cava drains directly into the coronary sinus leading to a characteristic sequence of contrast appearance: following injection of contrast into a left arm vein, contrast appears in the coronary sinus before appearing in the right atrium [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/3\">",
"     3",
"    </a>",
"    ]. Upon intravenous injection of contrast into the right arm, there is normal transit of contrast with right atrial opacification before appearance of contrast in the coronary sinus.",
"   </p>",
"   <p>",
"    Associated cardiovascular anomalies are present in a minority of patients with persistent left SVC [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. Associated venous anomalies include absence of the innominate vein and more rarely absence of the right superior vena cava or drainage of the left SVC into the left atrium.",
"   </p>",
"   <p>",
"    The presence of a left SVC may complicate transvenous placement of pulmonary artery (Swan-Ganz) catheters, pacemaker or implantable cardioverter-defibrillator leads, as well as retrograde cardioplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS FOR MICROBUBBLE CONTRAST AGENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Endocardial border definition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The second generation microbubble contrast agents (Definity and Optison are available in most countries, while SonoVue is also available in Europe) traverse the pulmonary vasculature and are indicated for LV opacification and LV endocardial border definition in patients with technically suboptimal echocardiograms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/49/23318?source=see_link\">",
"     \"Contrast echocardiography: Contrast agents, safety, and imaging technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Rest echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suboptimal images limit the interpretation in approximately 5 to 20 percent of echocardiographic studies, thereby impairing the assessment of segmental and global LV systolic function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/7\">",
"     7",
"    </a>",
"    ]. Contrast opacification of the LV cavity enhances border detection, decreasing the variability in the interpretation of regional wall motion abnormalities, LV volumes and remodeling, and the ejection fraction (EF) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef55017 \" href=\"UTD.htm?5/7/5239\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. It is an accurate and cost-effective method for evaluating LV function in situations where obtaining a study is technically difficult, such as in the intensive care unit [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The success of this technique is dependent upon the intensity and homogeneity of contrast within the LV cavity. Although Albunex was the first agent to produce LV opacification from an intravenous injection but produced LV opacification only 64 to 81 percent of the time [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/7,8,16\">",
"     7,8,16",
"    </a>",
"    ]. Second generation agents have been more successful, achieving LV opacification in 90 percent of cases in which baseline images are suboptimal [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A prospective study of 632 consecutive patients with technically difficult echocardiographic studies evaluated the impact of contrast (Definity) enhancement on diagnosis and management [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With contrast enhancement, the percent of uninterpretable studies decreased from 11.7 to 0.3 percent and technically difficult studies decreased from 86.7 to 9.8 percent.",
"     </li>",
"     <li>",
"      Without contrast, an LV thrombus was suspected in 35 patients and definite thrombus was identified in three patients. With contrast enhancement, LV thrombus was suspected in only one patient and definite thrombus was identified in five patients.",
"     </li>",
"     <li>",
"      With contrast enhancement, additional procedures were avoided in 32.8 percent of patients and drug management was altered in 10.4 percent, with some change in management in a total of 35.6 percent of patients.",
"     </li>",
"     <li>",
"      The impact of contrast increased with worsening quality of nonenhanced study, with greatest increment in quality seen in intensive care units.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following clinical applications were suggested in the 2008 American Society of Echocardiography (ASE) guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Difficult to image patients presenting for rest echocardiography with reduced image quality",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      To enable improved endocardial visualization and assessment of LV structure and function when &ge;2 contiguous segments are not seen on non-contrast images.",
"     </li>",
"     <li>",
"      To reduce variability and increase accuracy in LV volume and LVEF measurements by 2D echocardiography",
"     </li>",
"     <li>",
"      To increase the confidence of the interpreting clinician in LV functional, structure, and volume assessments",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In all patients presenting for rest echocardiographic assessment of LV systolic function (not solely difficult to image patients)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      To reduce variability in LV volume measurements through 2D echocardiography",
"     </li>",
"     <li>",
"      To increase the confidence of the interpreting clinician in LV volume measurement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To confirm or exclude the echocardiographic diagnosis of the following LV structural abnormalities, when nonenhanced images are suboptimal for definitive diagnosis:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Apical variant of hypertrophic cardiomyopathy",
"     </li>",
"     <li>",
"      LV noncompaction",
"     </li>",
"     <li>",
"      Apical thrombus",
"     </li>",
"     <li>",
"      Complications of myocardial infarction, such as LV aneurysm, pseudoaneurysm, and myocardial rupture",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To assist in the detection and correct classification of intracardiac masses, including tumors and thrombi",
"     </li>",
"     <li>",
"      For imaging in the intensive care unit (ICU) when standard tissue harmonic imaging does not provide adequate cardiac structural definition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For accurate assessment of LV volumes and LVEF",
"     </li>",
"     <li>",
"      For exclusion of complications of myocardial infarction, such as LV aneurysm, pseudoaneurysm, and myocardial rupture",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Stress echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic exercise and pharmacologic stress echocardiography depend upon the accurate assessment of segmental wall motion and thickening. Improved sensitivity with contrast echocardiography, as compared to conventional stress imaging, has led many laboratories to routinely use contrast during stress imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=see_link&amp;anchor=H3#H3\">",
"     \"Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\", section on 'Comparison of test performance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The efficacy of contrast echocardiography was evaluated in a retrospective multicenter study of 4,011 patients undergoing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography for evaluation of suspected coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/20\">",
"     20",
"    </a>",
"    ]. All patients received Definity or Optison for rest and peak stress imaging. Sensitivity and diagnostic accuracy for detection of significant coronary artery disease (defined as &gt;50 percent coronary artery stenosis by quantitative angiography) was compared to that obtained in 1923 matched patients with optimal images on stress echocardiography without use of contrast. Sensitivity and diagnostic accuracy were slightly but not significantly higher in the group receiving contrast (81 versus 73 percent and 82 versus 77 percent).",
"   </p>",
"   <p>",
"    Preliminary data suggest that stress echocardiography may provide an advantage over radionuclide myocardial perfusion imaging (rMPI) in women by overcoming the problem of nuclear image attenuation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/21\">",
"     21",
"    </a>",
"    ]. Small studies found that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    stress echocardiography had similar sensitivity and similar or greater specificity as compared to rMPI [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. Contrast LV opacification may further improve diagnostic accuracy, although this has not been directly compared to rMPI in women. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/10/25768?source=see_link\">",
"     \"Attenuation artifact in SPECT radionuclide myocardial perfusion imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2008 ASE guidelines suggest contrast echocardiography for difficult to image patients presenting for stress echocardiography with suboptimal image quality [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To obtain diagnostic assessment of segmental wall motion and thickening at rest and stress",
"     </li>",
"     <li>",
"      To increase the proportion of diagnostic studies",
"     </li>",
"     <li>",
"      To increase reader confidence in interpretation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Enhancement of Doppler signal",
"    </span>",
"    &nbsp;&mdash;&nbsp;These agents, like agitated saline, can be used to enhance Doppler signals. Since these agents pass into the left heart, they can be used to enhance right heart (tricuspid) or left heart (mitral) signals for evaluation of diastolic or valvular function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ADDITIONAL APPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Infarct size following alcohol septal ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrast echocardiography can be used to guide alcohol septal ablation used as a treatment to diminish LV outflow obstruction in patients with hypertrophic cardiomyopathy. Myocardial contrast echocardiography can accurately delineate the size of the septal vascular territory prior to ethanol injection and can predict the infarct size that results from ethanol infusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Optison and Levovist (as well as Albunex which is no longer available) have been used for this purpose. However the intra-arterial injection of contrast agents (Optison and Definity) remains contra-indicated by FDA regulations. The use of agitated radiographic contrast was suggested in the 2008 ASE guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Myocardial perfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Portable real-time, noninvasive assessment of myocardial perfusion may become possible with improved contrast echocardiography agents and detection algorithms. Since microbubble size is consistently smaller than erythrocyte size (10 microns), contrast reliably transverses the microvasculature.",
"   </p>",
"   <p>",
"    Early studies with intracoronary contrast injections found that contrast echocardiography compared favorably with established perfusion techniques, such as nuclear scintigraphy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/26-28\">",
"     26-28",
"    </a>",
"    ]. However, such studies required aortic root or intracoronary contrast injections as well as significant post-processing, thereby preventing immediate clinical application.",
"   </p>",
"   <p>",
"    Controlled investigations with newer, second generation agents have shown that routine intravenous injection accurately identifies myocardial perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Among patients with coronary artery disease, initial studies found been a variable correlation between contrast echocardiography and regional tracer uptake in nuclear SPECT imaging, which were probably due to the need for continued improvement and refinement of acquisition techniques with perfusion imaging and inexperience of the investigators [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. In later studies, real-time myocardial contrast echocardiography obtained during exercise or vasodilator correlated well with SPECT imaging, including localization of the vascular territory involved [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=see_link\">",
"     \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other possible settings in which information concerning the extent of coronary artery disease derived from contrast echocardiography may be clinically useful include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Since the degree of myocardial opacification in contrast echocardiography correlates with the blood volume in specific vascular beds, the severity and extent of ischemia may be quantifiable, possibly providing prognostic value (as is already demonstrated by nuclear perfusion techniques) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/26,35\">",
"       26,35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Contrast echocardiography myocardial perfusion may provide parallel information to that provided with an intracoronary Doppler flow wire or nuclear perfusion imaging (but possibly more easily obtainable) by quantifying flow changes in response to stress [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/29\">",
"       29",
"      </a>",
"      ]; such changes may be identified as differences in contrast intensity. Defects which develop under cardiovascular stress or in response to vasoactive agents would identify the distribution of inducible ischemia and the adequacy of flow reserve [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/36-40\">",
"       36-40",
"      </a>",
"      ]. Unlike nuclear imaging, CE may be performed at the bedside and may allow immediate on-line interpretation.",
"     </li>",
"     <li>",
"      Because symptoms and electrocardiographic changes do not always accurately identify ischemia in patients with chest pain in the emergency department, perfusion information obtained via nuclear cardiology has been utilized to help identify low risk patients [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=see_link\">",
"       \"Initial evaluation and management of suspected acute coronary syndrome in the emergency department\"",
"      </a>",
"      .) Contrast echocardiography may provide similar myocardial perfusion information without the difficulties of transporting the patient to a nuclear scanner. In addition, echocardiography provides wall motion information that further identifies chest pain patients at high risk for ischemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=see_link\">",
"       \"Role of echocardiography in acute myocardial infarction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Since symptoms and electrocardiographic changes are unreliable in the assessment of thrombolytic therapy, CE may be utilized to assess the adequacy of revascularization and the degree and time course of microvascular obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/41-44\">",
"       41-44",
"      </a>",
"      ]. In one study, the presence of CE Reflow was shown to reflect post-MI TIMI flow in the infarct-related artery [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. However, it may acutely underestimate infarct size due to reperfusion hyperemia or hemorrhage [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients with an acute myocardial infarction, contrast echocardiography before angioplasty can define the risk region, while CE repeated 24 hours after angioplasty can identify the \"no-reflow\" region. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29961?source=see_link\">",
"       \"Primary percutaneous coronary intervention versus fibrinolysis in acute ST elevation myocardial infarction: Clinical trials\"",
"      </a>",
"      .) The improvement of myocardial perfusion on CE was predictive of subsequent improvement in LV function [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/48\">",
"       48",
"      </a>",
"      ]. Assessment of myocardial perfusion and the coronary microcirculation with contrast echocardiography corresponded to evaluation using coronary flow reserve measurements obtained with a coronary artery Doppler wire. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=see_link\">",
"       \"Clinical use of coronary artery pressure and Doppler flow measurements\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Contrast echocardiography may also provide prognostic information. In one study of 50 patients with a first myocardial infarction who received thrombolytic therapy, the presence of reduced opacification on contrast echocardiography, performed on day two, predicted a higher major cardiac event rate (death, nonfatal infarction, or admission for congestive heart failure) during a mean follow up of 22 months (28 versus 4 percent in those with adequate opacification) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/43\">",
"       43",
"      </a>",
"      ]. In a second study, patients with a persistent defect in the infarct zone due to the no-reflow phenomenon, despite the restoration of TIMI grade 3 flow, had a deterioration of regional and global systolic dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/49\">",
"       49",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Contrast echocardiography also may enhance the predictive value of standard",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"       dobutamine",
"      </a>",
"      echocardiography. The potential value of this approach was illustrated in a retrospective study of 788 patients who underwent dobutamine stress with injection of microbubbles for real-time contrast echocardiography; 75 patients (9.6 percent) died or had a nonfatal MI at follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/50\">",
"       50",
"      </a>",
"      ]. Abnormal myocardial perfusion added significant incremental predictive value to clinical factors, the resting LVEF, and wall motion abnormalities. The three-year event-free survival was 95 percent in patients with normal wall motion and myocardial perfusion, 82 percent with normal wall motion and abnormal myocardial perfusion, and 68 percent for abnormalities in both wall motion and myocardial perfusion. Three-year event-free survival varied with multivessel perfusion defects (56 versus 85 percent with a single vessel perfusion defect). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=see_link&amp;anchor=H28#H28\">",
"       \"Stress echocardiography in the diagnosis and prognosis of coronary heart disease\", section on 'With contrast echocardiography'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocardial contrast echocardiography can be used to assess the location and structural and functional responses of the microvasculature to angiogenesis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/51\">",
"       51",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/4/6216?source=see_link\">",
"       \"Therapeutic angiogenesis for management of refractory angina\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hence, there is a growing body of evidence suggesting the utility of contrast echocardiography to evaluate myocardial perfusion. However, there is no contrast agent yet FDA approved for that purpose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Myocardial viability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myocardial viability assessment, particularly in the high risk patient with LV dysfunction, has had increasing importance in patient management and decision making. Current techniques used to determine myocardial viability include single photon emission computed tomography (SPECT) imaging, positron emission tomography scanning, nuclear magnetic imaging, and low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"     \"Evaluation of hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/18/15656?source=see_link\">",
"     \"Dobutamine stress echocardiography in the evaluation of hibernating myocardium\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=see_link\">",
"     \"Assessment of myocardial viability by nuclear imaging in coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By providing simultaneous LV function and perfusion information via a single modality, contrast echocardiography offers the advantages of improved image resolution (over SPECT), portability, cost economy, and practicality. The threshold of flow detectable with contrast echocardiography is comparable to the level of flow necessary to maintain viability (15 percent of normal or 0.25",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    per kg), thereby providing a rationale for contrast echocardiography as a potential tool to identify viable myocardium [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/52\">",
"     52",
"    </a>",
"    ]. The identification of subnormal flow (heterogeneous contrast effect) as opposed to no flow (fixed contrast defect) or normal flow (homogeneous contrast) within dysfunctional myocardium may predict long-term recovery of function following the restoration of normal blood supply [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Stunned myocardium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dysfunctional segments of the LV following an ischemic insult may represent either infarcted or stunned tissue. Contrast echocardiography may be helpful in differentiating these two patterns of myocardial dysfunction. Stunned myocardium has homogeneous myocardial contrast, representing normal blood flow with an intact microvasculature. Such a pattern implies either that the decrease in perfusion was not lethal or that reperfusion (either spontaneous or as a result of intervention) occurred prior to necrosis. In this setting, systolic function is likely to return over the next several weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. In one study of 96 patients with recent myocardial infarction, the positive and negative predictive value of homogeneous opacification for recovery of contractile function at six months was 47 and 84 percent, respectively; the positive predictive value for predicting functional recovery was 78 percent in those who were revascularized [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8759?source=see_link\">",
"     \"Clinical syndromes of stunned or hibernating myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of complete reperfusion, the identification of heterogeneous contrast effect within dysfunctional segments may represent collateral or partial anterograde blood supply within an area at risk; this also provides important prognostic information by predicting a more limited infarct [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Hibernating myocardium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hibernation is the metabolic adaptation and downregulation that occurs following a chronic ischemic insult. As with stunned myocardium, necrotic transformation is avoided and microvascular integrity is maintained, but blood flow and systolic function remain suboptimal. In this setting, findings obtained via contrast echocardiography may be informative. As an example, when myocardial contrast (which was representative of collateral flow) was present in one study, myocardial dysfunction within an infarct zone improved to a greater degree following revascularization than when collateral flow could not be demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/59\">",
"     59",
"    </a>",
"    ]. The degree of contrast homogeneity may be proportional to the extent of functional recovery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/60,61\">",
"     60,61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23335?source=see_link\">",
"     \"Pathophysiology of stunned or hibernating myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the detection of hibernating myocardium, contrast echocardiography compares well to both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/57/25494?source=see_link\">",
"     dobutamine",
"    </a>",
"    echocardiography and thallium scintigraphy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/62-67\">",
"     62-67",
"    </a>",
"    ]. In one study, 20 patients with coronary disease and ventricular dysfunction underwent MCE, dobutamine echocardiography, and rest-redistribution thallium scintigraphy prior to coronary artery bypass grafting (CABG) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/66\">",
"     66",
"    </a>",
"    ]. Echocardiography was repeated three to four months after surgery. The sensitivity of MCE in detecting segments with recovery of function after surgery was comparable to that of dobutamine echocardiography or thallium scintigraphy (90, 80, and 92 percent, respectively), and the specificity was significantly greater (63, 54, and 45 percent, respectively). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=see_link\">",
"     \"Evaluation of hibernating myocardium\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Intraventricular flow patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to improving endocardial border detection by LV opacification, the intraventricular dynamics of contrast exhibits characteristic flow patterns during the cardiac cycle, which may be associated with LV segmental or global function. One study of 348 patients found two different patterns of intracavitary contrast flow, as visualized in apical views [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/68\">",
"     68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A swift, vertical, and homogeneous flow towards the apex; 91 percent of patients with this pattern had normal LV segmental function and 93 percent had normal global LV function (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58747 \" href=\"UTD.htm?23/14/23776\">",
"       image 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A distinctly protracted, swirling, and heterogeneous pattern; 99 percent of patients with this pattern had one or more wall motion abnormality and 83 percent had various degrees of LV dysfunction (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79846 \" href=\"UTD.htm?10/10/10401\">",
"       image 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Local drug delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Utilizing known ultrasonic destruction of microbubbles, local drug delivery of agents (contained within the shell) could be performed with well-controlled end-organ targeting [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/69\">",
"     69",
"    </a>",
"    ]. As an example, enhancement of thrombolysis may be possible within a specific vascular area using targeted contrast agent destruction. Characterization of the effects of microbubble destruction on the endothelium has stimulated investigation into techniques for endothelial-directed drug therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13145/abstract/69\">",
"     69",
"    </a>",
"    ]. Genetic elements capable of stimulating angiogenesis or inhibiting neointimal proliferation following balloon injury could potentially be deposited at specific sites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H189182\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Contrast echocardiography is a technique for improving echocardiographic border delineation that can also enhance delineation of Doppler signal, permit detection of right-to-left shunts, and assess myocardial perfusion. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Agitated saline contrast is most commonly used for the detection of right-to-left shunts, although it can also be useful for enhancing Doppler signal and detecting a persistent left superior vena cava. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical applications for agitated saline contrast'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Microbubble contrast opacification of the LV cavity enhances endocardial border detection, decreasing the variability in the interpretation of regional wall motion abnormalities, LV volumes and remodeling, and the ejection fraction (EF) (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef55017 \" href=\"UTD.htm?5/7/5239\">",
"       image 1",
"      </a>",
"      ). Microbubble contrast can be used to enhance both resting and stress echocardiography as well as Doppler imaging. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical applications for microbubble contrast agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Microbubble contrast agents can also be used to assess myocardial perfusion during both resting and stress echocardiography. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Myocardial perfusion'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Meerbaum S. Introduction and general background. In: Myocardial Contrast Two-Dimensional Echocardiography, Meerbaum S, Meltzer R (Eds), Kluwer Academic Publishers, Boston 1989. p.2.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/2\">",
"      Attaran RR, Ata I, Kudithipudi V, et al. Protocol for optimal detection and exclusion of a patent foramen ovale using transthoracic echocardiography with agitated saline microbubbles. Echocardiography 2006; 23:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/3\">",
"      Stewart JA, Fraker TD Jr, Slosky DA, et al. Detection of persistent left superior vena cava by two-dimensional contrast echocardiography. J Clin Ultrasound 1979; 7:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/4\">",
"      Webb WR, Gamsu G, Speckman JM, et al. Computed tomographic demonstration of mediastinal venous anomalies. AJR Am J Roentgenol 1982; 139:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/5\">",
"      Goyal SK, Punnam SR, Verma G, Ruberg FL. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound 2008; 6:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/6\">",
"      Cohen JL, Cheirif J, Segar DS, et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial. J Am Coll Cardiol 1998; 32:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/7\">",
"      Crouse LJ, Cheirif J, Hanly DE, et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial. J Am Coll Cardiol 1993; 22:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/8\">",
"      Lindner JR, Dent JM, Moos SP, et al. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex. Am J Cardiol 1997; 79:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/9\">",
"      Kitzman DW, Goldman ME, Gillam LD, et al. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. Am J Cardiol 2000; 86:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/10\">",
"      Mulvagh SL, Rakowski H, Vannan MA, et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 2008; 21:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/11\">",
"      Voci P, Muan B, Morris H, et al. Assessment of left ventricular systolic function in low-echogenic patients by intravenous Infoson injection during dopamine echocardiography. An open, phase III trial. Cardiologia 1997; 42:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/12\">",
"      Firschke C, K&ouml;berl B, von Bibra H, et al. Combined use of contrast-enhanced 2-dimensional and color Doppler echocardiography for improved left ventricular endocardial border delineation using Levovist, a new venous echocardiographic contrast agent. Int J Card Imaging 1997; 13:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/13\">",
"      Lafitte S, Dos Santos P, Kerouani A, et al. Improved reliability for echocardiographic measurement of left ventricular volume using harmonic power imaging mode combined with contrast agent. Am J Cardiol 2000; 85:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/14\">",
"      Thomson HL, Basmadjian AJ, Rainbird AJ, et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study. J Am Coll Cardiol 2001; 38:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/15\">",
"      Yong Y, Wu D, Fernandes V, et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002; 89:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/16\">",
"      Shapiro JR, Reisner SA, Lichtenberg GS, Meltzer RS. Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol 1990; 16:1603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/17\">",
"      Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 2009; 53:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/18\">",
"      Leischik R, Kuhlmann C, Bruch C, et al. Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963). Int J Card Imaging 1997; 13:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/19\">",
"      Dolan MS, Riad K, El-Shafei A, et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 2001; 142:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/20\">",
"      Dolan MS, Gala SS, Dodla S, et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol 2009; 53:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/21\">",
"      Schartl M, Beckmann S, Bocksch W, et al. Stress echocardiography in special groups: in women, in left bundle branch block, in hypertension and after heart transplantation. Eur Heart J 1997; 18 Suppl D:D63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/22\">",
"      Takeuchi M, Sonoda S, Miura Y, Kuroiwa A. Comparative diagnostic value of dobutamine stress echocardiography and stress thallium-201 single-photon-emission computed tomography for detecting coronary artery disease in women. Coron Artery Dis 1996; 7:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/23\">",
"      Ho YL, Wu CC, Huang PJ, et al. Assessment of coronary artery disease in women by dobutamine stress echocardiography: comparison with stress thallium-201 single-photon emission computed tomography and exercise electrocardiography. Am Heart J 1998; 135:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/24\">",
"      Elhendy A, van Domburg RT, Bax JJ, et al. Noninvasive diagnosis of coronary artery stenosis in women with limited exercise capacity: comparison of dobutamine stress echocardiography and 99mTc sestamibi single-photon emission CT. Chest 1998; 114:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/25\">",
"      Nagueh SF, Lakkis NM, He ZX, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998; 32:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/26\">",
"      Cheirif J, Desir RM, Bolli R, et al. Relation of perfusion defects observed with myocardial contrast echocardiography to the severity of coronary stenosis: correlation with thallium-201 single-photon emission tomography. J Am Coll Cardiol 1992; 19:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/27\">",
"      Meza MF, Mobarek S, Sonnemaker R, et al. Myocardial contrast echocardiography in human beings: correlation of resting perfusion defects to sestamibi single photon emission computed tomography. Am Heart J 1996; 132:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/28\">",
"      Firschke C, Lindner JR, Goodman NC, et al. Myocardial contrast echocardiography in acute myocardial infarction using aortic root injections of microbubbles in conjunction with harmonic imaging: potential application in the cardiac catheterization laboratory. J Am Coll Cardiol 1997; 29:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/29\">",
"      Porter TR, Li S, Kricsfeld D, Armbruster RW. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J Am Coll Cardiol 1997; 29:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/30\">",
"      Leischik R, Beller KD, Erbel R. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity. Basic Res Cardiol 1996; 91:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/31\">",
"      Marwick TH, Brunken R, Meland N, et al. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators. J Am Coll Cardiol 1998; 32:1260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/32\">",
"      DeMaria AN, Cotter B, Ohmori K. Myocardial contrast echocardiography: too much, too soon? J Am Coll Cardiol 1998; 32:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/33\">",
"      Shimoni S, Zoghbi WA, Xie F, et al. Real-time assessment of myocardial perfusion and wall motion during bicycle and treadmill exercise echocardiography: comparison with single photon emission computed tomography. J Am Coll Cardiol 2001; 37:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/34\">",
"      Jeetley P, Hickman M, Kamp O, et al. Myocardial contrast echocardiography for the detection of coronary artery stenosis: a prospective multicenter study in comparison with single-photon emission computed tomography. J Am Coll Cardiol 2006; 47:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/35\">",
"      Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997; 96:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/36\">",
"      Meza M, Greener Y, Hunt R, et al. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent. Am Heart J 1996; 132:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/37\">",
"      Porter TR, Kricsfeld A, Deligonul U, Xie F. Detection of regional perfusion abnormalities during adenosine stress echocardiography with intravenous perfluorocarbon-exposed sonicated dextrose albumin. Am Heart J 1996; 132:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/38\">",
"      Perchet H, Dupouy P, Duval-Moulin AM, et al. Improvement of subendocardial myocardial perfusion after percutaneous transluminal coronary angioplasty. A myocardial contrast echocardiography study with correlation between myocardial contrast reserve and Doppler coronary reserve. Circulation 1995; 91:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/39\">",
"      Caiati C, Montaldo C, Zedda N, et al. Validation of a new noninvasive method (contrast-enhanced transthoracic second harmonic echo Doppler) for the evaluation of coronary flow reserve: comparison with intracoronary Doppler flow wire. J Am Coll Cardiol 1999; 34:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/40\">",
"      Wei K, Ragosta M, Thorpe J, et al. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echocardiography. Circulation 2001; 103:2560.",
"     </a>",
"    </li>",
"    <li>",
"     Castellanos A, Kessler KM, Myerburg RJ. Frequently Performed Diagnostic and Monitoring Procedures. In: Hurst's The Heart, Schlant RC, Alexander RW, O'Rourke RA, et al (Eds), McGraw-Hill, New York 1994. p.327.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/42\">",
"      Linka AZ, Ates G, Wei K, et al. Three-dimensional myocardial contrast echocardiography: validation of in vivo risk and infarct volumes. J Am Coll Cardiol 1997; 30:1892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/43\">",
"      Sakuma T, Hayashi Y, Sumii K, et al. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998; 32:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/44\">",
"      Wu KC, Kim RJ, Bluemke DA, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998; 32:1756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/45\">",
"      Iliceto S, Galiuto L, Marchese A, et al. Functional role of microvascular integrity in patients with infarct-related artery patency after acute myocardial infarction. Eur Heart J 1997; 18:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/46\">",
"      Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996; 93:1993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/47\">",
"      Asanuma T, Tanabe K, Ochiai K, et al. Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation 1997; 96:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/48\">",
"      Lepper W, Hoffmann R, Kamp O, et al. Assessment of myocardial reperfusion by intravenous myocardial contrast echocardiography and coronary flow reserve after primary percutaneous transluminal coronary angioplasty [correction of angiography] in patients with acute myocardial infarction. Circulation 2000; 101:2368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/49\">",
"      Porter TR, Li S, Oster R, Deligonul U. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction. Am J Cardiol 1998; 82:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/50\">",
"      Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005; 112:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/51\">",
"      Villanueva FS, Abraham JA, Schreiner GF, et al. Myocardial contrast echocardiography can be used to assess the microvascular response to vascular endothelial growth factor-121. Circulation 2002; 105:759.",
"     </a>",
"    </li>",
"    <li>",
"     Kaul S. Myocardial perfusion and other applications of contrast echocardiography. In: Marcus' Cardiac Imaging: A Companion to Braunwald's Heart Disease, Skorton DJ, Schelbert HR, Wolf GL, et al (Eds), WB Saunders, Philadelphia 1996. p.480.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/53\">",
"      Kenner MD, Zajac EJ, Kondos GT, et al. Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up. Am J Cardiol 1995; 76:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/54\">",
"      Ito H, Tomooka T, Sakai N, et al. Time course of functional improvement in stunned myocardium in risk area in patients with reperfused anterior infarction. Circulation 1993; 87:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/55\">",
"      Main ML, Magalski A, Chee NK, et al. Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction. J Am Coll Cardiol 2001; 38:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/56\">",
"      Swinburn JM, Lahiri A, Senior R. Intravenous myocardial contrast echocardiography predicts recovery of dysynergic myocardium early after acute myocardial infarction. J Am Coll Cardiol 2001; 38:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/57\">",
"      Balcells E, Powers ER, Lepper W, et al. Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol 2003; 41:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/58\">",
"      Vernon SM, Camarano G, Kaul S, et al. Myocardial contrast echocardiography demonstrates that collateral flow can preserve myocardial function beyond a chronically occluded coronary artery. Am J Cardiol 1996; 78:958.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/59\">",
"      Sabia PJ, Powers ER, Ragosta M, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992; 327:1825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/60\">",
"      Ragosta M, Camarano G, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography. Circulation 1994; 89:2562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/61\">",
"      Camarano G, Ragosta M, Gimple LW, et al. Identification of viable myocardium with contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. Am J Cardiol 1995; 75:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/62\">",
"      deFilippi CR, Willett DL, Irani WN, et al. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease. Circulation 1995; 92:2863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/63\">",
"      Nagueh SF, Vaduganathan P, Ali N, et al. Identification of hibernating myocardium: comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography. J Am Coll Cardiol 1997; 29:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/64\">",
"      Meza MF, Kates MA, Barbee RW, et al. Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium. J Am Coll Cardiol 1997; 29:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/65\">",
"      Waku S, Ohkubo T, Takada K, et al. Prediction of wall motion improvement after coronary revascularization in patients with postmyocardial infarction: diagnostic value of dobutamine stress echocardiography and myocardial contrast echocardiography. J Cardiol 1997; 30:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/66\">",
"      Shimoni S, Frangogiannis NG, Aggeli CJ, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation 2003; 107:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/67\">",
"      Ling LH, Christian TF, Mulvagh SL, et al. Determining myocardial viability in chronic ischemic left ventricular dysfunction: a prospective comparison of rest-redistribution thallium 201 single-photon emission computed tomography, nitroglycerin-dobutamine echocardiography, and intracoronary myocardial contrast echocardiography. Am Heart J 2006; 151:882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/68\">",
"      Thanigaraj S, Chugh R, Schechtman KB, et al. Defining left ventricular segmental and global function by echocardiographic intraventricular contrast flow patterns. Am J Cardiol 2000; 85:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13145/abstract/69\">",
"      Skyba DM, Price RJ, Linka AZ, et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998; 98:290.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5313 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-109.224.62.197-08224556E3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13145=[""].join("\n");
var outline_f12_53_13145=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H189182\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL APPLICATIONS FOR AGITATED SALINE CONTRAST",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Shunt detection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Doppler signal enhancement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis of persistent left superior vena cava",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL APPLICATIONS FOR MICROBUBBLE CONTRAST AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Endocardial border definition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Rest echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Stress echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Enhancement of Doppler signal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ADDITIONAL APPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Infarct size following alcohol septal ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Myocardial perfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Myocardial viability",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Stunned myocardium",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Intraventricular flow patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Local drug delivery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H189182\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/5313\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5313|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?5/7/5239\" title=\"diagnostic image 1\">",
"      Aprical 4 chamber contrast-enhanced left ventricle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/14/23776\" title=\"diagnostic image 2\">",
"      Apical 4 chamber contrast echo normal LV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/10/10401\" title=\"diagnostic image 3\">",
"      Apical 4 chamber contrast echo LV dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/33/23066?source=related_link\">",
"      Assessment of myocardial viability by nuclear imaging in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/10/25768?source=related_link\">",
"      Attenuation artifact in SPECT radionuclide myocardial perfusion imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/35/8759?source=related_link\">",
"      Clinical syndromes of stunned or hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/22/13672?source=related_link\">",
"      Clinical use of coronary artery pressure and Doppler flow measurements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/49/23318?source=related_link\">",
"      Contrast echocardiography: Contrast agents, safety, and imaging technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/18/15656?source=related_link\">",
"      Dobutamine stress echocardiography in the evaluation of hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14378?source=related_link\">",
"      Echocardiographic evaluation of the tricuspid valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/41/10905?source=related_link\">",
"      Evaluation of hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=related_link\">",
"      Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/48/5896?source=related_link\">",
"      Identification and assessment of atrial septal defects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/43/15034?source=related_link\">",
"      Initial evaluation and management of suspected acute coronary syndrome in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/50/23335?source=related_link\">",
"      Pathophysiology of stunned or hibernating myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/16/29961?source=related_link\">",
"      Primary percutaneous coronary intervention versus fibrinolysis in acute ST elevation myocardial infarction: Clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/32/32263?source=related_link\">",
"      Pulmonary arteriovenous malformations: Diagnostic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/6/11369?source=related_link\">",
"      Role of echocardiography in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/52/27466?source=related_link\">",
"      Stress echocardiography in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/4/6216?source=related_link\">",
"      Therapeutic angiogenesis for management of refractory angina",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_53_13146="The common cold in children: Treatment and prevention";
var content_f12_53_13146=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"7\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The common cold in children: Treatment and prevention",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13146/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13146/contributors\">",
"     Diane E Pappas, MD, JD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13146/contributors\">",
"     J Owen Hendley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13146/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13146/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/53/13146/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/53/13146/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/53/13146/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 7, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H199065117\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common cold is an acute, self-limiting viral infection of the upper respiratory tract, involving, to variable degrees, sneezing, nasal congestion and discharge (rhinorrhea), sore throat, cough, low grade fever, headache, and malaise. It can be caused by members of several families of viruses; the most common are the more than 100 serotypes of rhinoviruses.",
"   </p>",
"   <p>",
"    The common cold is the most frequent human illness. An estimated 25 million individuals seek medical care for uncomplicated upper respiratory tract infections (URI) annually in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Approximately 30 percent of these visits result in a prescription for antibiotics. Inaccurate perceptions that colds are caused by bacteria and that antibiotics improve outcome fuel the number of visits and requests for antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/3\">",
"     3",
"    </a>",
"    ]. Infants and children are affected more often and experience more prolonged symptoms than adults. The common cold accounts for approximately 22 million missed days of school and 20 million absences from work, including parents&rsquo; time away from work while caring for ill children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/2,4\">",
"     2,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The treatment and prevention of the common cold in children will be discussed here. The epidemiology, clinical features, and diagnosis of the common cold in children and the common cold in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link\">",
"     \"The common cold in children: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=see_link\">",
"     \"The common cold in adults: Diagnosis and clinical features\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link\">",
"     \"The common cold in adults: Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199065563\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199067993\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common cold is usually a mild and self-limiting illness. Anticipatory guidance and supportive care are the mainstays of management [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/5\">",
"     5",
"    </a>",
"    ]. There is no role for antibiotics in the absence of bacterial superinfection. Antiviral therapy is not available for most of the viruses that cause the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/6\">",
"     6",
"    </a>",
"    ]. Over-the-counter (OTC) cough and cold medications have no proven efficacy and potential for serious adverse effects (",
"    <a class=\"graphic graphic_table graphicRef67510 \" href=\"UTD.htm?38/42/39598\">",
"     table 1",
"    </a>",
"    ). There is no definitive evidence to indicate that treatment with zinc,",
"    <em>",
"     Echinacea",
"    </em>",
"    <em>",
"     purpurea",
"    </em>",
"    , or vitamin C is beneficial in the treatment of the common cold in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15315677\">",
"    <span class=\"h2\">",
"     Anticipatory guidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticipatory guidance is an important component of the management of the common cold in children and is recommended by the American Academy of Pediatrics (AAP) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7\">",
"     7",
"    </a>",
"    ], the United Kingdom&rsquo;s National Institute for Health and Clinical Excellence [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/8,9\">",
"     8,9",
"    </a>",
"    ], and British Thoracic Guidelines for the assessment and management of cough in children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/6\">",
"     6",
"    </a>",
"    ]. Important aspects of the anticipatory guidance include education about the expected course of illness and reasons to return for reevaluation, supportive measures, the risks and benefits of symptomatic therapy, and prevention of spread.",
"   </p>",
"   <p>",
"    The expected course of illness, supportive measures, and the use of OTC medications are discussed in this section. Prevention of spread is discussed below. (See",
"    <a class=\"local\" href=\"#H199065641\">",
"     'Prevention'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H487569015\">",
"    <span class=\"h3\">",
"     Expected course",
"    </span>",
"    &nbsp;&mdash;&nbsp;In infants and young children, the symptoms of the common cold usually peak on day two to three of illness and then gradually improve over 10 to 14 days (",
"    <a class=\"graphic graphic_figure graphicRef65898 \" href=\"UTD.htm?4/28/4559\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. In a minority of children the cough may linger, but should steadily resolve over three to four weeks. In older children and adolescents, symptoms usually resolve in five to seven days (longer in those with underlying lung disease or who smoke cigarettes) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/2,12,13\">",
"     2,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antibiotics do not alter the course of the common cold and do not prevent secondary complications [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H498160550\">",
"     'Antibiotic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Re-evaluation may be warranted if the symptoms worsen (eg, difficulty breathing or swallowing) or exceed the expected duration. Worsening or persistent symptoms may indicate the development of complications or the need to consider a diagnosis other than the common cold. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H7#H7\">",
"     \"The common cold in children: Clinical features and diagnosis\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H199066646#H199066646\">",
"     \"The common cold in children: Clinical features and diagnosis\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60855888\">",
"    <span class=\"h3\">",
"     Supportive interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Frequently suggested supportive interventions include maintaining adequate fluid intake; ingestion of warm liquids (eg, chicken soup, tea); suctioning the nose and upright positioning (for infants); saline nasal irrigation or sprays (for older children); and the use of cool mist humidifiers or vaporizers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7,16-20\">",
"     7,16-20",
"    </a>",
"    ]. Although most of these interventions have not been studied in randomized trials, they are relatively inexpensive and unlikely to be harmful [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/17,19,21\">",
"     17,19,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Maintaining adequate hydration",
"      </strong>",
"      &ndash; Maintaining adequate hydration may help to thin secretions and soothe the respiratory mucosa [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Ingestion of warm fluids",
"      </strong>",
"      &ndash; The ingestion of warm liquids (eg, apple juice, tea, chicken soup) may have a soothing effect on the respiratory mucosa, may increase the flow of nasal mucus (possibly also mediated by the inhalation of steam), and may loosen respiratory secretions, thereby enhancing their removal [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/18,19,22\">",
"       18,19,22",
"      </a>",
"      ]. Ingestion of warm liquids is a home remedy for the common cold that is shared by people of many cultures [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/23\">",
"       23",
"      </a>",
"      ]. The warmed liquids should be appropriate for the age of the infant or child. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10938?source=see_link&amp;anchor=H5#H5\">",
"       \"Introducing solid foods and vitamin and mineral supplementation during infancy\", section on 'When to initiate complementary foods'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=see_link&amp;anchor=H12#H12\">",
"       \"Dietary recommendations for toddlers, preschool, and school-age children\", section on 'Dietary guidelines'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Topical saline",
"      </strong>",
"      &ndash; We suggest the application of saline to the nasal cavity to temporarily remove bothersome nasal secretions. In infants, this may be accomplished with saline nose drops and a bulb syringe (",
"      <a class=\"graphic graphic_table graphicRef62558 \" href=\"UTD.htm?25/34/26155\">",
"       table 2",
"      </a>",
"      ). In older children, a saline nasal spray or nasal irrigation may be used.",
"      <br/>",
"      <br/>",
"      A 2003 systematic review found that saline nasal irrigation was associated with fewer physician visits and less reliance on other medications [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/24\">",
"       24",
"      </a>",
"      ]. However, the trials were small and several were not controlled. A subsequent open randomized trial compared nasal saline irrigation to standard therapy in 401 children (6 to 10 years of age) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/25\">",
"       25",
"      </a>",
"      ]. The use of saline irrigation was associated with a modest improvement of symptoms, decreased use of other therapies, decreased recurrence of symptoms, and decreased school absence.",
"     </li>",
"     <li>",
"      <strong>",
"       Humidified air",
"      </strong>",
"      &ndash; We suggest the use of a cool mist",
"      <span class=\"nowrap\">",
"       humidifier/vaporizer",
"      </span>",
"      to add moisture to the air to loosen nasal secretions although this treatment is not well studied [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/20,26,27\">",
"       20,26,27",
"      </a>",
"      ]. It is important to counsel caregivers who use cool mist humidifiers to clean the humidifier after each use according to the manufacturer&rsquo;s instructions to minimize the risk of infection or inhalation injury [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/28-30\">",
"       28-30",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      We do not recommend the inhalation of steam or heated humidified air as a treatment for nasal",
"      <span class=\"nowrap\">",
"       congestion/rhinorrhea",
"      </span>",
"      in children with the common cold. Studies evaluating the effects of inhalation of heated humidified air on symptoms of the common cold are inconsistent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/31\">",
"       31",
"      </a>",
"      ]. Although it was hypothesized that inhalation of heated air would decrease rhinovirus replication (because rhinoviruses replicate best at 33 to 34&deg;C), inhalation of heated air was not associated with decreased viral shedding or titers. Inhalation of heated humidified in children may result in burns [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/32\">",
"       32",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The World Health Organization (WHO) suggests that neither steam nor cold mist therapy be used in the management of a cough or cold [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60855895\">",
"    <span class=\"h3\">",
"     Over-the-counter medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of OTC products are marketed for symptomatic relief of the common cold in children. These include antihistamines, decongestants, antitussives, expectorants, mucolytics, antipyretics, and combinations of these medications (",
"    <a class=\"graphic graphic_table graphicRef67510 \" href=\"UTD.htm?38/42/39598\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H199065570\">",
"     'Symptomatic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Education about the risks and benefits of OTC medications is an important component of the anticipatory guidance for children with the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/5,7,17\">",
"     5,7,17",
"    </a>",
"    ]. In randomized trials, systematic reviews, and meta-analyses, OTC medications have not been proven to work any better than placebo in children and may have serious side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/33-41\">",
"     33-41",
"    </a>",
"    ]. We recommend not using OTC medications for the common cold in children younger than six years of age. We also suggest not using OTC medications for the common cold in children 6 to 12 years.",
"   </p>",
"   <p>",
"    OTC cough and cold medications have been associated with fatal overdose in children younger than two years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/42-44\">",
"     42-44",
"    </a>",
"    ]. OTC medications have the potential for enhanced toxicity in young children because metabolism, clearance, and drug effects may vary according to age. Safe dosing recommendations have not been established for children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The United States Food and Drug Administration (FDA) Advisory Committee recommends against the use of OTC cough and cold medications in children younger than six years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. The AAP recommends against the use of OTC cough and cold medications in children younger than four years and highlights the lack of proven efficacy and potential for toxicity for children younger than six years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If parents choose to administer OTC medications to treat the common cold in children older than six years of age, they should be advised to use single-ingredient medications for the most bothersome symptom and be provided with proper dosing instructions to avoid potential toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H199065570\">",
"     'Symptomatic therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H498160550\">",
"    <span class=\"h2\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is",
"    <strong>",
"     no",
"    </strong>",
"    role for antibiotics in the treatment of the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/6\">",
"     6",
"    </a>",
"    ]. Antibiotic therapy does not prevent secondary bacterial infection, may cause significant side effects, and may contribute to increasing bacterial antimicrobial resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. The use of antibiotics should be reserved for clearly diagnosed secondary bacterial infections, including bacterial otitis media, sinusitis, and pneumonia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H7#H7\">",
"     \"The common cold in children: Clinical features and diagnosis\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H498160572\">",
"    <span class=\"h2\">",
"     Antiviral therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiviral therapy is not available for the viruses that cause the common cold with the exception of influenza virus. The clinical features and treatment of influenza with antiviral agents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=see_link&amp;anchor=H20#H20\">",
"     \"Antiviral drugs for the prevention and treatment of seasonal influenza in children\", section on 'Antiviral therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199065570\">",
"    <span class=\"h2\">",
"     Symptomatic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic therapy is the mainstay of common cold treatment. However, symptomatic therapies have associated risks and benefits, particularly in young infants. Symptoms need not be treated unless they bother the child or other family members (eg, interrupting sleep, interfering with drinking, causing discomfort) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15315022\">",
"    <span class=\"h3\">",
"     Discomfort due to fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that discomfort due to fever in the first few days of the common cold be treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    (for children older than three months) or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/48/7946?source=see_link\">",
"     ibuprofen",
"    </a>",
"    (for children older than three months). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18570?source=see_link&amp;anchor=H11#H11\">",
"     \"Pathophysiology and management of fever in infants and children\", section on 'Management of fever'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When suggesting the use of antipyretics and analgesics, it is important for clinicians to counsel caregivers against the concomitant use of combination OTC medications, to avoid overdose from multiple medications that contain the same ingredient (eg,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/15/19705?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22186?source=see_link&amp;anchor=H5084958#H5084958\">",
"     \"Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents\", section on 'Inappropriate dosing by a caregiver'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=see_link&amp;anchor=H39#H39\">",
"     \"Management of acetaminophen (paracetamol) poisoning in children and adolescents\", section on 'Management of chronic poisoning'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15315029\">",
"    <span class=\"h3\">",
"     Nasal congestion and rhinorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal obstruction can interfere with drinking and may be the most bothersome symptom in infants and young children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/17\">",
"     17",
"    </a>",
"    ]. We suggest that nasal congestion and rhinorrhea in children younger than 12 years be treated with nasal suction, saline nasal drops or nasal spray, adequate hydration,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a cool mist humidifier, rather than with OTC medications. The supportive interventions have not been demonstrated to be effective in randomized trials, but they are safe and inexpensive [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H60855888\">",
"     'Supportive interventions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Ipratropium",
"      </strong>",
"      &ndash; Bothersome rhinorrhea in children older than five years of age that has not responded to treatment with supportive measures may be treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/12/35008?source=see_link\">",
"       ipratropium",
"      </a>",
"      nasal spray (0.06% two sprays in each nostril three times per day for four days).",
"      <br/>",
"      <br/>",
"      In a systematic review of seven randomized trials comparing nasal ipratropium with placebo for the treatment of nasal symptoms in patients (children &gt;5 years and adults), ipratropium nasal spray was effective in reducing subjective nasal discharge, but not nasal congestion [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/50\">",
"       50",
"      </a>",
"      ]. Adverse effects (nosebleeds, nasal dryness, mouth dryness) were approximately two to four times as common in patients treated with ipratropium.",
"     </li>",
"     <li>",
"      <strong>",
"       Decongestants",
"      </strong>",
"      &ndash; Decongestants cause vasoconstriction of the nasal mucosa. They are available in oral and topical formulations. Commonly used oral decongestants include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/8/20613?source=see_link\">",
"       pseudoephedrine",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/46/41696?source=see_link\">",
"       phenylephrine",
"      </a>",
"      . Side effects of oral decongestants may include tachycardia, elevated diastolic blood pressure, and palpitations [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/51\">",
"       51",
"      </a>",
"      ]. Commonly used topical decongestants include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/22/35168?source=see_link\">",
"       oxymetazoline",
"      </a>",
"      , xylometazoline, and phenylephrine [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/5\">",
"       5",
"      </a>",
"      ]. Side effects of topical decongestants include nosebleeds and drying of the nasal membranes. Discontinuation of nasal decongestants can result in rebound nasal congestion which is particularly problematic in young infants who are dependent on nasal airflow for respiration [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/5,17\">",
"       5,17",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In a meta-analysis of randomized trials in adults, oral and topical decongestants decreased nasal congestion and increased nasal patency, but there are no studies demonstrating their effectiveness in children younger than 12 years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/36\">",
"       36",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Given the lack of proven benefit and potential for serious side effects, we recommend that decongestants not be used in children younger than six years of age. We also suggest that decongestants not be used in children between 6 and 12 years of age. However, decongestants may be beneficial in the treatment of nasal symptoms in adolescents older than 12 years. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link&amp;anchor=H8#H8\">",
"       \"The common cold in adults: Treatment and prevention\", section on 'Decongestants'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Antihistamines and combination",
"       <span class=\"nowrap\">",
"        antihistamine/decongestants",
"       </span>",
"      </strong>",
"      &ndash; First generation antihistamines (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34256?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/52/25413?source=see_link\">",
"       chlorpheniramine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/23/19830?source=see_link\">",
"       hydroxyzine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/29/39381?source=see_link\">",
"       brompheniramine",
"      </a>",
"      ) are thought to decrease nasal congestion via their anticholinergic properties [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/17\">",
"       17",
"      </a>",
"      ]. Adverse effects of antihistamines include sedation, paradoxic excitability, respiratory depression, and hallucinations.",
"      <br/>",
"      <br/>",
"      We recommend not using antihistamines or combination",
"      <span class=\"nowrap\">",
"       antihistamine/decongestants",
"      </span>",
"      for nasal symptoms in children younger than six years. We also suggest that they not be used in children between 6 and 12 years.",
"      <br/>",
"      <br/>",
"      The anticholinergic effects of the first generation antihistamines may be expected to reduce the secretions associated with the common cold. However, in randomized controlled trials, antihistamines have been ineffective in relieving the symptoms of children with upper respiratory infection, whether administered alone or in combination with decongestants [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/34,37,38\">",
"       34,37,38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Aromatic vapors (for external rub) &ndash;",
"      </strong>",
"      We do not suggest the use of topical aromatic agents (eg, menthol, camphor, eucalyptus oil) for the treatment of nasal congestion in children with the common cold. In a randomized crossover trial comparing menthol and eucalyptus oil in 42 healthy school children, menthol increased the perception of nasal patency, but did not affect spirometry [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15315058\">",
"    <span class=\"h3\">",
"     Cough",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cough may affect the child&rsquo;s sleep, school performance, and ability to play; it also may disturb the sleep of other family members and be disruptive in the classroom [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/6\">",
"     6",
"    </a>",
"    ]. Caregivers frequently seek interventions to suppress cough. However, cough is a physiologic response to airway irritation and functions to clear secretions from the respiratory tract [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19\">",
"     19",
"    </a>",
"    ]. Suppression of cough may result in retention of secretions and potentially harmful airway obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7,19\">",
"     7,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternative diagnoses should be considered (eg, asthma, pertussis, cystic fibrosis, etc) in children who have cough that is more severe or prolonged than expected with the common cold (eg, persists for more than two weeks without improvement or is worsening) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H199066646#H199066646\">",
"     \"The common cold in children: Clinical features and diagnosis\", section on 'Differential diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28088?source=see_link\">",
"     \"Causes of chronic cough in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17561?source=see_link\">",
"     \"Approach to chronic cough in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neither prescription nor OTC medications have proven effective in the treatment of children with cough due to the common cold children in randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/34,39-41\">",
"     34,39-41",
"    </a>",
"    ]. We recommend not using OTC or prescription cough medications in children with the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7,19\">",
"     7,19",
"    </a>",
"    ]. We suggest that airway irritation be relieved with oral hydration, warm fluids (eg, tea, chicken soup), honey (in children older than one year), or cough lozenges or hard candy (in children in whom they are not an aspiration risk). (See",
"    <a class=\"local\" href=\"#H60855888\">",
"     'Supportive interventions'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Lozenges",
"      </strong>",
"      &ndash; There is no evidence from controlled trials to suggest that cough lozenges or hard candy are effective in decreasing cough. However, they are unlikely to be harmful in children for whom they are not an aspiration risk [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19\">",
"       19",
"      </a>",
"      ]. The AAP suggests that cough lozenges or hard candy may be used to coat the irritated throat for children older than six years [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Honey",
"      </strong>",
"      &ndash; Honey has a modest beneficial effect on nocturnal cough and is unlikely to be harmful in children older than one year of age.",
"      <br/>",
"      <br/>",
"      In a randomized trial, 300 children (one to five years of age) with upper respiratory infection and nocturnal cough were assigned to receive a single dose (10 g) of honey (eucalyptus, citrus, or labiatae) or placebo (an extract made from dates with structure, color, and taste similar to honey) before bedtime; caregivers completed a symptom survey on the days before and after the intervention; 270 children completed the study [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/54\">",
"       54",
"      </a>",
"      ]. Symptoms improved in all children after the intervention. However, children who received honey had greater mean improvement in cough frequency (1.77 to 1.85 versus 1.00 points), severity (1.78 to 1.94 versus 0.99 points) and bothersomeness (2.00 to 2.16 versus 1.25 points) than those who received placebo. Adverse effects (abdominal pain, nausea, vomiting) occurred in five patients, approximately evenly distributed among each of the honey and the placebo groups. This placebo-controlled trial is consistent with an earlier meta-analysis of two randomized trials [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/40,55\">",
"       40,55",
"      </a>",
"      ], in which the frequency of cough was slightly reduced with honey compared with no treatment (mean difference -1.07, 95% CI -1.53 to -0.60) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/56\">",
"       56",
"      </a>",
"      ]. However, the meta-analysis was limited because the subjects&rsquo; caregivers were not completely blinded, making it difficult to eliminate significant placebo effect [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/57\">",
"       57",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Given the relative safety and low cost of honey, the WHO and AAP suggest it as a potential treatment for URI in young children who are older than one year (0.5 to 1 tsp [2.5 to 5 mL] as needed); corn syrup can be substituted if honey is unavailable [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19,49\">",
"       19,49",
"      </a>",
"      ]. Honey should be avoided in children younger than one year because of the risk of botulism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link&amp;anchor=H9#H9\">",
"       \"Botulism\", section on 'Infant botulism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Antitussives",
"      </strong>",
"      &ndash; Antitussive agents (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/21/34132?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      ) act on the cough center to depress the cough reflex. Dextromethorphan is available over-the-counter; it does not have analgesic or addictive properties, but because of its euphoric effects is used illicitly as a recreational drug [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/53\">",
"       53",
"      </a>",
"      ]. Both codeine and dextromethorphan have potential toxicities, including respiratory and central nervous system depression [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/60/17353?source=see_link&amp;anchor=H2#H2\">",
"       \"Dextromethorphan poisoning: Epidemiology, pharmacology and clinical features\", section on 'Epidemiology'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=see_link&amp;anchor=H13#H13\">",
"       \"Opioid intoxication in children and adolescents\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      We recommend not using antitussive medications to treat cough in children with the common cold. Their efficacy has not been proven and they have the potential for enhanced toxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7,42\">",
"       7,42",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      In a randomized trial comparing placebo, dextromethorphan, and codeine for treatment of cough of &lt;4 days&rsquo; duration in 49 children (18 months to 12 years), mean parent reported cough score and composite symptom scores decreased in all groups and there were no differences between groups [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/39\">",
"       39",
"      </a>",
"      ]. Similar lack of efficacy was shown in another trial comparing dextromethorphan,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34256?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      , and placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/34\">",
"       34",
"      </a>",
"      ]. Insomnia was reported in 3 of 33 children in the dextromethorphan group and none of the children in the other groups.",
"      <br/>",
"      <br/>",
"      The AAP recommends that the cough associated with respiratory viral infections be treated with fluids and increased ambient humidity rather than antitussives [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/7\">",
"       7",
"      </a>",
"      ]. The WHO guidelines recommend against the use of codeine preparations for cough in children but suggest that dextromethorphan may be warranted in the unusual circumstance when severe prolonged coughing interferes with feeding or sleeping [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19\">",
"       19",
"      </a>",
"      ]. In such cases, a diagnosis other than the common cold should be considered (eg, pertussis, asthma) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/53\">",
"       53",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H199066646#H199066646\">",
"       \"The common cold in children: Clinical features and diagnosis\", section on 'Differential diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28088?source=see_link\">",
"       \"Causes of chronic cough in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17561?source=see_link\">",
"       \"Approach to chronic cough in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Antihistamines",
"      </strong>",
"      &ndash; Antihistamines (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/29/34256?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/52/25413?source=see_link\">",
"       chlorpheniramine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/23/19830?source=see_link\">",
"       hydroxyzine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/29/39381?source=see_link\">",
"       brompheniramine",
"      </a>",
"      ) have anticholinergic effects. Adverse effects of antihistamines include sedation, paradoxic excitability, respiratory depression, and hallucinations.",
"      <br/>",
"      <br/>",
"      We suggest not using antihistamines to treat cough in children with the common cold. They have not been proven to be beneficial and may have serious adverse effects.",
"      <br/>",
"      <br/>",
"      In a randomized trial, 100 children (2 to 18 years of age) with URI and nocturnal cough were assigned to treatment with antihistamine monotherapy (diphenhydramine),",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/21/34132?source=see_link\">",
"       dextromethorphan",
"      </a>",
"      , or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/34\">",
"       34",
"      </a>",
"      ]. Parents assessed the frequency, severity, and bothersome nature of the cough, as well as the cough&rsquo;s impact on the child's sleep on the day of presentation and on the following day (after the medication had been administered). All of the children were improved on the second day. Neither study drug was superior to placebo. Drowsiness was reported in 3 of 33 children in diphenhydramine group and none of the children in the other groups",
"     </li>",
"     <li>",
"      <strong>",
"       Expectorants and mucolytics",
"      </strong>",
"      &ndash; Expectorants (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/5/5204?source=see_link\">",
"       guaifenesin",
"      </a>",
"      ) and mucolytics (eg,",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/41/16022?source=see_link\">",
"       acetylcysteine",
"      </a>",
"      , bromhexine, letosteine) increase mucus production and thin respiratory secretions, respectively, to make the secretions easier to expel [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/41\">",
"       41",
"      </a>",
"      ]. Neither expectorants nor mucolytics are of proven benefit in children [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/17,19,41\">",
"       17,19,41",
"      </a>",
"      ]. By itself, guaifenesin alone is relatively safe, causing only mild gastrointestinal irritation, but in over-the-counter medications guaifenesin is usually combined with other ingredients [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/53\">",
"       53",
"      </a>",
"      ]. Adverse effects of mucolytics include bronchospasm, gastrointestinal disturbance, and fever [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Bronchodilators",
"      </strong>",
"      &ndash; We do not suggest the use of bronchodilators to treat cough in nonasthmatic children with the common cold. Bronchodilators are not effective for acute cough in nonasthmatic children [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/6,58,59\">",
"       6,58,59",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      However, children with asthma who develop a cold should use their bronchodilator rescue agent as indicated according to their asthma action plan. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39670?source=see_link&amp;anchor=H15#H15\">",
"       \"Chronic asthma in children younger than 12 years: Quick-relief agents\", section on 'Summary and recommendations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Aromatic vapors (for external rub) &ndash;",
"      </strong>",
"      We do not suggest the use of topical aromatic agents (eg, menthol, camphor, eucalyptus oil) for the treatment of cough in children with the common cold. There are few high-quality studies of their effectiveness.",
"      <br/>",
"      <br/>",
"      In a randomized trial in 138 children (2 to 11 years), application of a vapor rub combination (camphor, menthol, and eucalyptus oils) was compared with petrolatum and no treatment; outcomes included parent reported nocturnal cough, congestion, and sleep difficulty [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/60\">",
"       60",
"      </a>",
"      ]. In pairwise comparison, vapor rub treatment was more effective than petrolatum and no treatment for the cough severity, child and parent sleep, and combined symptoms score. The vapor rub combination was associated with at least one mild irritant effect in nearly one half of children. Because the study was not well blinded (86 percent of parents applying the vapor rub correctly guessed that they were applying it), the likelihood of a significant placebo effect cannot be eliminated [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/57\">",
"       57",
"      </a>",
"      ]. In addition, parental report of cough must be interpreted with caution; parental reporting of the frequency and severity of cough is unreliable compared with objective measures [",
"      <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/61-63\">",
"       61-63",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H60855102\">",
"    <span class=\"h3\">",
"     Sore throat",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic relief of sore throat in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27224?source=see_link\">",
"     \"Symptomatic relief of sore throat in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15315066\">",
"    <span class=\"h3\">",
"     Middle ear abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of middle ear pressure are common during the common cold, and may predispose to development of acute otitis media. However, in a prospective cross-over study, treatment with a decongestant-antihistamine (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/29/39381?source=see_link\">",
"     brompheniramine",
"    </a>",
"    and phenylpropanolamine) did not prevent the development of acute otitis media [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199065619\">",
"    <span class=\"h2\">",
"     Other remedies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other remedies that have been suggested as treatments for the common cold include zinc,",
"    <em>",
"     Echinacea",
"    </em>",
"    <em>",
"     purpurea",
"    </em>",
"    , and vitamin C.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15314143\">",
"    <span class=\"h3\">",
"     Zinc",
"    </span>",
"    &nbsp;&mdash;&nbsp;We do not suggest zinc for the treatment of the common cold in children. The efficacy of zinc in reducing the duration or severity of cold symptoms in children remains unclear and side effects are common [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The observation that zinc inhibits rhinovirus replication in vitro led to the proposal of zinc as a treatment for the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/5\">",
"     5",
"    </a>",
"    ]. Although several systematic reviews of randomized trials suggest that zinc may shorten the duration of cold symptoms, there was significant heterogeneity among the individual trials [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/65-67\">",
"     65-67",
"    </a>",
"    ]. In a 2012 systematic review and meta-analysis of eight trials (934 participants: 371 adults and 563 children), zinc reduced the duration of symptoms (mean difference -1.65 days, 95% CI -2.5 to -0.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/65\">",
"     65",
"    </a>",
"    ]. In subgroup analysis zinc reduced the duration of symptoms in adults (mean difference -2.63 days, 95% CI -3.69 to -1.58), but not in children (mean difference -0.26 days, 95% CI -0.78 to 0.25). The effects of zinc also differed by formulation (",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?37/56/38787?source=see_link\">",
"     zinc acetate",
"    </a>",
"    was effective; zinc gluconate and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/39/29301?source=see_link\">",
"     zinc sulfate",
"    </a>",
"    were not) and dose of ionic zinc (dose of &ge;75 mg were more effective than lower doses). Adverse effects, including bad taste and nausea, were common and may contribute to the limited usefulness of zinc in children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/65,68\">",
"     65,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Zinc nasal products, including homeopathic intranasal zinc gluconate, have been associated with long-standing or permanent loss of sense of smell and are not recommended for children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/69-71\">",
"     69-71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199068705\">",
"    <span class=\"h3\">",
"     Echinacea purpurea",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest not using",
"    <em>",
"     Echinacea",
"    </em>",
"    <em>",
"     purpurea",
"    </em>",
"    for the treatment of the common cold in children. Several rigorously designed randomized trials and a meta-analysis of randomized trials in adults found that echinacea is no better than placebo for the treatment of upper respiratory infections (URI) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/72-75\">",
"     72-75",
"    </a>",
"    ]. Similarly, a randomized trial in children (age 2 to 11 years) found no differences in the duration or severity of URI symptoms in children treated with echinacea or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/76\">",
"     76",
"    </a>",
"    ]. However, children treated with echinacea had an increased rate of rash (7 versus 2.7 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/63/23542?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical use of echinacea\", section on 'Upper respiratory tract infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199068712\">",
"    <span class=\"h3\">",
"     Vitamin C",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest not using vitamin C for the treatment of the common cold in children. A 2013 meta-analysis of randomized trials found that vitamin C (at least 200",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    initiated after the onset of cold symptoms did not reduce the duration (seven trials, 3249 cold episodes) or severity (four trials, 2708 cold episodes) of cold symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/77\">",
"     77",
"    </a>",
"    ]. No serious adverse effects were reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199065641\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15313690\">",
"    <span class=\"h2\">",
"     Child care and school",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most children with colds need not be excluded from out-of-home child care or school because transmission is likely to have occurred before the child became symptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/78\">",
"     78",
"    </a>",
"    ]. The risk of spread can be decreased by following common sense prevention measures, as discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199068746\">",
"    <span class=\"h2\">",
"     Hand hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best methods for preventing transmission of the common cold are frequent handwashing and avoiding touching one's mouth, nose, and eyes. In observational studies, the use of alcohol-based hand sanitizers and virucidal hand treatments (eg, iodine, salicylic acid, pyroglutamic acid) was associated with decreased transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/79-81\">",
"     79-81",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link&amp;anchor=H4#H4\">",
"     \"The common cold in children: Clinical features and diagnosis\", section on 'Transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cold viruses can be transmitted from the hands to objects in the environment or to other people. To avoid contaminating their hands, children with the common cold can be instructed to cough into a tissue, handkerchief, or the crook of their elbow rather than into their hands.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199068753\">",
"    <span class=\"h2\">",
"     Disinfectants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decontamination of environmental surfaces with virucidal disinfectants such as",
"    <span class=\"nowrap\">",
"     phenol/alcohol",
"    </span>",
"    (eg, Lysol) may help decrease the rate of transmission of cold-inducing viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/82\">",
"     82",
"    </a>",
"    ]. The use of virucidal impregnated nasal tissues also may reduce the transmission of cold viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/83-85\">",
"     83-85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized trial of antibacterial cleaning products versus standard cleaning products in households with at least one preschool child detected no difference in respiratory symptoms (runny nose, cough, sore throat) among household members [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/86\">",
"     86",
"    </a>",
"    ]. However, antibacterial products would not necessarily be expected to be active against viral pathogens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H487570456\">",
"    <span class=\"h2\">",
"     Immunizations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is not an immunization to prevent the common cold. However, there are immunizations to prevent some of the viruses that can cause clinical syndromes similar to common cold. &nbsp;",
"   </p>",
"   <p>",
"    Yearly influenza immunization is recommended for all individuals older than six months to prevent influenza infection and its complications, (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27946?source=see_link&amp;anchor=H7#H7\">",
"     \"Seasonal influenza vaccination in children\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Monthly injection of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/0/40964?source=see_link\">",
"     palivizumab",
"    </a>",
"    (a monoclonal antibody preparation) is recommended to prevent respiratory syncytial virus (RSV) lower respiratory tract infection in high risk infants. Prevention of RSV with palivizumab is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104278856#H104278856\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Immunoprophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H487570534\">",
"    <span class=\"h2\">",
"     Zinc",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review of two randomized trials in 394 children found that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?28/39/29301?source=see_link\">",
"     zinc sulfate",
"    </a>",
"    , taken for a minimum of five months decreased the rate of development of colds (incidence rate ratio 0.64, 95% CI 0.47-0.88), school absence, and antibiotic prescriptions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/66\">",
"     66",
"    </a>",
"    ]. The first trial used zinc sulfate syrup (15 mg per day for 7 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/87\">",
"     87",
"    </a>",
"    ]; the second used zinc sulfate tablets (10 mg per day for five months) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/88\">",
"     88",
"    </a>",
"    ]. Adverse effects included bad taste and nausea. However, given the prolonged duration of prophylactic therapy, we do not suggest zinc sulfate for the prevention of colds in children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H120608612\">",
"    <span class=\"h2\">",
"     Herbal products and vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses have not found conclusive evidence that",
"    <em>",
"     Echinacea",
"    </em>",
"    <em>",
"     purpurea, Allium sativum",
"    </em>",
"    (garlic), or vitamin C (&ge;200 mg per day) prevents the common cold in children [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/72,77,89\">",
"     72,77,89",
"    </a>",
"    ]. However, there is some evidence to suggest that vitamin C prophylaxis may shorten the duration of the common cold in children. In a 2013 meta-analysis of 14 trials (2530 cold episodes), regular use of vitamin C (at least 200",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    by children shortened the duration of the common cold by 14.2 percent (95% CI 7.3 to 21 percent); no serious adverse effects were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?12/53/13146/abstract/77\">",
"     77",
"    </a>",
"    ]. In randomized trials, neither daily nor monthly administration of vitamin D reduced the incidence or severity of the common cold in adults; studies in children are lacking. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=see_link&amp;anchor=H14671002#H14671002\">",
"     \"Vitamin D and extraskeletal health\", section on 'Innate'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=see_link\">",
"       \"Patient information: Giving your child over-the-counter medicines (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=see_link\">",
"       \"Patient information: Cough in children (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40643?source=see_link\">",
"       \"Patient information: The common cold in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H199067770\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common cold is usually a mild and self-limiting illness. Anticipatory guidance and supportive care are the mainstays of management. In infants and young children, the symptoms of usually peak on day two to three of illness and then gradually improve over 10 to 14 days (",
"    <a class=\"graphic graphic_figure graphicRef65898 \" href=\"UTD.htm?4/28/4559\">",
"     figure 1",
"    </a>",
"    ); the cough may linger, but should steadily improve. In older children and adolescents, symptoms usually resolve in five to seven days. Reevaluation may be warranted if the symptoms worsen or exceed the expected duration. (See",
"    <a class=\"local\" href=\"#H487569015\">",
"     'Expected course'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Supportive interventions for the common cold include maintaining adequate hydration; ingestion of warm fluids; the use of saline nose drops, sprays, or irrigation; and the use of a cool mist humidifier. Although supportive interventions have not been proven to be beneficial, they are inexpensive and unlikely to be harmful. (See",
"      <a class=\"local\" href=\"#H60855888\">",
"       'Supportive interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend not using over-the-counter (OTC) cough and cold medications for the treatment of the common cold in children younger than six years (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). We suggest not using OTC cough and cold medications in children six to 12 years of age (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). These medications have no proven benefit for children and potential for serious adverse effects (",
"      <a class=\"graphic graphic_table graphicRef67510 \" href=\"UTD.htm?38/42/39598\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H60855895\">",
"       'Over-the-counter medications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In the absence of secondary bacterial infection, we recommend not using antibiotics for the treatment of the common cold (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Antibiotics neither alter the course nor prevent secondary infections. (See",
"      <a class=\"local\" href=\"#H498160550\">",
"       'Antibiotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptomatic therapy may be warranted if the symptoms bother the child (eg, interrupting sleep, interfering with drinking, causing discomfort) or other family members. (See",
"      <a class=\"local\" href=\"#H199065570\">",
"       'Symptomatic therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest that nasal obstruction in children younger than 12 years be treated with supportive measures (eg, saline nose drops, sprays, or irrigation; maintaining adequate hydration; ingestion of warm fluids;",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a cool mist humidifier) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest not using topical rubs containing aromatic agents (eg, camphor, menthol, eucalyptus) for the treatment of nasal congestion in children with the common cold (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Bothersome rhinorrhea in children older than five years of age that has not responded to treatment with supportive measures may be treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/12/35008?source=see_link\">",
"       ipratropium",
"      </a>",
"      nasal spray (0.06% two sprays in each nostril three times per day for four days). (See",
"      <a class=\"local\" href=\"#H15315029\">",
"       'Nasal congestion and rhinorrhea'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that airway irritation contributing to cough be relieved with oral hydration (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); warm fluids (eg, tea, chicken soup) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ); honey (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      );",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cough lozenges or hard candy (in children in whom they are not an aspiration risk) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We suggest not using topical rubs containing aromatic agents (eg, camphor, menthol, eucalyptus) to treat cough in children with the common cold (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We suggest not using",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/30/32230?source=see_link\">",
"       codeine",
"      </a>",
"      to treat cough in children with the common cold (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Symptomatic relief of sore throat is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27224?source=see_link\">",
"       \"Symptomatic relief of sore throat in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest not using zinc,",
"      <em>",
"       Echinacea",
"      </em>",
"      <em>",
"       purpurea",
"      </em>",
"      , or vitamin C for the treatment of the common cold in children (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H199065619\">",
"       'Other remedies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most children with the common cold need not be excluded from out-of-home child care or school. The risk of spread can be decreased through frequent hand washing and appropriate cough hygiene. (See",
"      <a class=\"local\" href=\"#H199065641\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest not using zinc,",
"      <em>",
"       Echinacea",
"      </em>",
"      <em>",
"       purpurea, Allium sativum",
"      </em>",
"      (garlic), vitamin C, or vitamin D for the prevention of the common cold in children (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H487570534\">",
"       'Zinc'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H120608612\">",
"       'Herbal products and vitamins'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/1\">",
"      Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/2\">",
"      Heikkinen T, J&auml;rvinen A. The common cold. Lancet 2003; 361:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/3\">",
"      Lee GM, Friedman JF, Ross-Degnan D, et al. Misconceptions about colds and predictors of health service utilization. Pediatrics 2003; 111:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/4\">",
"      Bramley TJ, Lerner D, Sames M. Productivity losses related to the common cold. J Occup Environ Med 2002; 44:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/5\">",
"      Pappas DE, Hendley JO. The common cold and decongestant therapy. Pediatr Rev 2011; 32:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/6\">",
"      Shields MD, Bush A, Everard ML, et al. BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax 2008; 63 Suppl 3:iii1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/7\">",
"      Use of codeine- and dextromethorphan-containing cough remedies in children. American Academy of Pediatrics. Committee on Drugs. Pediatrics 1997; 99:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/8\">",
"      Tan T, Little P, Stokes T, Guideline Development Group. Antibiotic prescribing for self limiting respiratory tract infections in primary care: summary of NICE guidance. BMJ 2008; 337:a437.",
"     </a>",
"    </li>",
"    <li>",
"     National Institute for Health and Clinical Excellence. Prescribing of antibiotics for self limiting respiratory tract infections in adults and children in primary care. 2008. (Clinical guideline 69). www.nice.org.uk/guidance/index.jsp?action=download&amp;o=41323 (Accessed on August 31, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/10\">",
"      Hay AD, Wilson AD. The natural history of acute cough in children aged 0 to 4 years in primary care: a systematic review. Br J Gen Pract 2002; 52:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/11\">",
"      Pappas DE, Hendley JO, Hayden FG, Winther B. Symptom profile of common colds in school-aged children. Pediatr Infect Dis J 2008; 27:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/12\">",
"      Aronson MD, Weiss ST, Ben RL, Komaroff AL. Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA 1982; 248:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/13\">",
"      Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Semin Pediatr Infect Dis 1998; 9:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/14\">",
"      Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/15\">",
"      Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev 2005; :CD000247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/16\">",
"      Bell EA, Tunkel DE. Over-the-counter cough and cold medications in children: are they helpful? Otolaryngol Head Neck Surg 2010; 142:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/17\">",
"      Kelly LF. Pediatric cough and cold preparations. Pediatr Rev 2004; 25:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/18\">",
"      Saketkhoo K, Januszkiewicz A, Sackner MA. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 1978; 74:408.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Cough and cold remedies for the treatment of acute respiratory infections in young children, 2001. file://whqlibdoc.who.int/hq/2001/WHO_FCH_CAH_01.02.pdf.",
"    </li>",
"    <li>",
"     Parental instruction sheets. The common cold. In: Textbook of Pediatric Emergency Medicine, 6th, Fleisher GR, Ludwig S.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. p.1894.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/21\">",
"      Gadomski A, Horton L. The need for rational therapeutics in the use of cough and cold medicine in infants. Pediatrics 1992; 89:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/22\">",
"      Sanu A, Eccles R. The effects of a hot drink on nasal airflow and symptoms of common cold and flu. Rhinology 2008; 46:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/23\">",
"      Pfeiffer WF. A multicultural approach to the patient who has a common cold. Pediatr Rev 2005; 26:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/24\">",
"      Papsin B, McTavish A. Saline nasal irrigation: Its role as an adjunct treatment. Can Fam Physician 2003; 49:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/25\">",
"      Slapak I, Skoup&aacute; J, Strnad P, Horn&iacute;k P. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 2008; 134:67.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Caring for a child with a viral infection. file://www.healthychildren.org/English/health-issues/conditions/ear-nose-throat/Pages/Caring-for-a-Child-with-a-Viral-Infection.aspx.",
"    </li>",
"    <li>",
"     Fischer H. Common cold. In: American Academy of Pediatrics Textbook of Pediatric Care, McInerny TK.  (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.1934.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/28\">",
"      Joly JR, D&eacute;ry P, Gauvreau L, et al. Legionnaires' disease caused by Legionella dumoffii in distilled water. CMAJ 1986; 135:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/29\">",
"      Daftary AS, Deterding RR. Inhalational lung injury associated with humidifier \"white dust\". Pediatrics 2011; 127:e509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/30\">",
"      Volpe BT, Sulavik SB, Tran P, Apter A. Hypersensitivity pneumonitis associated with a portable home humidifier. Conn Med 1991; 55:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/31\">",
"      Singh M, Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev 2011; :CD001728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/32\">",
"      Ebrahim MK, Bang RL, Lari AR. Scald accidents during water aerosol inhalation in infants. Burns 1990; 16:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/33\">",
"      Smith MB, Feldman W. Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA 1993; 269:2258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/34\">",
"      Paul IM, Yoder KE, Crowell KR, et al. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics 2004; 114:e85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/35\">",
"      Schroeder K, Fahey T. Should we advise parents to administer over the counter cough medicines for acute cough? Systematic review of randomised controlled trials. Arch Dis Child 2002; 86:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/36\">",
"      Taverner D, Latte J. Nasal decongestants for the common cold. Cochrane Database Syst Rev 2007; :CD001953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/37\">",
"      Hutton N, Wilson MH, Mellits ED, et al. Effectiveness of an antihistamine-decongestant combination for young children with the common cold: a randomized, controlled clinical trial. J Pediatr 1991; 118:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/38\">",
"      Clemens CJ, Taylor JA, Almquist JR, et al. Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children? J Pediatr 1997; 130:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/39\">",
"      Taylor JA, Novack AH, Almquist JR, Rogers JE. Efficacy of cough suppressants in children. J Pediatr 1993; 122:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/40\">",
"      Paul IM, Beiler J, McMonagle A, et al. Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med 2007; 161:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/41\">",
"      Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2012; 8:CD001831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/42\">",
"      Centers for Disease Control and Prevention (CDC). Infant deaths associated with cough and cold medications--two states, 2005. MMWR Morb Mortal Wkly Rep 2007; 56:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/43\">",
"      Dart RC, Paul IM, Bond GR, et al. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med 2009; 53:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/44\">",
"      Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over-the-counter cough and cold medications. Pediatrics 2001; 108:E52.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Food and Drug Administration. Public Health Advisory. Nonprescription cough and cold medicine use in children. FDA recommends that over-the-counter (OTC) cough and cold products not be used for infants and children under 2 years of age. file://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/UCM051137 (Accessed on August 31, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/46\">",
"      Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar--pediatric cough and cold medications. N Engl J Med 2007; 357:2321.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Withdrawal of cold medicines: Addressing parent concerns. file://practice.aap.org/content.aspx?aid=2254 (Accessed on August 23, 2011).",
"    </li>",
"    <li>",
"     Choosing Wisely. American Academy of Pediatrics. file://www.choosingwisely.org/doctor-patient-lists/american-academy-of-pediatrics/ (Accessed on March 07, 2013).",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Coughs and colds: Medicines or home remedies? file://www.healthychildren.org/English/health-issues/conditions/ear-nose-throat/pages/Coughs-and-Colds-Medicines-or-Home-Remedies.aspx (Accessed on August 23, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/50\">",
"      Albalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for the common cold. Cochrane Database Syst Rev 2011; :CD008231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/51\">",
"      Morales-Carpi C, Torres-Chazarra C, Lurbe E, et al. Cold medication containing oral phenylephrine as a cause of hypertension in children. Eur J Pediatr 2008; 167:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/52\">",
"      Kenia P, Houghton T, Beardsmore C. Does inhaling menthol affect nasal patency or cough? Pediatr Pulmonol 2008; 43:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/53\">",
"      Carr BC. Efficacy, abuse, and toxicity of over-the-counter cough and cold medicines in the pediatric population. Curr Opin Pediatr 2006; 18:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/54\">",
"      Cohen HA, Rozen J, Kristal H, et al. Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized, placebo-controlled study. Pediatrics 2012; 130:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/55\">",
"      Shadkam MN, Mozaffari-Khosravi H, Mozayan MR. A comparison of the effect of honey, dextromethorphan, and diphenhydramine on nightly cough and sleep quality in children and their parents. J Altern Complement Med 2010; 16:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/56\">",
"      Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh EE. Honey for acute cough in children. Cochrane Database Syst Rev 2012; 3:CD007094.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/57\">",
"      Eccles R. Importance of placebo effect in cough clinical trials. Lung 2010; 188 Suppl 1:S53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/58\">",
"      Bernard DW, Goepp JG, Duggan AK, et al. Is oral albuterol effective for acute cough in non-asthmatic children? Acta Paediatr 1999; 88:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/59\">",
"      Smucny JJ, Flynn CA, Becker LA, Glazier RH. Are beta2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract 2001; 50:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/60\">",
"      Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics 2010; 126:1092.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/61\">",
"      Archer LN, Simpson H. Night cough counts and diary card scores in asthma. Arch Dis Child 1985; 60:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/62\">",
"      Chang AB, Newman RG, Carlin JB, et al. Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method. Eur Respir J 1998; 11:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/63\">",
"      Falconer A, Oldman C, Helms P. Poor agreement between reported and recorded nocturnal cough in asthma. Pediatr Pulmonol 1993; 15:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/64\">",
"      Randall JE, Hendley JO. A decongestant-antihistamine mixture in the prevention of otitis media in children with colds. Pediatrics 1979; 63:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/65\">",
"      Science M, Johnstone J, Roth DE, et al. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ 2012; 184:E551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/66\">",
"      Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev 2011; :CD001364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/67\">",
"      Hemil&auml; H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J 2011; 5:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/68\">",
"      Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges for treating the common cold in children: a randomized controlled trial. JAMA 1998; 279:1962.",
"     </a>",
"    </li>",
"    <li>",
"     FDA MedWatch. Zicam cold remedy nasal products (Cold Remedy Nasal Gel, Cold Remedy Nasal Swabs, and Cold Remedy Swabs, Kids Size). www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm166996.htm (Accessed on August 30, 2011).",
"    </li>",
"    <li>",
"     file://www.fda.gov/ForConsumers/ConsumerUpdates/ucm166931.htm (Accessed on April 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/71\">",
"      Davidson TM, Smith WM. The Bradford Hill criteria and zinc-induced anosmia: a causality analysis. Arch Otolaryngol Head Neck Surg 2010; 136:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/72\">",
"      Linde K, Barrett B, W&ouml;lkart K, et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2006; :CD000530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/73\">",
"      Turner RB, Bauer R, Woelkart K, et al. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005; 353:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/74\">",
"      Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2004; 164:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/75\">",
"      Barrett B, Brown R, Rakel D, et al. Echinacea for treating the common cold: a randomized trial. Ann Intern Med 2010; 153:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/76\">",
"      Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003; 290:2824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/77\">",
"      Hemil&auml; H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013; 1:CD000980.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Children in out-of-home child care. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th Ed, Pickering LK, Baker CJ, Kimberlin DW, et al.  (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.133.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/79\">",
"      Lee GM, Salomon JA, Friedman JF, et al. Illness transmission in the home: a possible role for alcohol-based hand gels. Pediatrics 2005; 115:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/80\">",
"      Sandora TJ, Taveras EM, Shih MC, et al. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics 2005; 116:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/81\">",
"      Turner RB, Hendley JO. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother 2005; 56:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/82\">",
"      Gwaltney JM Jr, Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol 1982; 116:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/83\">",
"      Dick EC, Hossain SU, Mink KA, et al. Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. J Infect Dis 1986; 153:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/84\">",
"      Farr BM, Hendley JO, Kaiser DL, Gwaltney JM. Two randomized controlled trials of virucidal nasal tissues in the prevention of natural upper respiratory infections. Am J Epidemiol 1988; 128:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/85\">",
"      Longini IM Jr, Monto AS. Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents. A field trial in Tecumseh, Michigan. Am J Epidemiol 1988; 128:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/86\">",
"      Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial. Ann Intern Med 2004; 140:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/87\">",
"      Kurug&ouml;l Z, Akilli M, Bayram N, Koturoglu G. The prophylactic and therapeutic effectiveness of zinc sulphate on common cold in children. Acta Paediatr 2006; 95:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/88\">",
"      Vakili R, Vahedian M, Khodaei GH, Mahmoudi M. Effects of zinc supplementation in occurrence and duration of common cold in school aged children during cold season: a double-blind placebo-controlled trial. Iran J Pediatr 2009; 19:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/53/13146/abstract/89\">",
"      Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. Cochrane Database Syst Rev 2009; :CD006206.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16629 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-210.101.131.232-9BEAA163C5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13146=[""].join("\n");
var outline_f12_53_13146=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H199067770\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199065117\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199065563\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199067993\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15315677\">",
"      Anticipatory guidance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H487569015\">",
"      - Expected course",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H60855888\">",
"      - Supportive interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H60855895\">",
"      - Over-the-counter medications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H498160550\">",
"      Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H498160572\">",
"      Antiviral therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199065570\">",
"      Symptomatic therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15315022\">",
"      - Discomfort due to fever",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15315029\">",
"      - Nasal congestion and rhinorrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15315058\">",
"      - Cough",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H60855102\">",
"      - Sore throat",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15315066\">",
"      - Middle ear abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199065619\">",
"      Other remedies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15314143\">",
"      - Zinc",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H199068705\">",
"      - Echinacea purpurea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H199068712\">",
"      - Vitamin C",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199065641\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15313690\">",
"      Child care and school",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199068746\">",
"      Hand hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H199068753\">",
"      Disinfectants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H487570456\">",
"      Immunizations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H487570534\">",
"      Zinc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H120608612\">",
"      Herbal products and vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H199067770\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/16629\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16629|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/28/4559\" title=\"figure 1\">",
"      Colds symptom profile",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16629|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/42/39598\" title=\"table 1\">",
"      Risks and benefits of cough and cold medications for children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/34/26155\" title=\"table 2\">",
"      Bulb syringe instructions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/7/26746?source=related_link\">",
"      Antiviral drugs for the prevention and treatment of seasonal influenza in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/9/17561?source=related_link\">",
"      Approach to chronic cough in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28088?source=related_link\">",
"      Causes of chronic cough in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/47/39670?source=related_link\">",
"      Chronic asthma in children younger than 12 years: Quick-relief agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/42/22186?source=related_link\">",
"      Clinical manifestations and diagnosis of acetaminophen (paracetamol) poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/63/23542?source=related_link\">",
"      Clinical use of echinacea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/60/17353?source=related_link\">",
"      Dextromethorphan poisoning: Epidemiology, pharmacology and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/0/18441?source=related_link\">",
"      Dietary recommendations for toddlers, preschool, and school-age children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/43/10938?source=related_link\">",
"      Introducing solid foods and vitamin and mineral supplementation during infancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/51/13114?source=related_link\">",
"      Management of acetaminophen (paracetamol) poisoning in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/21/22874?source=related_link\">",
"      Opioid intoxication in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/8/18570?source=related_link\">",
"      Pathophysiology and management of fever in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/7/13427?source=related_link\">",
"      Patient information: Cough in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=related_link\">",
"      Patient information: Giving your child over-the-counter medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?39/44/40643?source=related_link\">",
"      Patient information: The common cold in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/18/27946?source=related_link\">",
"      Seasonal influenza vaccination in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27224?source=related_link\">",
"      Symptomatic relief of sore throat in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/55/24440?source=related_link\">",
"      The common cold in adults: Diagnosis and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=related_link\">",
"      The common cold in adults: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=related_link\">",
"      The common cold in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=related_link\">",
"      Vitamin D and extraskeletal health",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_53_13147="Aminoglycoside dosing";
var content_f12_53_13147=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50722&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50722&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Once-daily aminoglycoside dose and dosing interval adjustments for renal function",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Creatinine clearance (mL/min/70 kg)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Initial and maintenance dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dosing interval (hour)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;120",
"       </td>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Use traditional intermittent dosing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60 to 119",
"       </td>",
"       <td>",
"        <p>",
"         7 mg/kg (based on dosing weight)",
"        </p>",
"        <p>",
"         Infuse over 1 hour",
"        </p>",
"       </td>",
"       <td>",
"        24",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40 to 59",
"       </td>",
"       <td>",
"        <p>",
"         7 mg/kg (based on dosing weight)",
"        </p>",
"        <p>",
"         Infuse over 1 hour",
"        </p>",
"       </td>",
"       <td>",
"        36 (or use traditional intermittent dosing)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;40",
"       </td>",
"       <td colspan=\"2\" rowspan=\"1\">",
"        Use traditional intermittent dosing",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13147=[""].join("\n");
var outline_f12_53_13147=null;
var title_f12_53_13148="Pathophysiology and therapy of AIHA";
var content_f12_53_13148=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F55710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F55710&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laboratory characteristics, pathophysiology, and therapy for primary autoimmune hemolytic anemia observed in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Parameter",
"       </td>",
"       <td class=\"subtitle1\">",
"        Warm-reactive AIHA",
"       </td>",
"       <td class=\"subtitle1\">",
"        Paroxysmal cold hemoglobinuria",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cold agglutinin disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoantibody isotype",
"       </td>",
"       <td>",
"        IgG",
"       </td>",
"       <td>",
"        IgG",
"       </td>",
"       <td>",
"        IgM",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Optimal thermal reactivity",
"       </td>",
"       <td>",
"        Warm",
"       </td>",
"       <td>",
"        Cold",
"       </td>",
"       <td>",
"        Cold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ability to fix complement",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive DAT (Coombs test)",
"       </td>",
"       <td>",
"        IgG, &plusmn; C3",
"       </td>",
"       <td>",
"        C3, &plusmn; IgG",
"       </td>",
"       <td>",
"        C3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythrocyte autoantigen",
"       </td>",
"       <td>",
"        Rh, others",
"       </td>",
"       <td>",
"        P",
"       </td>",
"       <td>",
"        I or i",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type of hemolysis*",
"       </td>",
"       <td>",
"        Extravascular",
"       </td>",
"       <td>",
"        Intravascular",
"       </td>",
"       <td>",
"        Both",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        First-line therapy",
"       </td>",
"       <td>",
"        Corticosteroids",
"       </td>",
"       <td>",
"        Avoidance of cold",
"       </td>",
"       <td>",
"        Avoidance of cold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Secondary therapy",
"       </td>",
"       <td>",
"        Splenectomy, Rituximab&bull;",
"       </td>",
"       <td>",
"        Corticosteroids",
"       </td>",
"       <td>",
"        Plasmapheresis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AIHA: autoimmune hemolytic anemia; IgG: immunoglobulin G; IgM: immunoglobulin M; DAT: direct antiglobulin test (Coombs test); C3: complement.",
"     <br>",
"      * Extravascular or intravascular hemolysis.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       This is an off-label use of rituximab.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Russell E Ware, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13148=[""].join("\n");
var outline_f12_53_13148=null;
var title_f12_53_13149="Red flags chronic abdominal pain";
var content_f12_53_13149=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64859&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64859&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Red flags in children and adolescents with chronic abdominal pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Red flags for comorbid psychologic condition",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Multiple somatic complaints",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Change in academic performance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Excessive fatigue",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sleep disturbance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Poor concentration",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Family history of anxiety or depression",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Symptoms of depression",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Dysphoria",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Anhedonia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Recurrent thoughts of death",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Sleep or appetite disruption",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Feelings of hopelessness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Recurrent thoughts of death",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Sleep or appetite disruption",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Red flags for comorbid psychologic condition (cont.)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Symptoms of anxiety",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Excessive worry",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Motor restlessness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Hypervigilance",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Fear of separation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Fears of humiliation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1_start\">",
"            Signs of anxiety",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Tachycardia",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Palpitations",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Tremulousness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Dizziness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Lightheadedness",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Diaphoresis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"sublist1\">",
"            Excessive nausea",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Red flags for abnormal illness behavior",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Disability disproportionate to detectable disease",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Excessive school absence",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Placement of responsibility for symptom control and functional outcomes with the physician",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Evaluation by multiple specialists",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Internalizing personality",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Evidence of parental overinvolvement, enmeshment, or hostility",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Few peer relationships; difficulty socializing",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Boyle JT, Hamel-Lambert J. Pediatr Ann 2001; 30:32.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13149=[""].join("\n");
var outline_f12_53_13149=null;
var title_f12_53_13150="Risk factors ERCP pancreatitis";
var content_f12_53_13150=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58237&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk factors for post-ERCP pancreatitis identified by multivariate analysis in large studies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Author",
"       </td>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Object of the study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Post-procedure pancreatitis rate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Independent risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Freeman et al 1996",
"       </td>",
"       <td rowspan=\"5\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"5\">",
"        Endoscopic biliary sphincterotomy",
"       </td>",
"       <td rowspan=\"5\">",
"        2347 patients",
"       </td>",
"       <td rowspan=\"5\">",
"        5.4 percent",
"       </td>",
"       <td>",
"        Suspected sphincter of Oddi dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Younger age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Precut sphincterotomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficult cannulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Number of pancreatic contrast injections",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Loperfido et al 1998",
"       </td>",
"       <td rowspan=\"3\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"3\">",
"        Therapeutic ERCP",
"       </td>",
"       <td rowspan=\"3\">",
"        1827 patients",
"       </td>",
"       <td rowspan=\"3\">",
"        1.6 percent*",
"       </td>",
"       <td>",
"        Small bile duct",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age under 70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic opacification",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Rabenstein et al 2000",
"       </td>",
"       <td rowspan=\"2\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"2\">",
"        Endoscopic sphincterotomy",
"       </td>",
"       <td rowspan=\"2\">",
"        438 patients",
"       </td>",
"       <td rowspan=\"2\">",
"        4.3 percent",
"       </td>",
"       <td>",
"        Sphincterotomy rate of the endoscopist (&lt;40 per year)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreas divisum",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Masci et al 2001",
"       </td>",
"       <td rowspan=\"3\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"3\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"3\">",
"        2444 procedures",
"       </td>",
"       <td rowspan=\"3\">",
"        1.8 percent",
"       </td>",
"       <td>",
"        Age under 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Precut sphincterotomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Failed clearance of biliary stones",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"9\">",
"        Freeman et al 2001",
"       </td>",
"       <td rowspan=\"9\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"9\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"9\">",
"        1963 procedures",
"       </td>",
"       <td rowspan=\"9\">",
"        6.7 percent",
"       </td>",
"       <td>",
"        Prior post-ERCP pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Suspected dysfunction of sphincter of Oddi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Female sex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal serum bilirubin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Absence of chronic pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biliary sphincter balloon dilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficult cannulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic sphincterotomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 or more injections of contrast into the pancreatic duct",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Vandervoort et al 2002",
"       </td>",
"       <td rowspan=\"6\">",
"        Prospective single center study",
"       </td>",
"       <td rowspan=\"6\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"6\">",
"        1223 patients",
"       </td>",
"       <td rowspan=\"6\">",
"        7.2 percent",
"       </td>",
"       <td>",
"        Recurrent pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prior post-ERCP pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficult cannulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pancreatic brush cytology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain during procedure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Precut sphincterotomy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Christensen et al 2004",
"       </td>",
"       <td rowspan=\"3\">",
"        Prospective single center study",
"       </td>",
"       <td rowspan=\"3\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"3\">",
"        1177 patients",
"       </td>",
"       <td rowspan=\"3\">",
"        3.8 percent",
"       </td>",
"       <td>",
"        Age under 40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dilated bile duct",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placement of stent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Cheng et al 2006",
"       </td>",
"       <td rowspan=\"6\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"6\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"6\">",
"        1115 patients",
"       </td>",
"       <td rowspan=\"6\">",
"        15.1 percent",
"       </td>",
"       <td>",
"        Minor papilla sphincterotomy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sphincter of Oddi dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prior post-ERCP pancreatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age under 70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2 or more injections of contrast into the pancreatic duct",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trainee involvement",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Cheon et al 2007",
"       </td>",
"       <td rowspan=\"2\">",
"        Prospective single center study",
"       </td>",
"       <td rowspan=\"2\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"2\">",
"        14,331 procedures",
"       </td>",
"       <td rowspan=\"2\">",
"        4.0 percent",
"       </td>",
"       <td>",
"        Extent of pancreatic opacification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sphincter of Oddi dysfunction with manometry",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Williams et al 2008",
"       </td>",
"       <td rowspan=\"4\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"4\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"4\">",
"        4561 patients",
"       </td>",
"       <td rowspan=\"4\">",
"        1.6 percent",
"       </td>",
"       <td>",
"        Female sex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Younger age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficult cannulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Performance in a district (as opposed to university)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Wang et al 2009",
"       </td>",
"       <td rowspan=\"5\">",
"        Prospective multicenter study",
"       </td>",
"       <td rowspan=\"5\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"5\">",
"        2691 patients",
"       </td>",
"       <td rowspan=\"5\">",
"        4.3 percent",
"       </td>",
"       <td>",
"        Female sex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age under 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficult cannulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;1 pancreatic deep wire pass",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Precut sphincterotomy",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Cotton et al 2009",
"       </td>",
"       <td rowspan=\"2\">",
"        Retrospective single center study",
"       </td>",
"       <td rowspan=\"2\">",
"        Diagnostic and therapeutic ERCP",
"       </td>",
"       <td rowspan=\"2\">",
"        11,497 procedures",
"       </td>",
"       <td rowspan=\"2\">",
"        2.6 percent",
"       </td>",
"       <td>",
"        Pancreatogram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sphincter of Oddi dysfunction",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Moderate to severe pancreatitis.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13150=[""].join("\n");
var outline_f12_53_13150=null;
var title_f12_53_13151="TEE bicaval view pacemaker wire vegetation";
var content_f12_53_13151=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/81420/teepwend_conv.mp4?title=TEE+bicaval+view+pacemaker+wire+vegetation\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transesophageal echocardiogram (TEE) bicaval view showing a vegetation on pacemaker wire suggesting endocarditis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 266px; height: 201px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transesophageal echocardiogram shows a large vegetation on a pacemaker electrode suggesting an infected wire.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_53_13151=[""].join("\n");
var outline_f12_53_13151=null;
